View Filing Data

Print Document View Excel Document

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2016	Jan. 31, 2017	Jun. 30, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	IMAX Corporation
Entity Central Index Key	0000921582
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 1,700.7
Entity Common Stock Shares Outstanding		66,313,034
Trading Symbol	IMAX

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Assets
Cash and cash equivalents	$ 204,759	$ 317,449
Accounts receivable, net of allowance for doubtful accounts of $1,250 (December 31, 2015 - $1,146)	96,349	97,981
Financing receivables (notes 4 and 19(c))	122,125	117,231
Inventories (note 5)	42,121	38,753
Prepaid expenses	6,626	6,498
Film assets (note 6)	16,522	14,571
Property, plant and equipment (note 7)	245,415	218,267
Other assets (notes 8 and 19(e))	33,195	26,136
Deferred income taxes (note 9)	20,779	25,766
Other intangible assets (note 10)	30,416	28,950
Goodwill	39,027	39,027
Total assets	857,334	930,629
Liabilities
Bank indebtedness (note 11)	27,316	29,276
Accounts payable	19,990	23,455
Accrued and other liabilities (notes 6, 12, 13, 14(c), 19(b), 19(d), 20 and 22)	93,208	95,748
Deferred revenue	90,266	104,993
Total liabilities	230,780	253,472
Commitments and contingencies (notes 12 and 13)
Non-controlling interests
Non-controlling interests (note 21)	4,980	3,307
Shareholders' equity
Capital stock (note 14) common shares - no par value. Authorized - unlimited number. 66,224,467 - issued and 66,159,902 - outstanding (December 31, 2015 - 69,673,244 - issued and outstanding)	439,213	448,310
Less: Treasury stock, 64,565 shares at cost (December 31, 2015 - nil)	(1,939)	0
Other equity	177,304	163,094
Accumulated (deficit) earnings	(47,366)	19,930
Accumulated other comprehensive loss	(5,200)	(7,443)
Total shareholders' equity attributable to common shareholders	562,012	623,891
Non-controlling interests (note 21)	59,562	49,959
Total shareholder's equity	621,574	673,850
Total liabilities and shareholders' equity	$ 857,334	$ 930,629

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Assets
Allowance for doubtful accounts	$ 1,250	$ 1,146
Shareholders' equity
Common stock, share issued	66,224,467	69,673,244
Common stock, share outstanding	66,159,902	69,673,244
Number of treasury shares held in trust	64,565	0

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues
Equipment and product sales (note 15(c))	$ 122,382	$ 118,937	$ 78,705
Services (note 15(c))	166,862	161,964	142,607
Rentals (note 15(c))	77,315	83,651	60,705
Finance income	9,500	9,112	8,524
Other (note 15(a))	1,275	141	0
Revenues	377,334	373,805	290,541
Costs and expenses applicable to revenues (note 2(m))
Equipment and product sales	69,680	63,635	36,997
Services (note 15(c))	83,780	70,855	62,228
Rentals	21,086	20,027	17,928
Other	110	0	0
Cost and expenses applicable to revenues, total	174,656	154,517	117,153
Gross margin	202,678	219,288	173,388
Selling, general and administrative expenses (note 15(b)) (including share-based compensation expense of $30.5 million, $21.9 million and $15.1 million for 2016, 2015 and 2014, respectively)	124,745	115,345	93,260
Research and development	16,315	12,730	16,096
Amortization of intangibles	2,079	1,860	1,724
Receivable provisions, net of recoveries (note 16)	954	752	918
Asset impairments (notes 7 and 19(e))	417	830	3,520
Income from operations	58,168	87,771	57,870
Interest income	1,490	968	405
Interest expense (note 9(g))	(1,805)	(1,661)	(924)
Income from operations before income taxes	57,853	87,078	57,351
Provision for income taxes	(16,212)	(20,052)	(14,466)
Loss from equity-accounted investments, net of tax	(2,321)	(2,402)	(1,071)
Income from continuing operations	39,320	64,624	41,814
Income from discontinued operations, net of tax	0	0	355
Net income	39,320	64,624	42,169
Less: net income attributable to non-controlling interests (note 21)	(10,532)	(8,780)	(2,433)
Net income attributable to common shareholders	$ 28,788	$ 55,844	$ 39,736
Net income per share attributable to common shareholders - basic and diluted: (note 14(d))
Net income per share from continuing operations - basic	$ 0.43	$ 0.79	$ 0.57
Net income per share from discontinued operations - basic	0.00	0.00	0.01
Net income per share - basic	0.43	0.79	0.58
Net income per share from continuing operations - diluted	0.42	0.78	0.56
Net income per share from discontinued operations - diluted	0.00	0.00	0.00
Net income per share - diluted	$ 0.42	$ 0.78	$ 0.56

Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Consolidated Statements of Operations [Abstract]
Compensation expense	$ 30.5	$ 21.9	$ 15.1

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Income And Comprehensive Income [Abstract]
Net income	$ 39,320	$ 64,624	$ 42,169
Unrealized defined benefit plan actuarial gain (loss) (note 20(a))	159	180	(857)
Unrealized postretirement benefit plans actuarial gain (loss) (notes 20(c) and 20(d))	184	79	(574)
Amortization of postretirement benefit plan actuarial loss (gain) (note 20(c))	69	135	(32)
Unrealized net gain (loss) from cash flow hedging instruments (note 19(d))	1,049	(5,881)	(2,524)
Realization of cash flow hedging net loss upon settlement (note 19(d))	3,078	3,217	1,186
Foreign currency translation adjustments (note 2)	(2,851)	(2,121)	(259)
Other-than-temporary impairment of available-for-sale investment	0	0	350
Other comprehensive income (loss), before tax	1,688	(4,391)	(2,710)
Income tax (expense) benefit related to other comprehensive (loss) income (note 9(h))	(1,180)	511	750
Other comprehensive income (loss), net of tax	508	(3,880)	(1,960)
Comprehensive income	39,828	60,744	40,209
Less: Comprehensive income attributable to non-controlling interests	(8,797)	(9,196)	(2,491)
Comprehensive income attributable to common shareholders	$ 31,031	$ 51,548	$ 37,718

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating Activities
Net income	$ 39,320	$ 64,624	$ 42,169
Income from discontinued operations, net of tax	0	0	(355)
Adjustments to reconcile net income to cash from operations:
Depreciation and amortization (notes 17(c) and 18(a))	46,485	42,803	33,756
Write-downs, net of recoveries (notes 17(d) and 18(a))	5,940	3,725	5,294
Change in deferred income taxes	4,940	(1,336)	627
Stock and other non-cash compensation	31,586	22,379	15,467
Unrealized foreign currency exchange loss	462	785	1,180
Loss from equity-accounted investments	2,685	3,838	1,774
Gain on non-cash contribution to equity-accounted investees	(364)	(1,436)	(703)
Investment in film assets	(22,308)	(15,119)	(19,233)
Changes in other non-cash operating assets and liabilities (note 17(a))	(30,874)	(36,058)	6,357
Net cash provided by operating activities from discontinued operations	0	0	572
Net cash provided by operating activities	77,872	84,205	86,905
Investing Activities
Purchase of property, plant and equipment	(15,278)	(43,257)	(40,104)
Investment in joint revenue sharing equipment	(42,910)	(28,474)	(16,838)
Investment in new business ventures	(1,911)	(2,000)	(2,500)
Proceeds from sale of business venture	0	0	507
Acquisition of other intangible assets	(4,787)	(5,065)	(2,918)
Net cash used in investing activities	(64,886)	(78,796)	(61,853)
Financing Activities
Increase in bank indebtedness (note 11)	0	25,290	4,710
Repayment of bank indebtedness (note 11)	(2,000)	(333)	0
Repurchase of common shares	(116,518)	(34,276)	(3,063)
Settlement of restricted share units and options	(17,889)	(10,000)	(790)
Exercise of stock options (note 14(b))	13,113	35,609	10,834
Taxes paid on secondary sales and repatriation dividend	(2,443)	0	0
Treasury stock repurchased for future settlement of restricted share units	(1,996)	0	0
Taxes withheld and paid on employee stock awards vested	(528)	(520)	(300)
Issuance of subsidiary shares to non-controlling interests - private offering	2,479	40,000	44,551
Share issuance costs from the issuance of subsidiary shares to non-controlling interests - private offering	0	(2,000)	(3,556)
Issuance of subsidiary shares to non-controlling interests - public offering	0	178,226	0
Share issuance expenses - public offering	0	(16,257)	0
Dividends paid to non-controlling interests	0	(9,511)	0
Credit facility amendment fees paid	0	(1,533)	(427)
Net cash (used in) provided by financing activities	(125,782)	204,695	51,959
Effects of exchange rate changes on cash	106	842	(54)
(Decrease) increase in cash and cash equivalents during year	(112,690)	210,946	76,957
Cash and cash equivalents, beginning of year	317,449	106,503	29,546
Cash and cash equivalents, end of year	$ 204,759	$ 317,449	$ 106,503

Consolidated Statements of Shareholder's Equity - USD ($) $ in Thousands	Total	Common Shares Issued and Outstanding [Member]	Capital Stock [Member]	Other Equity [Member]	Acumulated (Deficit) Earnings [Member]	Accumulated Other Comprehensive (Loss) [Member]	Non-controlling Interests [Member]
Movement of Shareholders Equity
Balance as at	$ 319,585		$ 327,313	$ 36,452	$ (43,051)	$ (1,129)	$ 0
Common stock, share outstanding		67,841,233
Net income	42,169				42,169
Other comprehensive income (loss), net of tax	(1,960)					(1,960)
Other comprehensive (loss) income, net of tax	(2,710)
Other comprehensive loss attributable to a non-controlling interest (note 21(a))	(58)					(58)
Net income attributable to non-controlling interests	(2,433)				(2,433)
Paid-in-capital for non-employee stock options granted (note 14(c))	$ 149			149
Employee stock options exercised (note 14(b))	1,149,587	1,116,586
Employee stock options exercised (note 14(b))	$ 10,550		14,810	(4,260)
Non-employee stock options exercised		33,001
Non-employee stock options exercised	283		448	(165)
Paid-in-capital for employee stock options granted (note 14(c))	9,275			9,275
Restricted share units vested (net of shares withheld for tax) (note 14(c))	$ (312)		2,836	(3,148)
Restricted share units vested (net of shares withheld for tax) (note 14(c))	109,264	109,264
Restricted share units vested and issued to employees purchased on open market	$ (790)			(790)
Repurchase of common shares	(3,063)		(545)		(2,518)
Repurchase of common shares		(112,034)
Accretion charges associated with redeemable common stock	(426)				(426)
Utilization of windfall tax benefits from vested restricted share units and expensed stock options (note 9(f))	4,026			4,026
Issuance of subsidiary shares, initial public offering	0
Share issuance expenses, initial public offering	0
Dividends paid (note 21)	0
Income tax expense (recovery) related to other comprehensive income (loss) (note 9(h))	(750)
Income tax (expense) benefit related to other comprehensive (loss) income (note 9(h))	750
Balance as at	382,775		344,862	47,319	(6,259)	(3,147)	0
Common stock, share outstanding		68,988,050
Paid-in capital for restricted share units granted (note 14(c))	5,780			5,780
Net income	64,624				64,624
Other comprehensive income (loss), net of tax	(3,880)					(4,296)
Other comprehensive (loss) income, net of tax	(4,391)						416
Net income attributable to non-controlling interests	(8,780)				(8,780)		9,113
Net (Income) Loss Attributable To Noncontrolling Interest Film Fund	333
Paid-in-capital for non-employee stock options granted (note 14(c))	$ 81			81
Employee stock options exercised (note 14(b))	1,761,675	1,650,643
Employee stock options exercised (note 14(b))	$ 35,478		49,756	(14,278)
Non-employee stock options exercised		9,000
Non-employee stock options exercised	131		206	(75)
Paid-in-capital for employee stock options granted (note 14(c))	12,225			12,225
Restricted share units vested (net of shares withheld for tax) (note 14(c))	$ (525)		626	(1,151)
Restricted share units vested (net of shares withheld for tax) (note 14(c))	25,551	25,551
Restricted share units vested and issued to employees purchased on open market	$ (6,203)			(6,203)
Stock option exercises settled from treasury shares purchased on open market	(3,797)			(3,797)
Repurchase of common shares	$ (34,276)		(5,390)		(28,886)
Repurchase of common shares	1,000,000	(1,000,000)
Accretion charges associated with redeemable common stock	$ (769)				(769)
Utilization of windfall tax benefits from vested restricted share units and expensed stock options (note 9(f))	529			529
Issuance of subsidiary shares, initial public offering	178,226		71,291	106,935
Share issuance expenses, initial public offering	(16,257)		(13,041)	(3,216)
Dividends paid (note 21)	(9,511)						(9,511)
Tax impact of sale of subsidiary shares in initial public offering	(12,450)			(12,450)
Reduction in non-controlling interest value upon qualified initial public offering	0			29,100			(29,100)
Conversion of Class C Shares upon initial public ofering	79,041						79,041
Income tax expense (recovery) related to other comprehensive income (loss) (note 9(h))	(511)
Income tax (expense) benefit related to other comprehensive (loss) income (note 9(h))	$ 511
Shares held in treasury	0
Balance as at	$ 673,850		448,310	163,094	19,930	(7,443)	49,959
Common stock, share outstanding	69,673,244	69,673,244
Paid-in capital for restricted share units granted (note 14(c))	$ 8,075			8,075
Shares held in treasury	0
Net income	39,320				39,320
Other comprehensive income (loss), net of tax	508					2,243
Other comprehensive (loss) income, net of tax	1,688						(1,735)
Net income attributable to non-controlling interests	(10,532)				(10,532)		11,338
Net (Income) Loss Attributable To Noncontrolling Interest Film Fund	806
Paid-in-capital for non-employee stock options granted (note 14(c))	$ 30			30
Employee stock options exercised (note 14(b))	518,018	347,814
Employee stock options exercised (note 14(b))	$ 8,292		11,431	(3,139)
Fair value of stock options exercised at the grant date	3,139		3,139
Paid-in-capital for employee stock options granted (note 14(c))	13,766			13,766
Restricted share units vested (net of shares withheld for tax) (note 14(c))	$ (13,533)		1,198	(14,731)
Restricted share units vested (net of shares withheld for tax) (note 14(c))	54,159	52,631
Stock option exercises settled from treasury shares purchased on open market	$ (5,224)			(5,224)
Repurchase of common shares	$ (116,518)		(24,865)		(91,653)
Repurchase of common shares	3,849,222	(3,849,222)
Accretion charges associated with redeemable common stock	$ 0
Issuance of subsidiary shares, initial public offering	0
Share issuance expenses, initial public offering	0
Dividends paid (note 21)	0
Income tax expense (recovery) related to other comprehensive income (loss) (note 9(h))	1,180
Income tax (expense) benefit related to other comprehensive (loss) income (note 9(h))	$ (1,180)
Shares held in treasury	(64,565)	(64,565)
Balance as at	$ 621,574		437,274	177,304	(47,366)	$ (5,200)	$ 59,562
Common stock, share outstanding	66,159,902	66,159,902.00
Retrospective adjustment related to forfeiture rates (note 3)	$ 900			5,331	$ (4,431)
Paid-in capital for restricted share units granted (note 14(c))	16,493			16,493
Cash received from the issuance of common shares in excess of par value	1,684			$ 1,684
Shares held in treasury	$ (1,939)		$ (1,939)

Description of the Business	12 Months Ended
Description of the Business	Dec. 31, 2016
Description of Business [Abstract]
Description of the Business [Text Block]	1. Description of the Business IMAX Corporation, together with its consolidated subsidiaries (the “Company”), is an entertainment technology company specializing in digital and film-based motion picture technologies, whose principal activities are the: design, manufacture, sale and lease of proprietary theater systems for IMAX theaters principally owned and operated by commercial and institutional customers located in 75 countries as at December 31, 2016; production, digital re-mastering, post-production and/or distribution of certain films shown throughout the IMAX theater network; provision of other services to the IMAX theater network, including ongoing maintenance and extended warranty services for IMAX theater systems; operation of certain theaters primarily in the United States; and other activities, which includes short-term rental of cameras and aftermarket sales of projector system components. The Company refers to all theaters using the IMAX theater system as “IMAX theaters.” The Company’s revenues from equipment and product sales include the sale and sales-type leasing of its theater systems and sales of their associated parts and accessories, contingent rentals on sales-type leases and contingent additional payments on sales transactions. The Company’s revenues from services include the provision of maintenance and extended warranty services, digital re-mastering services, film production and film post-production services, film distribution, and the operation of certain theaters. The Company’s rentals include revenues from the leasing of its theater systems that are operating leases, contingent rentals on operating leases, joint revenue sharing arrangements and the rental of the Company’s cameras and camera equipment. The Company’s finance income represents interest income arising from the sales-type leases and financed sales of the Company’s theater systems. The Company’s other revenues include the settlement of contractual obligations with customers.

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Significant Accounting Policies [Text Block]

2. Summary of Significant Accounting Policies

Significant accounting policies are summarized as follows:

The Company prepares its consolidated financial statements in accordance with U.S. GAAP.

Basis of Consolidation

The consolidated financial statements include the accounts of the Company together with its consolidated subsidiaries, except for subsidiaries which the Company has identified as variable interest entities (“VIEs”) where the Company is not the primary beneficiary.

The Company has evaluated its various variable interests to determine whether they are VIEs as required by the Consolidation Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC” or “Codification”).

The Company has 11 film production companies that are VIEs. For five of the Company’s film production companies, the Company has determined that it is the primary beneficiary of these entities as the Company has the power to direct the activities of the respective VIE that most significantly impact the respective VIE's economic performance and has the obligation to absorb losses of the VIE that could potentially be significant to the respective VIE or the right to receive benefits from the respective VIE that could potentially be significant to the respective VIE. These consolidated production companies have total assets of $10.3 million (December 31, 2015 — $7.2 million) and total liabilities of $6.4 million as at December 31, 2016 (December 31, 2015 — $4.1 million). The majority of these consolidated assets are held by the IMAX Original Film Fund (the “Film Fund”) as described in note 21(b). For the other six film production companies which are VIEs, the Company did not consolidate these film entities since it does not have the power to direct activities and does not absorb the majority of the expected losses or expected residual returns. The Company equity accounts for these entities. As at December 31, 2016, these six VIEs have total assets and total liabilities of $0.4 million (December 31, 2015 — $0.4 million). Earnings of the investees included in the Company’s consolidated statement of operations amounted to $nil in 2016 (2015 — $nil). The carrying value of these investments in VIEs that are not consolidated is $nil at December 31, 2016 (December 31, 2015 — $nil). A loss in value of an investment other than a temporary decline is recognized as a charge to the consolidated statement of operations. The Company’s exposure, which is determined based on the level of funding contributed by the Company and the development stage of the respective film, is $nil at December 31, 2016 (2015 — $nil).

The Company accounts for investments in new business ventures using the guidance of the FASB ASC 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”) and ASC 320 “Investments in Debt and Equity Securities” (“ASC 320”), as appropriate.

All intercompany accounts and transactions, including all unrealized intercompany profits on transactions with equity-accounted investees, have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could be materially different from these estimates. Significant estimates made by management include, but are not limited to: selling prices associated with the individual elements in multiple element arrangements; residual values of leased theater systems; economic lives of leased assets; allowances for potential uncollectibility of accounts receivable, financing receivables and net investment in leases; provisions for inventory obsolescence; ultimate revenues for film assets; impairment provisions for film assets, long-lived assets and goodwill; depreciable lives of property, plant and equipment; useful lives of intangible assets; pension plan assumptions; accruals for contingencies including tax contingencies; valuation allowances for deferred income tax assets; and, estimates of the fair value of stock-based payment awards.

Cash and Cash Equivalents

The Company considers all highly liquid investments convertible to a known amount of cash and with an original maturity to the Company of three months or less to be cash equivalents.

Accounts Receivable and Financing Receivables

Allowances for doubtful accounts receivable are based on the Company’s assessment of the collectibility of specific customer balances, which is based upon a review of the customer’s credit worthiness, past collection history and the underlying asset value of the equipment, where applicable. Interest on overdue accounts receivable is recognized as income as the amounts are collected.

For trade accounts receivable that have characteristics of both a contractual maturity of one year or less, and arose from the sale of other goods or services, the Company charges off the balance against the allowance for doubtful accounts when it is known that a provided amount will not be collected.

The Company monitors the performance of the theaters to which it has leased or sold theater systems which are subject to ongoing payments. When facts and circumstances indicate that there is a potential impairment in the net investment in lease or a financing receivable, the Company will evaluate the potential outcome of either a renegotiation involving changes in the terms of the receivable or defaults on the existing lease or financed sale agreements. The Company will record a provision if it is considered probable that the Company will be unable to collect all amounts due under the contractual terms of the arrangement or a renegotiated lease amount will cause a reclassification of the sales-type lease to an operating lease.

When the net investment in lease or the financing receivable is impaired, the Company will recognize a provision for the difference between the carrying value in the investment and the present value of expected future cash flows discounted using the effective interest rate for the net investment in the lease or the financing receivable. If the Company expects to recover the theater system, the provision is equal to the excess of the carrying value of the investment over the fair value of the equipment.

When the minimum lease payments are renegotiated and the lease continues to be classified as a sales-type lease, the reduction in payments is applied to reduce unearned finance income.

These provisions are adjusted when there is a significant change in the amount or timing of the expected future cash flows or when actual cash flows differ from cash flow previously expected.

Once a net investment in lease or financing receivable is considered impaired, the Company does not recognize interest income until the collectibility issues are resolved. When finance income is not recognized, any payments received are applied against outstanding gross minimum lease amounts receivable or gross receivables from financed sales. Once the collectibility issues are resolved, the Company will once again commence the recognition of interest income.

Inventories

Inventories are carried at the lower of cost, determined on an average cost basis, and net realizable value except for raw materials, which are carried at the lower of cost and replacement cost. Finished goods and work-in-process include the cost of raw materials, direct labor, theater design costs, and an applicable share of manufacturing overhead costs.

The costs related to theater systems under sales and sales-type lease arrangements are relieved from inventory to costs and expenses applicable to revenues-equipment and product sales when revenue recognition criteria are met. The costs related to theater systems under operating lease arrangements and joint revenue sharing arrangements are transferred from inventory to assets under construction in property, plant and equipment when allocated to a signed joint revenue sharing arrangement or when the arrangement is first classified as an operating lease.

The Company records provisions for excess and obsolete inventory based upon current estimates of future events and conditions, including the anticipated installation dates for the current backlog of theater system contracts, technological developments, signings in negotiation, growth prospects within the customers’ ultimate marketplace and anticipated market acceptance of the Company’s current and pending theater systems.

Finished goods inventories can contain theater systems for which title has passed to the Company’s customer (as the theater system has been delivered to the customer) but the revenue recognition criteria as discussed in note 2(m) have not been met.

Film Assets

Costs of producing films, including labor, allocated overhead, capitalized interest, and costs of acquiring film rights are recorded as film assets and accounted for in accordance with Entertainment-Films Topic of the FASB ASC. Production financing provided by third parties that acquire substantive rights in the film is recorded as a reduction of the cost of the production. Film assets are amortized and participation costs are accrued using the individual-film-forecast method in the same ratio that current gross revenues bear to current and anticipated future ultimate revenues. Estimates of ultimate revenues are prepared on a title-by-title basis and reviewed regularly by management and revised where necessary to reflect the most current information. Ultimate revenues for films include estimates of revenue over a period not to exceed ten years following the date of initial release.

Film exploitation costs, including advertising costs, are expensed as incurred.

Costs, including labor and allocated overhead, of digitally re-mastering films where the copyright is owned by a third party and the Company shares in the revenue of the third party are included in film assets. These costs are amortized using the individual-film-forecast method in the same ratio that current gross revenues bear to current and anticipated future ultimate revenues from the re-mastered film.

The recoverability of film assets is dependent upon commercial acceptance of the films. If events or circumstances indicate that the recoverable amount of a film asset is less than the unamortized film costs, the film asset is written down to its fair value. The Company determines the fair value of its film assets using a discounted cash flow model.

Property, Plant and Equipment

Property, plant and equipment are recorded at cost and are depreciated on a straight-line basis over their estimated useful lives as follows:

Theater system components(1)	—	over the equipment’s anticipated useful life (7 to 20 years)
Camera equipment	—	5 to 10 years
Buildings	—	20 to 25 years
Office and product equipment	—	3 to 5 years
Leasehold improvements	—	over the shorter of the initial term of the underlying leases plus any
		reasonably assured renewal terms, and the useful life of the asset

______________

(1)	Includes equipment under joint revenue sharing arrangements.

Equipment and components allocated to be used in future operating leases and joint revenue sharing arrangements, as well as direct labor costs and an allocation of direct production costs, are included in assets under construction until such equipment is installed and in working condition, at which time the equipment is depreciated on a straight-line basis over the lesser of the term of the joint revenue sharing arrangement and the equipment’s anticipated useful life.

The Company reviews the carrying values of its property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. Assets are grouped at the lowest level for which identifiable cash flows are largely independent when testing for, and measuring for, impairment. In performing its review of recoverability, the Company estimates the future cash flows expected to result from the use of the asset or asset group and its eventual disposition. If the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset or asset group, an impairment loss is recognized in the consolidated statements of operations. Measurement of the impairment loss is based on the excess of the carrying amount of the asset or asset group over the fair value calculated using discounted expected future cash flows.

A liability for the fair value of an asset retirement obligation associated with the retirement of tangible long-lived assets and the associated asset retirement costs are recognized in the period in which the liability and costs are incurred if a reasonable estimate of fair value can be made using a discounted cash flow model. The associated asset retirement costs are capitalized as part of the carrying amount of the long-lived asset and subsequently amortized over the asset’s useful life. The liability is accreted over the period to expected cash outflows.

Other Assets

Other assets include prepaid taxes, insurance recoverable, deferred charges on debt financing, deferred selling costs that are direct and incremental to the acquisition of sales contracts, foreign currency derivatives, lease incentives and various investments.

Costs of debt financing are deferred and amortized over the term of the debt using the effective interest method.

Selling costs related to an arrangement incurred prior to recognition of the related revenue are deferred and expensed to costs and expenses applicable to revenues upon: (i) recognition of the contract’s theater system revenue; or (ii) abandonment of the sale arrangement.

Foreign currency derivatives are accounted for at fair value using quoted prices in closed exchanges (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy).

The Company may provide lease incentives to certain exhibitors which are essential to entering into the respective lease arrangement. Lease incentives include payments made to or on behalf of the exhibitor. These lease incentives are recognized as a reduction in rental revenue on a straight-line basis over the term of the lease.

Investments in new business ventures are accounted for using ASC 323 as described in note 2(a). The Company currently accounts for its joint venture investment with TCL Multimedia Technology Holdings Limited (“TCL”), using the equity method of accounting. The Company accounts for in-kind contributions to its equity investment in accordance with ASC 845 “Non-Monetary Transactions” (“ASC 845”) whereby if the fair value of the asset or assets contributed is greater than the carrying value a partial gain shall be recognized.

The Company’s investment in debt securities is classified as an available-for-sale investment in accordance with ASC 320. Unrealized holding gains and losses for this investment is excluded from earnings and reported in other comprehensive income until realized. Realization occurs upon sale of a portion of or the entire investment. The investment is impaired if the fair value is less than cost, which is assessed in each reporting period. When the Company intends to sell a specifically identified beneficial interest, a write-down for other-than-temporary impairment shall be recognized in earnings.

The Company’s investment in preferred shares, which meets the criteria for classification as an equity security in accordance with ASC 325, is accounted for at cost. The Company records the related warrants at fair value upon recognition date. Warrants are recognized over the term of the agreement.

Goodwill

Goodwill represents the excess of purchase price over the fair value of net identifiable assets acquired in a purchase business combination. Goodwill is not subject to amortization and is tested for impairment annually or more frequently if events or circumstances indicate that the asset might be impaired. The Company performs a qualitative assessment of its reporting units and certain select quantitative calculations against its current long range plan to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount. The Company first assesses certain qualitative factors to determine whether the existence of events or circumstances leads to determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, the Company determines it is not more likely than not that the fair value of a reporting unit is less than its carry amount, then performing the two-step impairment test is unnecessary. When necessary, impairment of goodwill is tested at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit. The fair value of the reporting unit is estimated using a discounted cash flow approach. If the carrying amount of the reporting unit exceeds its fair value, then a second step is performed to measure the amount of impairment loss, if any, by comparing the fair value of each identifiable asset and liability in the reporting unit to the total fair value of the reporting unit. Any impairment loss is expensed in the consolidated statement of operations and is not reversed if the fair value subsequently increases.

Other Intangible Assets

Patents, trademarks and other intangibles are recorded at cost and are amortized on a straight-line basis over estimated useful lives ranging from 4 to 10 years except for intangible assets that have an identifiable pattern of consumption of the economic benefit of the asset, which are amortized over the consumption pattern.

The Company reviews the carrying values of its other intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. Assets are grouped at the lowest level for which identifiable cash flows are largely independent when testing for, and measuring for, impairment. In performing its review for recoverability, the Company estimates the future cash flows expected to result from the use of the asset or asset group and its eventual disposition. If the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset or asset group, an impairment loss is recognized in the consolidated statement of operations. Measurement of the impairment loss is based on the excess of the carrying amount of the asset or asset group over the fair value calculated using discounted expected future cash flows.

Deferred Revenue

Deferred revenue represents cash received prior to revenue recognition criteria being met for theater system sales or leases, film contracts, maintenance and extended warranty services, film related services and film distribution.

Income Taxes

Income taxes are accounted for under the liability method whereby deferred income tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the accounting and tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates or laws is recognized in the consolidated statement of operations in the period in which the change is enacted. Investment tax credits are recognized as a reduction of income tax expense.

The Company assesses realization of deferred income tax assets and, based on all available evidence, concludes whether it is more likely than not that the net deferred income tax assets will be realized. A valuation allowance is provided for the amount of deferred income tax assets not considered to be realizable.

The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional tax expense based upon the outcomes of such matters. In addition, when applicable, the Company adjusts tax expense to reflect the Company’s ongoing assessments of such matters which require judgment and can materially increase or decrease its effective rate as well as impact operating results. The Company provides for such exposures in accordance with the Income Taxes Topic of the FASB ASC.

Revenue Recognition

Multiple Element Arrangements

The Company’s revenue arrangements with certain customers may involve multiple elements consisting of a theater system (projector, sound system, screen system and, if applicable, 3D glasses cleaning machine); services associated with the theater system including theater design support, supervision of installation, and projectionist training; a license to use of the IMAX brand; 3D glasses; maintenance and extended warranty services; and licensing of films. The Company evaluates all elements in an arrangement to determine what are considered deliverables for accounting purposes and which of the deliverables represent separate units of accounting based on the applicable accounting guidance in the Leases Topic of the FASB ASC; the Guarantees Topic of the FASB ASC; the Entertainment – Films Topic of FASB ASC; and the Revenue Recognition Topic of the FASB. If separate units of accounting are either required under the relevant accounting standards or determined to be applicable under the Revenue Recognition Topic, the total consideration received or receivable in the arrangement is allocated based on the applicable guidance in the above noted standards.

Theater Systems

The Company has identified the projection system, sound system, screen system and, if applicable, 3D glasses cleaning machine, theater design support, supervision of installation, projectionist training and the use of the IMAX brand to be a single deliverable and a single unit of accounting (the “System Deliverable”). When an arrangement does not include all the elements of a System Deliverable, the elements of the System Deliverable included in the arrangement are considered by the Company to be a single deliverable and a single unit of accounting. The Company is not responsible for the physical installation of the equipment in the customer’s facility; however, the Company supervises the installation by the customer. The customer has the right to use the IMAX brand from the date the Company and the customer enter into an arrangement.

The Company’s System Deliverable arrangements involve either a lease or a sale of the theater system. Consideration for the System Deliverable, other than for those delivered pursuant to joint revenue sharing arrangements, consist of upfront or initial payments made before and after the final installation of the theater system equipment and ongoing payments throughout the term of the lease or over a period of time, as specified in the arrangement. The ongoing payments are the greater of an annual fixed minimum amount or a certain percentage of the theater box-office. Amounts received in excess of the annual fixed minimum amounts are considered contingent payments. The Company’s arrangements are non-cancellable, unless the Company fails to perform its obligations. In the absence of a material default by the Company, there is no right to any remedy for the customer under the Company’s arrangements. If a material default by the Company exists, the customer has the right to terminate the arrangement and seek a refund only if the customer provides notice to the Company of a material default and only if the Company does not cure the default within a specified period.

For arrangements entered into or materially modified after January 1, 2011, consideration is allocated to each unit of accounting based on the unit’s relative selling prices. The Company uses vender-specific objective evidence of selling price (VSOE) when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. VSOE is established for the Company’s System Deliverable, maintenance and extended warranty services and film license arrangements. The Company uses a best estimate of selling price (BESP) for units of accounting that do not have VSOE or third party evidence of selling price. The Company determines BESP for a deliverable by considering multiple factors including the Company’s historical pricing practices, product class, market competition and geography.

Sales Arrangements

For arrangements qualifying as sales, the revenue allocated to the System Deliverable is recognized in accordance with the Revenue Recognition Topic of the FASB ASC, when all of the following conditions have been met: (i) the projector, sound system and screen system have been installed and are in full working condition, (ii) the 3D glasses cleaning machine, if applicable, has been delivered, (iii) projectionist training has been completed and (iv) the earlier of (a) receipt of written customer acceptance certifying the completion of installation and run-in testing of the equipment and the completion of projectionist training or (b) public opening of the theater, provided there is persuasive evidence of an arrangement, the price is fixed or determinable and collectibility is reasonably assured.

The initial revenue recognized consists of the initial payments received and the present value of any future initial payments and fixed minimum ongoing payments that have been attributed to this unit of accounting. Contingent payments in excess of the fixed minimum ongoing payments are recognized when reported by theater operators, provided collectibility is reasonably assured.

The Company has also agreed, on occasion, to sell equipment under lease or at the end of a lease term. Consideration agreed to for these lease buyouts is included in revenues from equipment and product sales, when persuasive evidence of an arrangement exists, the fees are fixed or determinable, collectibility is reasonably assured and title to the theater system passes from the Company to the customer.

Lease Arrangements

The Company uses the Leases Topic of FASB ASC to evaluate whether an arrangement is a lease within the scope of the accounting standard. Arrangements not within the scope of the accounting standard are accounted for either as a sales or services arrangement, as applicable.

For lease arrangements, the Company determines the classification of the lease in accordance with the Lease Topic of FASB ASC. A lease arrangement that transfers substantially all of the benefits and risks incident to ownership of the equipment is classified as a sales-type lease based on the criteria established by the accounting standard; otherwise the lease is classified as an operating lease. Prior to commencement of the lease term for the equipment, the Company may modify certain payment terms or make concessions. If these circumstances occur, the Company reassesses the classification of the lease based on the modified terms and conditions.

For sales-type leases, the revenue allocated to the System Deliverable is recognized when the lease term commences, which the Company deems to be when all of the following conditions have been met: (i) the projector, sound system and screen system have been installed and are in full working condition; (ii) the 3D glasses cleaning machine, if applicable, has been delivered; (iii) projectionist training has been completed; and (iv) the earlier of (a) receipt of the written customer acceptance certifying the completion of installation and run-in testing of the equipment and the completion of projectionist training or (b) public opening of the theater, provided collectibility is reasonably assured.

The initial revenue recognized for sales-type leases consists of the initial payments received and the present value of future initial payments and fixed minimum ongoing payments computed at the interest rate implicit in the lease. Contingent payments in excess of the fixed minimum payments are recognized when reported by theater operators, provided collectibility is reasonably assured.

For operating leases, initial payments and fixed minimum ongoing payments are recognized as revenue on a straight-line basis over the lease term. For operating leases, the lease term is considered to commence when all of the following conditions have been met: (i) the projector, sound system and screen system have been installed and in full working condition; (ii) the 3D glasses cleaning machine, if applicable, has been delivered; (iii) projectionist training has been completed; and (iv) the earlier of (a) receipt of written customer acceptance certifying the completion of installation and run-in testing of the equipment and the completion of projectionist training or (b) public opening of the theater. Contingent payments in excess of fixed minimum ongoing payments are recognized as revenue when reported by theater operators, provided collectibility is reasonably assured.

Revenues from joint revenue sharing arrangements with upfront payments that qualify for classification as sales and sales-type leases are recognized in accordance with the sales and sales-type lease criteria discussed above. Contingent revenues from joint revenue sharing arrangements are recognized as box-office results and concessions revenues are reported by the theater operator, provided collectibility is reasonably assured.

Finance Income

Finance income is recognized over the term of the sales-type lease or financed sales receivable, provided collectibility is reasonably assured. Finance income recognition ceases when the Company determines that the associated receivable is not collectible.

Finance income is suspended when the Company identifies a theater that is delinquent, non-responsive or not negotiating in good faith with the Company. Once the collectibility issues are resolved the Company will resume recognition of finance income.

Improvements and Modifications

Improvements and modifications to the theater system after installation are treated as separate revenue transactions, if and when the Company is requested to perform these services. Revenue is recognized for these services when the performance of the services has been completed, provided there is persuasive evidence of an arrangement, the fee is fixed or determinable and collectibility is reasonably assured.

Cost of Equipment and Product Sales

Theater systems and other equipment subject to sales-type leases and sales arrangements includes the cost of the equipment and costs related to project management, design, delivery and installation supervision services as applicable. The costs related to theater systems under sales and sales-type lease arrangements are relieved from inventory to costs and expenses applicable to revenues-equipment and product sales when revenue recognition criteria are met. In addition, the Company defers direct selling costs such as sales commissions and other amounts related to these contracts until the related revenue is recognized. These costs included in costs and expenses applicable to revenues-equipment and product sales, totaled $3.3 million in 2016 (2015 – $3.4 million, 2014 – $2.5 million). The cost of equipment and product sales prior to direct selling costs was $66.5 million in 2016 (2015 – $60.2 million, 2014 – $34.5 million). The Company may have warranty obligations at or after the time revenue is recognized which require replacement of certain parts that do not affect the functionality of the theater system or services. The costs for warranty obligations for known issues are accrued as charges to costs and expenses applicable to revenues-equipment and product sales at the time revenue is recognized based on the Company’s past historical experience and cost estimates.

Cost of Rentals

For theater systems and other equipment subject to an operating lease or placed in a theater operators’ venue under a joint revenue sharing arrangement, the cost of equipment and those costs that result directly from and are essential to the arrangement, is included within property, plant and equipment. Depreciation and impairment losses, if any, are included in cost of rentals based on the accounting policy set out in note 2(g). Commissions are recognized as costs and expenses applicable to revenues-rentals in the month they are earned, which is typically the month of installation. These costs totaled $1.8 million in 2016 (2015 – $1.1 million, 2014 – $1.1 million). Direct advertising and marketing costs for each theater are charged to costs and expenses applicable to revenues-rentals as incurred. These costs totaled $0.9 million in 2016 (2015 – $1.9 million, 2014 – $1.5 million).

Terminations, Consensual Buyouts and Concessions

The Company enters into theater system arrangements with customers that contain customer payment obligations prior to the scheduled installation of the theater system. During the period of time between signing and the installation of the theater system, which may extend several years, certain customers may be unable to, or may elect not to, proceed with the theater system installation for a number of reasons including business considerations, or the inability to obtain certain consents, approvals or financing. Once the determination is made that the customer will not proceed with installation, the arrangement may be terminated under the default provisions of the arrangement or by mutual agreement between the Company and the customer (a “consensual buyout”). Terminations by default are situations when a customer does not meet the payment obligations under an arrangement and the Company retains the amounts paid by the customer. Under a consensual buyout, the Company and the customer agree, in writing, to a settlement and to release each other of any further obligations under the arrangement or an arbitrated settlement is reached. Any initial payments retained or additional payments received by the Company are recognized as revenue when the settlement arrangements are executed and the cash is received, respectively. These termination and consensual buyout amounts are recognized in Other revenues.

In addition, the Company could agree with customers to convert their obligations for other theater system configurations that have not yet been installed to arrangements to acquire or lease the IMAX digital theater system. The Company considers these situations to be a termination of the previous arrangement and origination of a new arrangement for the IMAX digital theater system. For all arrangements entered into or modified prior to the date of adoption of the amended FASB ASC 605-25, the Company continues to defer an amount of any initial fees received from the customer such that the aggregate of the fees deferred and the net present value of the future fixed initial and ongoing payments to be received from the customer equals the selling price of the IMAX digital theater system to be leased or acquired by the customer. Any residual portion of the initial fees received from the customer for the terminated theater system is recorded in other revenues at the time when the obligation for the original theater system is terminated and the new theater system arrangement is signed. Under the amended FASB ASC 605-25, for all arrangements entered into or materially modified after the date of adoption, the total arrangement consideration to be received is allocated on a relative selling price basis to the digital upgrade and the termination of the previous theater system. The arrangement consideration allocated to the termination of the existing arrangement is recorded in Other revenues at the time when the obligation for the original theater system is terminated and the new theater system arrangement is signed.

The Company may offer certain incentives to customers to complete theater system transactions including payment concessions or free services and products such as film licenses or 3D glasses. Reductions in, and deferral of, payments are taken into account in determining the sales price either by a direct reduction in the sales price or a reduction of payments to be discounted in accordance with the Leases or Interests Topic of the FASB ASC. Free products and services are accounted for as separate units of accounting. Other consideration given by the Company to customers are accounted for in accordance with the Revenue Recognition Topic of the FASB ASC.

Maintenance and Extended Warranty Services

Maintenance and extended warranty services may be provided under a multiple element arrangement or as a separately priced contract. Revenues related to these services are deferred and recognized on a straight-line basis over the contract period and are recognized in Services revenues. Maintenance and extended warranty services includes maintenance of the customer’s equipment and replacement parts. Under certain maintenance arrangements, maintenance services may include additional training services to the customer’s technicians. All costs associated with this maintenance and extended warranty program are expensed as incurred. A loss on maintenance and extended warranty services is recognized if the expected cost of providing the services under the contracts exceeds the related deferred revenue.

Film Production and IMAX DMR Services

In certain film arrangements, the Company produces a film financed by third parties whereby the third party retains the copyright and the Company obtains exclusive distribution rights. Under these arrangements, the Company is entitled to receive a fixed fee or to retain as a fee the excess of funding over cost of production (the “production fee”). The third parties receive a portion of the revenues received by the Company from distributing the film, which is charged to costs and expenses applicable to revenues-services. The production fees are deferred, and recognized as a reduction in the cost of the film based on the ratio of the Company’s distribution revenues recognized in the current period to the ultimate distribution revenues expected from the film. Film exploitation costs, including advertising and marketing totaled $17.5 million in 2016 (2015 — $13.3 million, 2014 — $7.1 million) and are recorded in costs and expenses applicable to revenues-services as incurred.

Revenue from film production services where the Company does not hold the associated distribution rights are recognized in Services revenues when performance of the contractual service is complete, provided there is persuasive evidence of an agreement, the fee is fixed or determinable and collectibility is reasonably assured.

Revenues from digitally re-mastering (IMAX DMR) films where third parties own or hold the copyrights and the rights to distribute the film are derived in the form of processing fees and recoupments calculated as a percentage of box-office receipts generated from the re-mastered films. Processing fees are recognized as Services revenues when the performance of the related re-mastering service is completed provided there is persuasive evidence of an arrangement, the fee is fixed or determinable and collectibility is reasonably assured. Recoupments, calculated as a percentage of box-office receipts, are recognized as Services revenue when box-office receipts are reported by the third party that owns or holds the related film rights, provided collectibility is reasonably assured.

Losses on film production and IMAX DMR services are recognized as costs and expenses applicable to revenues-services in the period when it is determined that the Company’s estimate of total revenues to be realized by the Company will not exceed estimated total production costs to be expended on the film production and the cost of IMAX DMR services.

Film Distribution

Revenue from the licensing of films is recognized in Services revenues when persuasive evidence of a licensing arrangement exists, the film has been completed and delivered, the license period has begun, the fee is fixed or determinable and collectibility is reasonably assured. When license fees are based on a percentage of box-office receipts, revenue is recognized when box-office receipts are reported by exhibitors, provided collectibility is reasonably assured. Film exploitation costs, including advertising and marketing, totaled an expense of $2.2 million in 2016 (2015 — recovery of $0.1 million, 2014 — expense of $0.6 million) and are recorded in costs and expenses applicable to revenues-services as incurred.

Film Post-Production Services

Revenues from post-production film services are recognized in Services revenues when performance of the contracted services is complete provided there is persuasive evidence of an arrangement, the fee is fixed or determinable and collectibility is reasonably assured.

Other

The Company recognizes revenue in Services revenues from its owned and operated theaters resulting from box-office ticket and concession sales as tickets are sold, films are shown and upon the sale of various concessions. The sales are cash or credit card transactions with theater goers based on fixed prices per seat or per concession item.

In addition, the Company enters into commercial arrangements with third party theater owners resulting in the sharing of profits and losses which are recognized in Services revenues when reported by such theaters. The Company also provides management services to certain theaters and recognizes revenue over the term of such services.

Revenues on camera rentals are recognized in Rental revenues over the rental period.

Revenue from the sale of 3D glasses is recognized in Equipment and product sales revenue when the 3D glasses have been delivered to the customer.

Other service revenues are recognized in Service revenues when the performance of contracted services is complete.

Research and Development

Research and development costs are expensed as incurred and primarily include projector and sound parts, labor, consulting fees, allocation of overheads and other related materials which pertain to the Company’s development of ongoing product and services. Research and development costs pertaining to fixed and intangible assets that have alternative future uses are capitalized and amortized under their related policies.

Foreign Currency Translation

Monetary assets and liabilities of the Company’s operations which are denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the end of the period. In 2013, the Company determined that the functional currency of one of its consolidated subsidiaries had changed from the Company’s reporting currency to the currency of the nation in which it is domiciled. As a result, in accordance with the FASB ASC 830 “Foreign Currency Matters”, the adjustment attributable to current-rate translation of non-monetary assets as of the date of the change was reported in other comprehensive income (“OCI”). The functional currency of its other consolidated subsidiaries continues to be the United States dollar. Foreign exchange translation gains and losses are included in the determination of earnings in the period in which they arise.

Foreign currency derivatives are recognized and measured in the balance sheet at fair value. Changes in the fair value (gains or losses) are recognized in the consolidated statement of operations except for derivatives designated and qualifying as foreign currency hedging instruments. For foreign currency hedging instruments, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in other comprehensive income and reclassified to the consolidated statement of operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the consolidated statement of operations.

Stock-Based Compensation

The Company’s stock-based compensation generally includes stock options and restricted share units (“RSUs”). Stock-based compensation is recognized in accordance with the FASB ASC Topic 505, “Equity” and Topic 718, “Compensation-Stock Compensation.”

The Company estimates the fair value of stock option awards on the date of grant using fair value measurement techniques such as an option-pricing model. The fair value of RSU awards is equal to the closing price of the Company’s common stock on the date of grant. The value of the portion of the employee award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s consolidated statement of operations.

The Company utilizes a lattice-binomial option-pricing model (“Binomial Model”) to determine the fair value of stock option awards. The fair value determined by the Binomial Model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the Company’s expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The Binomial Model also considers the expected exercise multiple which is the multiple of exercise price to grant price at which exercises are expected to occur on average. Option-pricing models were developed for use in estimating the value of traded options that have no vesting or hedging restrictions and are fully transferable. Because the Company’s employee stock options have certain characteristics that are significantly different from traded options, and because changes in the subjective assumptions can materially affect the estimated value, in management’s opinion, the Binomial Model best provides a fair measure of the fair value of the Company’s employee stock options. See note 14(c) for the assumptions used to determine the fair value of stock-based payment awards.

Stock-based compensation expense includes compensation cost for employee stock-based payment awards granted and all modified, repurchased or cancelled employee awards. In addition, compensation expense includes the compensation cost, based on the grant-date fair value calculated for pro forma disclosures under ASC 718-10-55, for the portion of awards for which required service had not been rendered that were outstanding. Compensation expense for these employee awards is recognized using the straight-line single-option method. Stock-based compensation expense is not adjusted for estimated forfeitures, but instead adjusted upon an actual forfeiture of a stock option or RSU award. The Company utilizes the market yield on U.S. treasury securities (also known as nominal rate) over the contractual term of the instrument being issued.

Stock Options

As the Company stratifies its employees into homogeneous groups in order to calculate fair value under the Binomial Model, ranges of assumptions used are presented for expected option life. The Company uses historical data to estimate option exercise within the valuation model; various groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected volatility rate is estimated based on a blended volatility method which takes into consideration the Company’s historical share price volatility, the Company’s implied volatility which is implied by the observed current market prices of the Company’s traded options and the Company’s peer group volatility. The Company utilizes the Binomial Model to determine expected option life based on such data as vesting periods of awards, historical data that includes past exercise and post-vesting cancellations and stock price history.

The Company’s policy is to issue new common shares from treasury or shares purchased in the open market to satisfy stock options which are exercised.

Restricted Share Units

The Company’s RSUs have been classified as equity in accordance with Topic 505. The fair value of RSU awards is equal to the closing price of the Company’s common stock on the date of grant.

Awards to Non-Employees

Stock-based awards for services provided by non-employees are accounted for based on the fair value of the services received or the stock-based award, whichever is more reliably determinable. If the fair value of the stock-based award is used, the fair value is measured at the date of the award and remeasured until the earlier of the date that the Company has a performance commitment from the non-employees, the date performance is completed, or the date the awards vest.

Pension Plans and Postretirement Benefits

The Company has a defined benefit pension plan, the Supplemental Executive Retirement Plan (the “SERP”). As the Company’s SERP is unfunded, as at December 31, 2016, a liability is recognized for the projected benefit obligation.

Assumptions used in computing the defined benefit obligations are reviewed annually by management in consultation with its actuaries and adjusted for current conditions. Actuarial gains or losses and prior service costs or credits that arise during the period but are not recognized as components of net periodic benefits cost are recognized as a component of other comprehensive income. Amounts recognized in accumulated other comprehensive income including unrecognized actuarial gains or losses and prior service costs are adjusted as they are subsequently recognized in the consolidated statement of operations as components of net periodic benefit cost. Prior service costs resulting from the pension plan inception or amendments are amortized over the expected future service life of the employees, cumulative actuarial gains and losses in excess of 10% of the projected benefit obligation are amortized over the expected average remaining service life of the employees, and current service costs are expensed when earned. The remaining weighted average future service life of the employee used in computing the defined benefit obligation for the year ended December 31, 2016 was 3.0 years.

For defined contribution pension plans, required contributions by the Company are recorded as an expense.

A liability is recognized for the unfunded accumulated benefit obligation of the postretirement benefits plan. Assumptions used in computing the accumulated benefit obligation are reviewed by management in consultation with its actuaries and adjusted for current conditions. Current service cost is recognized as incurred and actuarial gains and losses are recognized as a component of other comprehensive income (loss). Amounts recognized in accumulated other comprehensive income (loss) including unrecognized actuarial gains or losses are adjusted as they are subsequently recognized in the consolidated statement of operations as components of net periodic benefit cost.

Guarantees

The FASB ASC Guarantees Topic requires a guarantor to recognize, at the inception of a guarantee, a liability for the fair value of certain guarantees. Disclosures as required under the accounting guidance have been included in note 13(f).

New Accounting Pronouncements and Changes in Accounting Principles	12 Months Ended
	Dec. 31, 2016
New Accounting Standards and Accounting Changes [Abstract]
New Accounting Standards and Accounting Changes [Text Block]	3. New Accounting Standards and Accounting Changes Adoption of New Accounting Policies In January 2015, the FASB issued ASU No. 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items” (“ASU 2015-01”). Prior to the changes under ASU 2015-01, an entity was required to separately classify, present and disclose extraordinary events and transactions under the disclosure requirements of Subtopic 225-20, “Income Statement – Extraordinary and Unusual Items” (“Subtopic 225-20”). ASU 2015-01 eliminates from U.S. GAAP the concept of extraordinary items therefore such separate disclosure is no longer required in the Income Statement of an entity. For public companies, the amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments can be applied prospectively or retrospectively. The Company prospectively adopted the amendments under ASU 2015-01 on January 1, 2016. The adoption of the standard did not have an impact on the disclosures presented in the consolidated statements of operations for the years ended December 31, 2016 and 2015, respectively. In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis” (“ASU 2015-02”). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities such as limited partnerships and similar entities, and variable interest entities that have free arrangements and related party relationships. Furthermore, all legal entities are subject to re-evaluation under the revised consolidation model. The amendments also provide a scope exception from consolidation guidance for reporting entities with interests in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds. For public companies, the amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments can be applied retrospectively or using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The Company adopted the amendments under ASU 2015-02 retrospectively on January 1, 2016. The adoption of the standard did not have an impact on the Company’s consolidated financial statements. In April 2015, the FASB issued ASU No. 2015-03, “Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”), and in August 2015 issued ASU No. 2015-15, “Interest – Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements” (“ASU 2015-15”). Under ASU 2015-03, debt issuance costs reported on the balance sheet will be reflected as a direct deduction from the related debt liability rather than as an asset. While ASU 2015-03 addresses costs related to term debt, ASU 2015-15 provides clarification regarding costs to secure revolving lines of credit, which are, at the outset, not associated with an outstanding borrowing. ASU 2015-15 provides commentary that the U.S Securities and Exchange Commission (“SEC”) staff would not object to an entity deferring and presenting costs associated with line-of-credit arrangements as an asset and subsequently amortizing them ratably over the term of the revolving debt arrangement. For public companies, the amendments apply to annual periods beginning on or after December 15, 2015, and interim periods within those years and are to be applied retrospectively. The Company adopted these standards on January 1, 2016. As at December 31, 2015, $0.4 million of unamortized debt issuance costs related to the Company’s loan to finance the construction of its Playa Vista facility were reclassified in the consolidated balance sheet from Other assets to Bank indebtedness. The Company will continue to defer and present the debt issuance cost related to its senior secured revolving credit facility in Other assets and amortize it ratably over the term of the agreement. In March 2016, the FASB issued ASU No. 2016-09, “Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”). The amendment is to simplify several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in ASU 2016-09 are effective for interim and annual reporting periods beginning after December 15, 2016. ASU 2016-09 requires that the Company elect to account for forfeitures based on an estimate of the number of awards for which the requisite service period will not be rendered or to account for forfeitures as they occur. The Company elected to early adopt ASU 2016-09 in 2016 and to account for forfeitures as they occur. The impact from the adoption of the provisions related to forfeiture rates was reflected in the Company’s consolidated financial statements on a modified retrospective basis resulting in a $4.4 million decrease to Accumulated earnings, $0.9 million increase to Deferred income taxes and $5.3 million increase to Other equity. A recovery of stock-based compensation expense of $2.7 million for the year ended December 31, 2016 was also recorded. Amendments related to accounting for excess tax benefits have been adopted prospectively resulting in a tax benefit of $0.1 million for the year ended December 31, 2016, and amendments related to the consolidated statement of cash flows have been adopted retrospectively. See notes 9 and 14 for further discussion of the impact on the Company’s consolidated financial statements from the adoption of ASU 2016-09. In May 2016, the FASB issued ASU No. 2016-11, “Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 pursuant to Staff announcements at the March 3, 2016 EITF Meeting” (“ASU 2016-11”). The purpose of ASU 2016-11 is to rescind from the FASB Accounting Standards Codification certain SEC paragraphs as a result of two SEC Staff Announcements at the March 3, 2016 meeting. For public entities, the amendments in ASU 2016-11 related to Topic 605 are effective for interim and annual reporting periods beginning after December 15, 2017 and amendments related to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2015. The adoption of ASU 2016-11 related to Topic 815, on January 1, 2016, did not have an impact on the Company’s consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments” (“ASU 2016-15”). The purpose of ASU 2016-15 is to reduce the diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flow (Topic 230)”. The purpose of ASU 2016-18 is to require that a statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning of period and end of period total amounts shown on the statement of cash flows. For public entities, the amendments in ASU 2016-15 and ASU 2016-18 are effective for interim and annual reporting periods beginning after December 15, 2017. The Company has elected to early adopt this standard, which did not have an impact on the Company’s consolidated statements of cash flows. In December 2016, the FASB issued ASU No. 2016-19, “Technical Corrections and Improvements”. The amendments in ASU 2016-19 represent changes to clarify the accounting standard codification, correct unintended application of guidance, or make minor improvements to the accounting standards codification that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. For public companies, the standard is effective immediately for amendments that do not have transition guidance. Amendments that are subject to transition guidance, the effective date is interim and annual reporting periods beginning after December 15, 2016. The Company adopted the standard immediately upon issuance for amendments that do not have transition guidance. The adoption of the standard did not have an impact on the Company’s consolidated financial statements.
Description of New Accounting Pronouncements Not yet Adopted [Text Block]	Recently Issued FASB Accounting Standard Codification Updates In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40)” (“ASU 2014-15”). This amendment requires management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern, which is currently performed by the external auditors. Management will be required to perform this assessment for both interim and annual reporting periods and must make certain disclosures if it concludes that substantial doubt exists. The amendments in ASU 2014-15 are effective for annual periods ending after December 31, 2016, and for annual and interim periods thereafter. The adoption of this standard did not have any effect on the consolidated financial statements as no substantial doubt exists about the Company’s ability to continue as a going concern. In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” (“ASU 2015-11”). The purpose of the amendment is to more closely align the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards. The clarifications are not intended to result in any changes in practice and to reduce the complexity in guidance on the subsequent measurement of inventory. This standard only applies to inventory being measured using the first-in, first-out or average cost methods of accounting for inventory. For public entities, the amendments are effective for interim and annual reporting periods beginning after December 15, 2016. The adoption of ASU 2015-11 will not have a material impact to the Company’s consolidated financial statements. In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). The purpose of the amendment is intended to provide users of financial statements with more useful information on the recognition, measurement, presentation, and disclosure of financial instruments. For public entities, the amendments in ASU 2016-01 are effective for interim and annual reporting periods beginning after December 15, 2017. While the Company continues to evaluate the effect of the standard on its ongoing financial reporting, it anticipates that the adoption of ASU 2016-01 may have an effect on the Company’s consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). The purpose of the amendment is to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. New disclosures will include qualitative and quantitative requirements to provide additional information about the amounts recorded in the financial statements. Lessor accounting will remain largely unchanged from current guidance, however ASU 2016-02 will provide improvements that are intended to align lessor accounting with the lessee model and with updated revenue recognition guidance. For public entities, the amendments in ASU 2016-02 are effective for interim and annual reporting periods beginning after December 15, 2018. While the Company continues to evaluate the effect of the standard on its ongoing financial reporting, it anticipates that the adoption of ASU 2016-02 may materially affect its consolidated financial statements. In March 2016, the FASB issued ASU No. 2016-05, “Derivatives and Hedging (Topic 815): Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships” (“ASU 2016-05”). The amendments in ASU 2016-05 apply to all reporting entities for which there is a change in the counterparty to a derivative instrument that has been designated as a hedging instrument under Topic 815. The amendments clarify that a change in the counterparty to a derivative instrument that has been designated as the hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship provided that all other hedge accounting criteria (including those in paragraphs 815-20-35-14 through 35-18) continue to be met. For public entities, the amendments in ASU 2016-05 are effective for interim and annual reporting periods beginning after December 15, 2016. The adoption of this ASU 2016-05 will not have a material impact to the Company’s consolidated financial statements. In March 2016, the FASB issued ASU No. 2016-07, “Investments – Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting” (“ASU 2016-07”). The purpose of the amendment is to eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by step basis as if the equity method had been in effect during all previous periods that the investment had been held. For public entities, the amendments in ASU 2016-07 are effective for interim and annual reporting periods beginning after December 15, 2016. The adoption of ASU 2016-07 will not have a material impact to the Company’s consolidated financial statements. In March 2016, the FASB issued ASU No. 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations” (“ASU 2016-08”). The purpose of ASU 2016-08 is to clarify the implementation of guidance on principal versus agent considerations. In April 2016, the FASB issued ASU No. 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” (“ASU 2016-10”). The purpose of ASU 2016-10 is to provide more detailed guidance in the following key areas: identifying performance obligations and licenses of intellectual property. In May 2016, the FASB issued ASU No. 2016-11, to rescind from the FASB Accounting Standards Codification certain SEC paragraphs as a result of two SEC Staff Announcements at the March 3, 2016 meeting. In May 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” (“ASU 2016-12”). The purpose of ASU 2016-12 is to clarify certain narrow aspects of Topic 606 such as assessing the collectibility criterion, presentation of sales taxes and other similar taxes collected from customers, noncash consideration, contract modifications at transition, completed contracts at transition, and technical corrections. In December 2016, the FASB issued ASU No. 2016-20, “Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers”. The amendments in ASU 2016-20 represent changes to clarify the accounting standard codification, correct unintended application of guidance, or make minor improvements to the accounting standards codification that are related to Topic 606, Revenue from Contracts with Customers. For public companies, ASU 2016-08, ASU 2016-10, ASU 2016-11, ASU 2016-12 and ASU 2016-20, which are all related to Topic 606, are effective for interim and annual reporting periods beginning after December 15, 2017. The Company has performed an analysis of its contracts to determine those in scope of the standard, has performed detailed analyses of those contracts and identified its performance obligations. The Company is currently in the process of determining contract consideration and is determining the appropriate timing for revenue recognition of those performance obligations. Since many of the Company’s contracts involve variable payments tied to box-office, the Company is currently assessing an appropriate constraint to variable revenue streams in determining contract consideration under the new standard. The Company is currently considering adopting the new standard using the modified retrospective method and has begun the process of gathering historical information on its contracts in preparation for the standard’s expanded disclosure requirements. In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). The purpose of ASU 2016-13 is to require a financial asset measured on the amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. For public entities, the amendments in ASU 2016-13 are effective for interim and annual reporting periods beginning after December 15, 2019. The Company is currently assessing the impact of ASU 2016-13 on its consolidated financial statements. In October 2016, the FASB issued ASU No. 2016-16, “Income Taxes (Topic 740)”. The purpose of ASU 2016-16 is to eliminate the exception for an intra-entity transfer of an asset other than inventory. The amendments require the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. For public entities, the amendments in ASU 2016-16 are effective for interim and annual reporting periods beginning after December 15, 2017. The Company is currently assessing the impact of ASU 2016-16 on its consolidated financial statements. In October 2016, the FASB issued ASU No. 2016-17, “Consolidation (Topic 810)”. The purpose of ASU 2016-17 is to update the requirement of the reporting entity, in determining whether it satisfies the second characteristic of a primary beneficiary, to include all of its direct variable interests in a VIE and, on a proportionate basis, its indirect variable interests in a VIE held through related parties, including related parties that are under common control with the reporting entity. For public entities, the amendments in ASU 2016-17 are effective for interim and annual reporting periods beginning after December 15, 2016. While the Company continues to evaluate the effect of the standard on its ongoing financial reporting, the adoption of this guidance will not have any effect on the Company’s consolidated financial statements. Recently issued FASB accounting standard codification updates, except for the above noted standards, were not material to the Company’s consolidated financial statements for the year ended December 31, 2016.

- Definition

The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.

+ References + Details

Lease Arrangements

12 Months Ended

Dec. 31, 2016

Lease Arrangements [Abstract]

Financing Receivables

4. Lease Arrangements

General Terms of Lease Arrangements

A number of the Company’s leases are classified as sales-type leases. Certain arrangements that are legal sales are also classified as sales-type leases as certain clauses within the arrangements limit transfer of title or provide the Company with conditional rights to the system. The customer’s rights under the Company’s lease arrangements are described in note 2(m). The Company classifies its lease arrangements at inception of the arrangement and, if required, after a modification of the lease arrangement, to determine whether they are sales-type leases or operating leases. Under the Company’s lease arrangements, the customer has the ability and the right to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company’s lease portfolio terms are typically non-cancellable for 10 to 20 years with renewal provisions from inception. Except for those sales arrangements that are classified as sales-type leases, the Company’s leases generally do not contain an automatic transfer of title at the end of the lease term. The Company’s lease arrangements do not contain a guarantee of residual value at the end of the lease term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and extended warranty generally after the first year of the lease until the end of the lease term. The customer is responsible for obtaining insurance coverage for the theater systems commencing on the date specified in the arrangement’s shipping terms and ending on the date the theater systems are delivered back to the Company.

The Company has assessed the nature of its joint revenue sharing arrangements and concluded that, based on the guidance in the Revenue Recognition Topic of the ASC, the arrangements contain a lease. Under joint revenue sharing arrangements, the customer has the ability and the right to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company’s joint revenue sharing arrangements are typically non-cancellable for 10 years or longer with renewal provisions. Title to equipment under joint revenue sharing arrangements does not transfer to the customer. The Company’s joint revenue sharing arrangements do not contain a guarantee of residual value at the end of the term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and extended warranty throughout the term. The customer is responsible for obtaining insurance coverage for the theater systems commencing on the date specified in the arrangement’s shipping terms and ending on the date the theater systems are delivered back to the Company. See additional details regarding the Company’s traditional and hybrid joint revenue sharing arrangements as described in note 2(m).

Financing Receivables

Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales of theater systems are as follows:

	As at December 31,
	2016		2015
Gross minimum lease payments receivable	$	10,466	$	13,998
Unearned finance income		(1,710)		(2,381)
Minimum lease payments receivable		8,756		11,617
Accumulated allowance for uncollectible amounts		(672)		(672)
Net investment in leases		8,084		10,945
Gross financed sales receivables		154,301		146,232
Unearned finance income		(39,766)		(39,378)
Financed sales receivables		114,535		106,854
Accumulated allowance for uncollectible amounts		(494)		(568)
Net financed sales receivables		114,041		106,286
Total financing receivables	$	122,125	$	117,231

Net financed sales receivables due within one year	$	21,980	$	19,068
Net financed sales receivables due after one year	$	92,061	$	87,218

In 2016, the financed sales receivables had a weighted average effective interest rate of 9.3% (2015 — 9.4%).

Contingent Fees

Contingent fees that meet the Company’s revenue recognition policy, from customers under various theater system arrangements, have been reported in revenue as follows:

	Years Ended December 31,
	2016		2015		2014
Sales	$	3,308	$	2,492	$	2,058
Sales-type leases		375		363		102
Operating leases		602		901		886
Subtotal - sales, sales-type leases and operating leases		4,285		3,756		3,046
Joint revenue sharing arrangements		73,976		82,016		57,973
	$	78,261	$	85,772	$	61,019

Future Minimum Rental Payments

Future minimum rental payments receivable from operating and sales-type leases at December 31, 2016, for each of the next five years are as follows:

	Operating Leases		Sales-Type Leases
2017	$	614	$	1,513
2018		335		1,522
2019		166		1,499
2020		69		1,314
2021		69		1,118
Thereafter		286		1,999
Total	$	1,539	$	8,965

Total future minimum rental payments receivable from sales-type leases at December 31, 2016 exclude $1.5 million which represents amounts billed but not yet received.

Inventories

12 Months Ended

Dec. 31, 2016

Inventories [Abstract]

Inventories

5. Inventories

	As at December 31,
	2016		2015
Raw materials	$	28,000	$	25,750
Work-in-process		3,818		2,628
Finished goods		10,303		10,375
	$	42,121	$	38,753

At December 31, 2016, finished goods inventory for which title had passed to the customer and revenue was deferred amounted to $2.3 million (December 31, 2015 — $5.4 million).

Inventories at December 31, 2016 include impairments and write-downs for excess and obsolete inventory based upon current estimates of net realizable value considering future events and conditions of $0.5 million (December 31, 2015 — $0.6 million).

Film Assets

12 Months Ended

Dec. 31, 2016

Film Costs [Abstract]

Film Assets

6. Film Assets

		As at December 31,
		2016		2015
Completed and released films, net of accumulated amortization of		$	10,643	$	6,445
	$128,650 (2015 ― $112,571)
Films in production			325		1,538
Films in development			5,554		6,588
		$	16,522	$	14,571

The Company expects to amortize film costs of $4.8 million for released films within three years from December 31, 2016 (December 31, 2015 — $6.3 million), including $2.4 million, which reflects the portion of the costs of the Company’s completed films that are expected to be amortized within the next year. The amount of participation payments to third parties related to these films that the Company expects to pay during 2017, which is included in accrued liabilities at December 31, 2016, is $4.2 million (2015 — $3.9 million).

The Company recorded a charge of $3.0 million (2015 — $nil) in costs and expenses applicable to revenues – services, after an assessment of the carrying value of certain documentary films and their estimated future box-office was performed.

Property, Plant and Equipment

12 Months Ended

Dec. 31, 2016

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

7. Property, Plant and Equipment

		As at December 31, 2016
				Accumulated		Net Book
		Cost		Depreciation		Value
Equipment leased or held for use
	Theater system components(1)(2)(3)(4)	$	224,890	$	89,218	$	135,672
	Camera equipment		5,739		3,732		2,007
			230,629		92,950		137,679
Assets under construction(5)			18,315		-		18,315
Other property, plant and equipment
	Land		8,203		-		8,203
	Buildings		69,861		14,877		54,984
	Office and production equipment(6)		41,128		21,935		19,193
	Leasehold improvements		10,067		3,026		7,041
			129,259		39,838		89,421
		$	378,203	$	132,788	$	245,415

		As at December 31, 2015
				Accumulated		Net Book
		Cost		Depreciation		Value
Equipment leased or held for use
	Theater system components(1)(2)(3)	$	199,974	$	74,568	$	125,406
	Camera equipment		5,393		3,368		2,025
			205,367		77,936		127,431
Assets under construction(5)			9,616		-		9,616
Other property, plant and equipment
	Land		8,203		-		8,203
	Buildings		67,150		12,679		54,471
	Office and production equipment(6)		34,396		17,035		17,361
	Leasehold improvements		3,512		2,327		1,185
			113,261		32,041		81,220
		$	328,244	$	109,977	$	218,267

The Company recognized asset impairment charges of $0.2 million (2015 — $0.4 million, 2014 — $0.3 million) against property, plant and equipment after an assessment of the carrying value of certain assets in light of their future expected cash flows.

_________

(1)	Included in theater system components are assets with costs of $10.3 million (2015 — $11.5 million) and accumulated depreciation of $8.1 million (2015 — $7.3 million) that are leased to customers under operating leases.
(2)	Included in theater system components are assets with costs of $205.2 million (2015 — $178.0 million) and accumulated depreciation of $75.7 million (2015 — $62.2 million) that are used in joint revenue sharing arrangements.
(3)	In 2016, the Company identified and wrote off $0.6 million (2015 — $1.1 million) of theater system components upon the upgrade of xenon-based digital systems under operating lease arrangements to laser-based digital systems under sales or sales-type lease arrangements. In 2016, the Company recorded $nil (2015 — $2.2 million) related to theater system components that are no longer in use and fully amortized.
(4)	During 2016, the Company signed certain amending agreements which increased the length of the term for all applicable existing and future theaters under joint revenue sharing arrangement. As a result, the Company adjusted the estimated useful life of its theater system components in use for those respective joint revenue sharing theaters, on a prospective basis, to reflect the change in term. This resulted in decreased depreciation expense of $0.1 million in 2016 and $1.0 million in each of the next 5 years since the Systems will now be depreciated over a longer useful life.
(5)	Included in assets under construction are components with costs of $8.6 million (2015 — $6.0 million) that will be utilized to construct assets to be used in joint revenue sharing arrangements.
(6)	Fully amortized office and production equipment is still in use by the Company. In 2016, the Company identified and wrote off $0.7 million (2015 — $3.1 million) of office and production equipment that is no longer in use and fully amortized.

Other Assets

12 Months Ended

Dec. 31, 2016

Disclosure Text Block Supplement [Abstract]

Other Assets Disclosure [Text Block]

8. Other Assets

	As at December 31,
	2016		2015
Prepaid taxes (note 9)	$	14,728	$	9,064
Lease incentives provided to theaters		5,632		5,852
Commissions and other deferred selling expenses		3,352		3,933
Insurance recoverable		2,708		2,842
Deferred charges on debt financing		1,713		2,247
Investment in film business		1,389		-
Other investments		2,000		1,193

Foreign currency derivatives		480		-
Equity-accounted investments		-		1,005
Other		1,193		-
	$	33,195	$	26,136

Income Taxes

12 Months Ended

Dec. 31, 2016

Income Taxes [Abstract]

Income Taxes

9. Income Taxes

Income (loss) from continuing operations before income taxes by tax jurisdiction are comprised of the following:

	Years Ended December 31,
	2016		2015		2014

Canada	$	21,002	$	41,099	$	15,453
United States		505		4,504		10,350
China		41,224		45,818		26,327
Ireland		(9,768)		(10,581)		-
Other		4,890		6,238		5,221
	$	57,853	$	87,078	$	57,351

The provision for income taxes related to income from continuing operations is comprised of the following:

		Years Ended December 31,
		2016		2015		2014
Current:
	Canada	$	(1,396)	$	(10,862)	$	(3,495)
	United States		1,756		985		(4,072)
	China		(10,131)		(10,591)		(6,023)
	Ireland		(405)		-		-
	Other		(1,093)		(920)		(249)
			(11,269)		(21,388)		(13,839)
Deferred:(1)
	Canada		(3,583)		(518)		433
	United States		(4,359)		147		(791)
	China		776		(83)		(216)
	Ireland		2,352		1,840		-
	Other		(129)		(50)		(53)
			(4,943)		1,336		(627)
		$	(16,212)	$	(20,052)	$	(14,466)

______________

(1)

For the year ended December 31, 2016, the Company has decreased the valuation allowance by $0.1 million (2015 — less than $0.1 million increase) relating to the future utilization of deductible temporary differences, tax credits, and certain net operating loss carryforwards. Also included in the provision for income taxes is the deferred tax related to amounts recorded in and reclassified from other comprehensive income in the year of $1.2 million.

The provision for income taxes from continuing operations differs from the amount that would have resulted by applying the combined Canadian federal and provincial statutory income tax rates to earnings due to the following:

		Years Ended December 31,
		2016		2015		2014

Income tax provision at combined statutory rates		$	(15,330)	$	(23,081)	$	(15,189)
Adjustments resulting from:
	Stock based compensation		(565)		2,387		(2,244)
	Other non-deductible/non-includable items		(1,254)		(439)		1,257
	Decrease (increase) in valuation allowance relating to current year temporary
	differences		129		(16)		429
	Changes to tax reserves		1,628		(453)		230
	U.S. federal and state taxes		(767)		(27)		(200)
	Withholding taxes		(786)		(716)		(200)
	Income tax at different rates in foreign and other provincial jurisdictions		50		961		516
	Investment and other tax credits (non-refundable)		2,190		1,597		1,973
	Changes to deferred tax assets and liabilities resulting from audit and other tax
	return adjustments		(1,612)		(242)		(1,013)
	Windfall tax benefit		57		-		-
	Tax effect of loss from equity-accounted investments		-		-		(41)
	Other		48		(23)		16
Provision for income taxes, as reported		$	(16,212)	$	(20,052)	$	(14,466)

The net deferred income tax asset is comprised of the following:

	As at December 31,
	2016		2015


Net operating loss carryforwards	$	2,893	$	1,158
Investment tax credit and other tax credit carryforwards		-		-
Write-downs of other assets		759		720
Excess tax over accounting basis in property, plant and equipment, inventories and other assets		-		9,577
Accrued pension liability		6,571		6,626
Accrued stock-based compensation		12,352		9,261
Other accrued reserves		3,754		559
Total deferred income tax assets		26,329		27,901
Income recognition on net investment in leases		(3,985)		(1,809)
Excess accounting over tax basis in property, plant and equipment, inventories and other assets		(1,368)		-
		20,976		26,092
Valuation allowance		(197)		(326)
Net deferred income tax asset	$	20,779	$	25,766

The gross deferred tax assets include an asset of $0.1 million relating to the remaining tax effect resulting from the Company’s defined benefit pension plan, the related actuarial gains and losses, and unrealized net gains and losses on cash flow hedging instruments recorded in accumulated other comprehensive income.

ASU 2016-09, related to stock-based compensation, was issued in March 2016 and early adopted by the Company in June 2016. ASU 2016-09 eliminates additional paid in capital ("APIC") pools and requires excess tax benefits and tax deficiencies to be recorded in the consolidated statements of operations when the awards vest or are settled. Amendments related to accounting for excess tax benefits have been adopted prospectively resulting in a tax benefit of $0.1 million for the year ended December 31, 2016. In addition, modified retrospective adoption of ASC 2016-09 eliminates the requirement that excess tax benefits be realized before they can be recognized. The Company has also recorded a cumulative-effect adjustment of $0.9 million to Accumulated earnings and Deferred income taxes related to the impact from adoption of the provisions related to forfeiture rates. See notes 3 and 14 for further discussion of the impact from the adoption of ASU 2016-09.

In 2015, the Company recorded an adjustment of $14.0 million to deferred tax assets, $5.9 million to the income tax provision and $8.1 million to shareholders’ equity related to excess tax benefits generated on the exercise of certain employee stock options. In conjunction with this, a provision for uncertain tax positions of $3.9 million was recorded to income tax provision and $7.9 million was recorded against shareholders’ equity.

During the year, the Company and its subsidiaries completed a number of intra-entity sales of assets. The Company has deferred or eliminated the related tax expense and deferred taxes specifically associated with such intra-entity transfers, and is included in Other Assets as disclosed in note 8.

The Company has not provided Canadian taxes on cumulative earnings of non-Canadian affiliates and associated companies that have been reinvested indefinitely. Taxes are provided for earnings of non-Canadian affiliates and associated companies when the Company determines that such earnings are no longer indefinitely reinvested.

Estimated net operating loss carryforwards (excluding state losses) and estimated tax credit carryforwards expire as follows:

	Investment Tax
	Credits and
	Other		Net Operating
	Tax Credit		Loss
	Carryforwards		Carryforwards
2017	$	-	$	-
2018		-		-
2019		-		-
2020		-		-
2021		-		-
Thereafter		2,194		37,664
	$	2,194	$	37,664

Estimated net operating loss carryforwards of $17.6 million can be carried forward to reduce taxable income through to 2037 and the remaining $20.1 million can be carried forward indefinitely. Investment tax credits and other tax credits can be carried forward to reduce income taxes payable through to 2037.

Valuation allowance

The provision for income taxes in the year ended December 31, 2016 includes a net income tax recovery of $0.1 million (2015 — less than $0.1 million expense) in continuing operations related to a decrease in the valuation allowance for the Company’s deferred tax assets and other tax adjustments. During the year ended December 31, 2016, after considering all available evidence, both positive (including recent and historical profits, projected future profitability, backlog, carryforward periods for, and utilization of net operating loss carryovers and tax credits, discretionary deductions and other factors) and negative (including cumulative losses in past years and other factors), it was concluded that the valuation allowance against the Company’s deferred tax assets should be decreased by $0.1 million (2015 — less than $0.1 million increase). The remaining $0.2 million (2015 — $0.3 million) balance in the valuation allowance as at December 31, 2016 is primarily attributable to certain U.S. state net operating loss carryovers that may expire unutilized.

Uncertain tax positions

The Company recorded a net decrease of $1.6 million related to the measurement of potential international withholding tax requirements and a decrease in reserves for income taxes. As at December 31, 2016 and December 31, 2015, the Company had total unrecognized tax benefits (including interest and penalties) of $12.6 million and $14.6 million, respectively, for deductibility of stock based compensation, international withholding taxes and other items. Approximately $12.6 million of the unrecognized tax benefits could impact the Company's effective tax rate if recognized. While the Company believes it has adequately provided for all tax positions, amounts asserted by taxing authorities could differ from the Company's accrued position. Accordingly, additional provisions on federal, provincial, state and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved.

A reconciliation of the beginning and ending amount of unrecognized tax benefits (excluding interest and penalties) for the years ended December 31 is as follows:


(In thousands of U.S. Dollars)	2016		2015		2014
Balance at beginning of the year	$	14,221	$	1,972	$	2,202
Additions based on tax positions related to the current year		314		12,694		237
Reductions for tax positions of prior years		(500)		-		-
Reductions resulting from lapse of applicable statute of limitations and administrative
practices		(1,442)		(445)		(467)
Balance at the end of the year	$	12,593	$	14,221	$	1,972

Consistent with its historical financial reporting, the Company has elected to classify interest and penalties related to income tax liabilities, when applicable, as part of the interest expense in its consolidated statements of operations rather than income tax expense. The Company recovered less than $0.1 million in potential interest and penalties associated with its provision for uncertain tax positions for the years ended December 31, 2016 (2015 — less than $0.1 million recovery, 2014 — $0.2 million recovery).

The number of years with open tax audits varies depending on the tax jurisdiction. The Company's major taxing jurisdictions include Canada, the province of Ontario, the United States (including multiple states), Ireland and China.

The Company's 2011 through 2016 tax years remain subject to examination by the IRS for U.S. federal tax purposes, and the 2006 through 2016 tax years remain subject to examination by the appropriate governmental agencies for Canadian federal tax purposes. There are other on-going audits in various other jurisdictions that are not material to the financial statements.

Income Tax Effect on Comprehensive Income

The income tax (expense) benefit related to the following items included in other comprehensive income (loss) are:

	Years Ended December 31,
	2016		2015		2014

Unrecognized actuarial gain or loss on defined benefit plan	$	(41)	$	(47)	$	225
Unrecognized actuarial gain or loss on postretirement benefit plans		(48)		(21)		151
Amortization of actuarial gain or loss on postretirement benefit plan		(18)		(35)		8
Other-than-temporary impairment of available-for-sale investment		-		-		(45)
Unrealized change in cash flow hedging instruments		(271)		1,543		658
Realized change in cash flow hedging instruments upon settlement		(802)		(844)		(306)
Foreign currency translation adjustments		-		(85)		59
	$	(1,180)	$	511	$	750

Other Intangible Assets

12 Months Ended

Dec. 31, 2016

Other Intangible Assets [Abstract]

Other Intangible Assets

10. Other Intangible Assets

	As at December 31, 2016
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	11,395	$	7,046	$	4,349
Licenses and intellectual property		22,490		7,620		14,870
Other		15,352		4,155		11,197
	$	49,237	$	18,821	$	30,416

	As at December 31, 2015
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	10,399	$	6,502	$	3,897
Licenses and intellectual property		22,390		6,464		15,926
Other		11,878		2,751		9,127
	$	44,667	$	15,717	$	28,950

Other intangible assets of $15.4 million are comprised mainly of the Company’s investment in a new enterprise resource planning system. Fully amortized other intangible assets are still in use by the Company. In 2016, the Company identified and wrote off $0.2 million (2015 ─ $0.1 million) of patents and trademarks that are no longer in use.

During 2016, the Company acquired $4.8 million in other intangible assets. The net book value of these other intangible assets was $4.3 million as at December 31, 2016. The weighted average amortization period for these additions is 10 years.

During 2016, the Company incurred costs of $0.2 million to renew or extend the term of acquired patents and trademarks which were recorded in selling, general and administrative expenses (2015 ─ less than $0.1 million).

The estimated amortization expense for each of the years ended December 31, are as follows:

2017	$	3,470
2018		3,470
2019		3,470
2020		3,470
2021		3,470

Credit Facility and Playa Vista Loan

12 Months Ended

Dec. 31, 2016

Credit Facility and Playa Vista Construction Loan [Abstract]

Credit Facility and Playa Vista Construction Loan

11. Credit Facility and Playa Vista Loan

The Company maintains a senior secured credit facility (the “Credit Facility”) with a maximum borrowing capacity of $200.0 million and a scheduled maturity of March 3, 2020. The Credit Facility is collateralized by a first priority security interest in substantially all of the present and future assets of the Company and the Guarantors. Certain of the Company’s subsidiaries serve as guarantors (the “Guarantors”) of the Company’s obligations under the Credit Facility.

The terms of the Credit Facility are set forth in the Fourth Amended and Restated Credit Agreement (as amended, the “Credit Agreement”), dated March 3, 2015, among the Company, the Guarantors, the lenders named therein, Wells Fargo Bank, National Association (“Wells Fargo”), as agent and issuing lender (Wells Fargo, together with the lenders named therein, the “Lenders”) and Wells Fargo Securities, LLC, as Sole Lead Arranger and Sole Bookrunner and in various collateral and security documents entered into by the Company and the Guarantors. Each of the Guarantors has also entered into a guarantee in respect of the Company’s obligations under the Credit Facility. On February 22, 2016, the Company amended the terms of the Credit Agreement to increase the general restricted payment basket thereunder (which covers, among other things, the repurchase of shares) from $150.0 million to $350.0 million in the aggregate after the amendment date.

The Company was in compliance with all of its requirements at December 31, 2016.

Total amounts drawn and available under the Credit Facility at December 31, 2016 were $nil and $200.0 million, respectively (December 31, 2015 — $nil and $200.0 million, respectively).

As at December 31, 2016, the Company did not have any letters of credit and advance payment guarantees outstanding (December 31, 2015 — $nil), under the Credit Facility.

Playa Vista Financing

On October 6, 2014, IMAX PV Development Inc., a Delaware corporation (“PV Borrower”) and wholly-owned subsidiary of the Company, entered into a construction loan agreement with Wells Fargo. The construction loan (the “Playa Vista Construction Loan”) was used to fund $22.3 million of the costs of development and construction of the West Coast headquarters of the Company, located in the Playa Vista neighborhood of Los Angeles, California (the “Playa Vista Project”).

On October 19, 2015, PV Borrower converted the Playa Vista Construction Loan from a construction loan into a permanent loan (“Playa Vista Loan”) pursuant to the terms of the loan documents. Pursuant to the conversion, PV Borrower increased the principal balance of the loan by an additional $7.7 million, to $30.0 million. Prior to the conversion, the Playa Vista Construction Loan bore interest at a variable interest rate per annum equal to 2.25% above the 30-day LIBOR rate, and PV Borrower was required to make monthly payments of interest only. As a result of the conversion, the interest rate decreased from 2.25% to 2.0% above the 30-day LIBOR rate, and PV Borrower will be required to make monthly payments of combined principal and interest over a 10-year term with a lump sum payment at the end of year 10. The Playa Vista Loan is being amortized over 15 years. The Playa Vista Loan will be fully due and payable on October 19, 2025 (the “Maturity Date”), and may be prepaid at any time without premium, but with all accrued interest and other applicable payments.

The Playa Vista Loan is secured by a deed of trust from PV Borrower in favor of Wells Fargo and other documents evidencing and securing the loan (the “Loan Documents”), granting a first lien on and security interest in the Playa Vista property and the Playa Vista Project, including all improvements to be constructed thereon. The Loan Documents include absolute and unconditional payment and completion guarantees provided by the Company to Wells Fargo for the performance by PV Borrower of all the terms and provisions of the Playa Vista Loan.

The Loan Documents contain affirmative, negative and financial covenants (including compliance with the financial covenants of the Company’s outstanding Credit Facility), agreements, representations, warranties, borrowing conditions, and events of default customary for development projects such as the Playa Vista Project.

Bank indebtedness includes the following:

	As at December 31,
	2016		2015
Playa Vista Loan		27,667		29,667
Deferred charges on debt financing		(351)		(391)
	$	27,316	$	29,276

Total amounts drawn under the Playa Vista Loan at December 31, 2016 was $27.7 million (December 31, 2015 — $29.7 million) at an effective interest rate of 2.52% (December 31, 2015 — 2.40%).

In accordance with the Playa Vista Loan Documents, the Company is obligated to make principal payments on the loan as follows:

2017	$	2,000
2018		2,000
2019		2,000
2020		2,000
2021		2,000
Thereafter		17,667
	$	27,667

Wells Fargo Foreign Exchange Facility

Within the Credit Facility, the Company is able to purchase foreign currency forward contracts and/or other swap arrangements. The settlement risk on its foreign currency forward contracts was $0.3 million at December 31, 2016 as the notional value exceeded the fair value of the forward contracts. As at December 31, 2016, the Company has $37.8 million in notional value of such arrangements outstanding.

Bank of Montreal Facility

As at December 31, 2016, the Company has available a $10.0 million facility (December 31, 2015 — $10.0 million) with the Bank of Montreal for use solely in conjunction with the issuance of performance guarantees and letters of credit fully insured by Export Development Canada (the “Bank of Montreal Facility”). As at December 31, 2016, the Company has letters of credit and advance payment guarantees outstanding of $0.1 million (2015 — $0.3 million) under the Bank of Montreal Facility.

Commitments

12 Months Ended

Dec. 31, 2016

Commitments, Contingencies and Guarantees [Abstract]

Commitments

12. Commitments

In the ordinary course of business, the Company enters into contractual agreements with third parties that include non-cancelable payment obligations, for which it is liable in future periods. These arrangements can include terms binding the Company to minimum payments and/or penalties if it terminates the agreement for any reason other than an event of default as described by the agreement. The following table presents a summary of the Company’s contractual obligations and commitments as at December 31, 2016:

	Payments Due by Fiscal Year
	Total
(In thousands of U.S. Dollars)	Obligations		2017		2018		2019		2020		2021		Thereafter

Purchase obligations	$	25,283	$	25,283	$	-	$	-	$	-	$	-	$	-
Pension obligations		21,115		-		-		-		21,115		-		-
Operating lease obligations		18,670		6,203		5,033		2,831		674		498		3,431
Playa Vista Loan		27,667		2,000		2,000		2,000		2,000		2,000		17,667
Postretirement benefits obligations		5,042		1,138		1,197		680		140		145		1,742
Other financial commitments		39,173		39,173		-		-		-		-		-
	$	136,950	$	73,797	$	8,230	$	5,511	$	23,929	$	2,643	$	22,840

Operating Lease Obligations

The Company’s lease commitments consist of rent and equipment under operating leases. The Company accounts for any incentives provided over the term of the lease. The following table summarizes information about the Company’s total rental expenses under operating leases:

	Years Ended December 31,
	2016		2015		2014

Total rent expense	$	5,106	$	4,766	$	6,567

Recorded in the accrued liabilities balance as at December 31, 2016 is $1.6 million (December 31, 2015 — $1.1 million) related to accrued rent and lease inducements being recognized as an offset to rent expense over the term of the respective leases.

Subsequent to December 31, 2016, the Company entered into a premises lease arrangement, related to the New York corporate office, with a commitment of approximately $17.1 million over a 12-year term. The term is expected to begin in January 2018.

Purchase Obligations

Purchase obligations primarily consist of the Company’s commitments made under long-term supplier contracts.

Pension and Postretirement Benefits Obligations

The Company has an unfunded defined benefit pension plan, covering certain individuals and a postretirement plan to provide health and welfare benefits to Canadian employees meeting certain eligibility requirements. See note 20 for further information.

Playa Vista Loan

The Company is required to make monthly payments of combined principal and interest over a 10-year term with a lump sum payment at the end of year 10. The Playa Vista Loan will be fully due and payable on October 19, 2025. See note 11 for further information.

Other Financial Commitments

Other financial commitments include the Company’s total minimum commitment toward the development, production, post-production and marketing, related to certain film and new content initiatives.

As at December 31, 2016 the Company did not have any letters of credit and advance payment guarantees outstanding (December 31, 2015 — $nil), under the Credit Facility. As at December 31, 2016 the Company had letters of credit and advance payment guarantees outstanding of $0.1 million as compared to $0.3 million as at December 31, 2015, under the Bank of Montreal Facility.

The Company compensates its sales force with both fixed and variable compensation. Commissions on the sale or lease of the Company’s theater systems are payable in graduated amounts from the time of collection of the customer’s first payment to the Company up to the collection of the customer’s last initial payment. At December 31, 2016, $2.0 million (December 31, 2015 —$1.7 million) of commissions have been accrued and will be payable in future periods.

Contingencies and Guarantees

12 Months Ended

Dec. 31, 2016

Commitments, Contingencies and Guarantees [Abstract]

Contingencies and Guarantees

13. Contingencies and Guarantees

The Company is involved in lawsuits, claims, and proceedings, including those identified below, which arise in the ordinary course of business. In accordance with the Contingencies Topic of the FASB ASC, the Company will make a provision for a liability when it is both probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company believes it has adequate provisions for any such matters. The Company reviews these provisions in conjunction with any related provisions on assets related to the claims at least quarterly and adjusts these provisions to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other pertinent information related to the case. Should developments in any of these matters outlined below cause a change in the Company’s determination as to an unfavorable outcome and result in the need to recognize a material provision, or, should any of these matters result in a final adverse judgment or be settled for significant amounts, they could have a material adverse effect on the Company’s results of operations, cash flows, and financial position in the period or periods in which such a change in determination, settlement or judgment occurs.

The Company expenses legal costs relating to its lawsuits, claims and proceedings as incurred.

On May 15, 2006, the Company initiated arbitration against Three-Dimensional Media Group, Ltd. (“3DMG”) before the International Centre for Dispute Resolution in New York (the “ICDR”), alleging breaches of the license and consulting agreements between the Company and 3DMG. On June 15, 2006, 3DMG filed an answer denying any breaches and asserting counterclaims that the Company breached the parties’ license agreement. On June 21, 2007, the ICDR unanimously denied 3DMG’s Motion for Summary Judgment filed on April 11, 2007 concerning the Company’s claims and 3DMG’s counterclaims. The proceeding was suspended on May 4, 2009 due to failure of 3DMG to pay fees associated with the proceeding. The proceeding was further suspended on October 11, 2010 pending resolution of re-examination proceedings involving one of 3DMG’s patents. Following a status conference on April 27, 2016 before the ICDR, the ICDR granted 3DMG leave to amend its answer and counterclaims, and subsequently lifted the stay in this matter. In its amended counterclaims, 3DMG seeks damages for alleged unpaid royalties and other fees under the license and consulting agreements. Discovery is currently ongoing and a final hearing before the ICDR has been scheduled for the week of July 10, 2017. Given the stage of discovery, the Company is unable to determine a range of potential damages in this matter. However, the Company believes that the amount of loss, if any, suffered in connection with the amended counterclaims would not have a material impact on the financial position or results of operations of the Company, although no assurance can be given with respect to the ultimate outcome of the arbitration.

In January 2004, the Company and IMAX Theatre Services Ltd., a subsidiary of the Company, commenced an arbitration seeking damages before the International Court of Arbitration of the International Chamber of Commerce (the “ICC”) with respect to the breach by Electronic Media Limited (“EML”) of its December 2000 agreement with the Company. In June 2004, the Company commenced a related arbitration before the ICC against EML’s affiliate, E-City Entertainment (I) PVT Limited (“E-City”). On March 27, 2008, the arbitration panel issued a final award in favor of the Company in the amount of $11.3 million, consisting of past and future rents owed to the Company, plus interest and costs, as well as an additional $2,512 each day in interest from October 1, 2007 until the date the award is paid. In July 2008, E-City commenced a proceeding in Mumbai, India seeking an order that the ICC award may not be recognized in India. The Company has opposed that application on a number of grounds and seeks to have the ICC award recognized in India. On June 13, 2013, the Bombay High Court ruled that it has jurisdiction over the proceeding but on November 19, 2013, the Supreme Court of India stayed proceedings in the High Court pending Supreme Court review of the High Court’s ruling. On June 24, 2011, the Company commenced a proceeding in the Ontario Superior Court of Justice for recognition of the ICC final award. On December 2, 2011, the Ontario Court issued an order recognizing the final award and requiring E-City to pay the Company $30,000 to cover the costs of the application. In January 2013, the Company filed an action in the New York Supreme Court seeking to collect the amount owed to the Company by certain entities and individuals affiliated with E-City. On October 16, 2015, the New York Supreme Court denied the Company’s petition, and the Company is appealing that decision. On July 29, 2014, the Company commenced a separate proceeding to have the Canadian judgment against E-City recognized in New York, and on October 2, 2015, the New York Supreme Court granted IMAX’s request, recognizing the Canadian judgment and entering it as a New York judgment. On November 26, 2014, E-City filed a motion in the Bombay High Court seeking to enjoin IMAX from continuing the New York legal proceedings. On February 2, 2015, the Bombay High Court denied E-City’s request for an injunction. On March 16, 2015, E-City filed an appeal of this Bombay High Court decision.

In March 2013, IMAX (Shanghai) Multimedia Technology Co., Ltd. (“IMAX Shanghai”), the Company’s majority-owned subsidiary in China, received notice from the Shanghai office of the General Administration of Customs (“Customs Authority”) that it had been selected for a customs audit (the “Audit”). A key issue raised by the Audit is the transfer pricing policy basis for the importation of IMAX theater systems by IMAX Shanghai into the People’s Republic of China and the applicability of customs duties and taxes to the trademark and technology license fees paid by IMAX Shanghai to the Company. In December 2016, the Customs Authority conclusively determined that any trademark, technology and warranty fees paid by IMAX Shanghai on systems revenue directly related to imported theater systems should be included as part of the tax cost base of these systems and subject to applicable duties and taxes. In connection with the conclusion, for the period beginning January 1, 2012 through October 31, 2016, IMAX Shanghai recorded $2.95 million in duties and taxes on the trademark, technology and warranty fees for applicable to theater systems imported during that period and settled the payment in January 2017. In the course of the Audit, the Customs Authority discovered the underpayment by IMAX Shanghai of the freight and insurance portion of the customs duties and taxes applicable to the importation of certain IMAX theater systems during the period from October 2011 through March 2013 of approximately $0.1 million. Though IMAX Shanghai’s importation agent accepted responsibility for the error giving rise to the underpayment, the matter has been transferred to the Anti-Smuggling Bureau of the Customs Authority for further review. IMAX Shanghai is unable to assess the potential impact, if any, of this outstanding matter at this time.

On November 11, 2013, Giencourt Investments, S.A. (“Giencourt”) initiated arbitration before the International Centre for Dispute Resolution in Miami, Florida, based on alleged breaches by the Company of its theater agreement and related license agreement with Giencourt. Giencourt submitted its statement of claim in January 2015, the Company submitted its statement of defense and counterclaim in April 2015 and Giencourt submitted its arbitration reply paper in September 2015. An arbitration hearing for witness testimony was held during the week of December 14, 2015. At the hearing, Giencourt’s expert identified monetary damages of up to approximately $10.4 million, which Giencourt seeks to recover from the Company. The Company has asserted a counterclaim against Giencourt for breach of contract and seeks to recover lost profits in excess of $24.0 million under the agreements. In addition, on December 10, 2015, Giencourt made a motion to the panel seeking to enforce a purported settlement of the matter based on negotiations between Giencourt and the Company. The panel held a final hearing with closing arguments on October 20 and 21, 2016. On February 7, 2017, the panel issued a Partial Final Award (the “Award”), which held that the parties had reached a binding settlement, and therefore the panel did not reach the merits of the dispute. The Company strongly disputes that discussions about a potential resolution of this matter amounted to an enforceable settlement. The Company is currently reviewing the Award and assessing its response and potential next steps, including a potential challenge in Florida court on the grounds that the panel exceeded its jurisdiction. At this time, the Company is unable to determine the amounts that it may owe pursuant to the Award, or the timing of any such payments, and therefore no assurances can be given with respect to the ultimate outcome of the matter.

In addition to the matters described above, the Company is currently involved in other legal proceedings or governmental inquiries which, in the opinion of the Company’s management, will not materially affect the Company’s financial position or future operating results, although no assurance can be given with respect to the ultimate outcome of any such proceedings.

In the normal course of business, the Company enters into agreements that may contain features that meet the definition of a guarantee. The Guarantees Topic of the FASB ASC defines a guarantee to be a contract (including an indemnity) that contingently requires the Company to make payments (either in cash, financial instruments, other assets, shares of its stock or provision of services) to a third party based on (a) changes in an underlying interest rate, foreign exchange rate, equity or commodity instrument, index or other variable, that is related to an asset, a liability or an equity security of the counterparty, (b) failure of another party to perform under an obligating agreement or (c) failure of another third party to pay its indebtedness when due.

Financial Guarantees

The Company has provided no significant financial guarantees to third parties.

Product Warranties

The following summarizes the accrual for product warranties that was recorded as part of accrued liabilities in the consolidated balance sheets:

	As at December 31,
	2016		2015
Balance at the beginning of the year	$	-	$	6
Warranty redemptions		-		(6)
Warranties issued		30		-
Revisions		-		-
Balance at the end of the year	$	30	$	-

Director/Officer Indemnifications

The Company’s General By-law contains an indemnification of its directors/officers, former directors/officers and persons who have acted at its request to be a director/officer of an entity in which the Company is a shareholder or creditor, to indemnify them, to the extent permitted by the Canada Business Corporations Act, against expenses (including legal fees), judgments, fines and any amount actually and reasonably incurred by them in connection with any action, suit or proceeding in which the directors and/or officers are sued as a result of their service, if they acted honestly and in good faith with a view to the best interests of the Company. The nature of the indemnification prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. The Company has purchased directors’ and officers’ liability insurance. No amount has been accrued in the consolidated balance sheet as at December 31, 2016 and December 31, 2015 with respect to this indemnity.

Other Indemnification Agreements

In the normal course of the Company’s operations, the Company provides indemnifications to counterparties in transactions such as: theater system lease and sale agreements and the supervision of installation or servicing of the theater systems; film production, exhibition and distribution agreements; real property lease agreements; and employment agreements. These indemnification agreements require the Company to compensate the counterparties for costs incurred as a result of litigation claims that may be suffered by the counterparty as a consequence of the transaction or the Company’s breach or non-performance under these agreements. While the terms of these indemnification agreements vary based upon the contract, they normally extend for the life of the agreements. A small number of agreements do not provide for any limit on the maximum potential amount of indemnification; however, virtually all of the Company’s system lease and sale agreements limit such maximum potential liability to the purchase price of the system. The fact that the maximum potential amount of indemnification required by the Company is not specified in some cases prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. Historically, the Company has not made any significant payments under such indemnifications and no amounts have been accrued in the consolidated financial statements with respect to the contingent aspect of these indemnities.

Capital Stock

12 Months Ended

Dec. 31, 2016

Capital Stock [Abstract]

Capital Stock

14. Capital Stock

Authorized

Common Shares

The authorized capital of the Company consists of an unlimited number of common shares. The following is a summary of the rights, privileges, restrictions and conditions of the common shares.

The holders of common shares are entitled to receive dividends if, as and when declared by the directors of the Company, subject to the rights of the holders of any other class of shares of the Company entitled to receive dividends in priority to the common shares.

The holders of the common shares are entitled to one vote for each common share held at all meetings of the shareholders.

Changes during the Year

During 2016, the Company settled 518,018 (2015 — 1,761,675, 2014 — 1,149,587) common shares pursuant to the exercise of stock options for cash proceeds of $11.4 million (2015 — $35.6 million, 2014 — $10.8 million). 347,814 (2015 — 1,659,643, 2014 — 1,149,587) common shares were newly issued from treasury and 170,204 (2015 — 102,032, 2014 — nil) common shares were purchased in the open market by the IMAX Long-Term Incentive Plan trustee.

In addition, during 2016, in connection with the vesting of RSUs, the Company settled 466,918 (2015 — 207,371, 2014 — 148,001) common shares to IMAX LTIP participants, of which 54,159 (2015 – 25,551, 2014 – 109,264) common shares, net of shares withheld for tax withholdings of 18,336 (2015 – 14,351, 2014 – 10,921) were issued as new shares from treasury, and 394,423 (2015 — 167,469, 2014 — 27,816) common shares were purchased in the open market by the IMAX Long-Term Incentive Plan trustee.

Stock-Based Compensation

The Company issues stock-based compensation to eligible employees, directors and consultants under the IMAX Corporation Amended and Restated Long- Term Incentive Plan and the China Long-Term Incentive Plan, as described below.

On June 11, 2013, the Company’s shareholders approved the IMAX 2013 Long-Term Incentive Plan (the “2013 IMAX LTIP”). On June 6, 2016, the Company’s shareholders approved the amendment and restatement of the 2013 IMAX LTIP at the Company’s Annual and Special Meeting, such that the IMAX Corporation Amended and Restated Long-Term Incentive Plan (the “IMAX LTIP”) is now the governing document, Awards to employees, directors and consultants under the IMAX LTIP may consist of stock options, RSUs and other awards.

The Company’s Stock Option Plan (“SOP”), which shareholders approved in June 2008, permitted the grant of stock options to employees, directors and consultants. Following the implementation of the 2013 IMAX LTIP on June 11, 2013, stock options are no longer granted under the SOP.

A separate stock option plan, the China Long-Term Incentive Plan (the “China LTIP”) was adopted by a subsidiary of the Company in October 2012.

The compensation costs recorded in the consolidated statement of operations for these plans were $30.5 million in 2016 (2015 — $21.9 million, 2014 — $15.1 million).

As at December 31, 2016, the Company has reserved a total of 12,012,572 (December 31, 2015 — 7,023,258) common shares for future issuance under the SOP and IMAX LTIP. Of the common shares reserved for issuance, there are options in respect of 5,190,542 common shares and RSUs in respect of 1,124,180 common shares outstanding at December 31, 2016. At December 31, 2016 options in respect of 4,001,078 common shares were vested and exercisable.

Stock Option Plan

The Company’s policy is to issue new common shares from treasury or shares purchased in the open market to satisfy stock options which are exercised.

The Company utilizes a Binomial Model to determine the fair value of stock-based payment awards. The fair value determined by the Binomial Model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the Company’s expected stock price volatility over the term of the awards, and employee stock option exercise behaviors. The Binomial Model also considers the expected exercise multiple which is the multiple of exercise price to grant price at which exercises are expected to occur on average. Option-pricing models were developed for use in estimating the value of traded options that have no vesting or hedging restrictions and are fully transferable. Because the Company’s employee stock options have certain characteristics that are significantly different from traded options, and because changes in the subjective assumptions can materially affect the estimated value, in management’s opinion, the Binomial Model best provides a fair measure of the fair value of the Company’s employee stock options.

All awards of stock options are made at fair market value of the Company’s common shares on the date of grant. The fair market value of a common share on a given date means the higher of the closing price of a common share on the grant date (or the most recent trading date if the grant date is not a trading date) on the New York Stock Exchange (“NYSE”) or such national exchange as may be designated by the Company’s Board of Directors (the “Fair Market Value”). The stock options vest within 5 years and expire 10 years or less from the date granted. The SOP and IMAX LTIP provide for double-trigger accelerated vesting in the event of a change in control, as defined in each plan.

The Company recorded an expense of $12.8 million in 2016 (2015 — $10.7 million, 2014 — $8.9 million) related to stock option grants issued to employees and directors in the IMAX LTIP and SOP plans. An income tax benefit is recorded in the consolidated statement of operations of $3.8 million for these costs. Total stock-based compensation expense related to non-vested employee stock options not yet recognized at December 31, 2016 and the weighted average period over which the awards are expected to be recognized is $5.9 million and 2.3 years respectively (2015 — $12.6 million and 1.7 years, 2014 — $14.8 million and 2.3 years).

The weighted average fair value of all stock options granted to employees and directors in 2016 at the measurement date was $8.16 per share (2015 — $8.07 per share, 2014 — $8.25 per share). For the years ended December 31, the following assumptions were used to estimate the average fair value of the stock options:

	2016	2015	2014

Average risk-free interest rate	1.67%	1.97%	2.46%
Expected option life (in years)	4.44 - 5.24	3.55 - 5.76	4.15 - 5.82
Expected volatility	30%	30%	32.5% - 37.5%
Dividend yield	0%	0%	0%

Stock options to Non-Employees

There were no common share options issued to non-employees in 2016 or 2015. During 2014, an aggregate of 10,000 stock options to purchase the Company’s common stock with an average exercise price of $26.47 were granted to certain advisors and strategic partners of the Company. These stock options granted have a maximum contractual life of 7 years. The stock options granted in 2014 were granted under the IMAX LTIP.

As at December 31, 2016 non-employee options outstanding amounted to 17,000 stock options (2015 — 38,750, 2014 — 31,500) with a weighted average exercise price of $29.64 (2015 — $26.79, 2014 — $21.75). 15,200 stock options (2015 — 21,525, 2014 — 16,100) were exercisable with an average weighted exercise price of $30.10 (2015 — $26.34, 2014 — $18.14) and the vested options have an aggregate intrinsic value of $0.1 million (2015 — $0.2 million, 2014 — $0.2 million). The weighted average fair value of stock options granted to non-employees during 2014 at the measurement date was $4.84 per share, utilizing a Binomial Model with the following underlying assumptions:

		Years Ended December 31
	2016		2015	2014

Average risk-free interest rate		n/a	n/a	0.53%
Contractual option life		n/a	n/a	2 years
Average expected volatility		n/a	n/a	32.5%
Dividend yield		n/a	n/a	0%

In 2016, the Company recorded a charge of less than $0.1 million, (2015 — $0.1 million, 2014 — $0.1 million) to selling, general and administrative expenses related to the non-employee stock options. Included in accrued liabilities is an accrual of less than $0.1 million for non-employee stock options (December 31, 2015 — less than $0.1 million).

China Long-Term Incentive Plan (“China LTIP”)

The China LTIP was adopted by IMAX China Holding, Inc. (“IMAX China”), a subsidiary of the Company, in October 2012. Each stock option (“China Option”), RSU or cash settled share-based payment (“CSSBP”) issued under the China LTIP represents an opportunity to participate economically in the future growth and value creation of IMAX China. Prior to the initial public offering of IMAX China on October 8, 2015 (the “IMAX China IPO”), the China Options and CSSBPs issued by IMAX China operated in tandem with options granted to certain employees of IMAX China under the Company’s SOP and the IMAX LTIP (“Tandem Options”).

During 2015, no Tandem Options were granted in conjunction with China Options or CSSBPs. Immediately prior to the IMAX China IPO, there were 186,446 outstanding and unvested Tandem Options issued under the Company’s SOP and IMAX LTIP with a weighted average exercise price of $23.70 per share. The Tandem Options had a maximum contractual life of 7 years. The total fair value of the Tandem Options granted with respect to the China LTIP was $1.9 million. The Company was recognizing this expense over a 5-year period.

Pursuant to their terms, upon the occurrence of a qualified initial public offering, the 186,446 Tandem Options issued would forfeit immediately and the related charge would be reversed. As a result of the IMAX China IPO on October 8, 2015, the 186,446 Tandem Options with an average price of $23.70 per share were forfeited immediately. The Company recorded a recovery of $0.6 million in 2015 (2014 - $0.3 million expense) related to the forfeiture of Tandem Options issued under the Company’s SOP and IMAX LTIP.

The Company subsequently recognized an immediate charge related to the vesting of China Options and certain CSSBPs for China employees. The total fair value of the China Options and CSSBP awards granted with respect to the China LTIP was $3.9 million and $2.1 million, respectively. During the fourth quarter of 2015, a charge of $2.1 million and $1.4 million was recorded relating to the China Options and CSSBPs, respectively. The remaining charge will be recognized over the related requisite period. The CSSBPs represent the right to receive cash payments in an amount equal to a certain percentage of the excess of the total equity value of IMAX China based on the per share price in the IMAX China IPO over the strike price of the CSSBPs. The CSSBPs were issued in conjunction with the China LTIP, with similar terms and conditions as the China Options. The CSSBP awards are accounted as liability awards, however the fair value of the liability is fixed at the time of the initial public offering. During the fourth quarter of 2016, a portion of the CSSBPs vested and were settled in cash for $0.5 million (2015 — $1.0 million).

In connection with the IMAX China IPO and in accordance with the China LTIP, IMAX China adopted a post-IPO share option plan and a post-IPO restricted stock unit plan. Pursuant to these plans, IMAX China issued additional China Options and China LTIP Restricted Share Units (“China RSUs”) during the year ended December 31, 2016.

In 2016, the Company recorded an expense related to the China Options, China RSUs and CSSBPs of $1.0 million, $0.5 million and $0.4 million, respectively. The liability recognized with respect to the CSSBPs as at December 31, 2016 was $0.3 million (December 31, 2015 — $0.4 million).

Stock Option Summary

The following table summarizes certain information in respect of option activity under the SOP and IMAX LTIP:

					Weighted Average Exercise
	Number of Shares				Price Per Share
	2016	2015	2014	2016		2015		2014

Options outstanding, beginning of year	4,805,244	5,925,660	6,263,121	$	27.03	$	24.24	$	21.11
Granted	984,452	873,929	872,155		31.49		31.59		27.48
Exercised	(518,018)	(1,761,675)	(1,149,587)		22.07		20.21		9.42
Forfeited	(66,903)	(232,670)	(36,242)		29.28		24.60		24.63
Cancelled	(14,233)	-	(23,787)		24.82		-		33.60
Options outstanding, end of year	5,190,542	4,805,244	5,925,660		28.35		27.03		24.24
Options exercisable, end of year	4,001,078	2,800,723	3,368,558		27.79		25.83		22.69

In 2016, the Company cancelled 14,233 stock options from its IMAX LTIP surrendered by Company employees (2015 — nil, 2014 — nil). In 2016 and 2015, the Company did not cancel any stock options from its SOP. In 2014 the Company cancelled 23,787 stock options from its SOP surrendered by Company employees.

As at December 31, 2016, 5,190,542 options included both fully vested and unvested options with a weighted average exercise price of $28.35, aggregate intrinsic value of $17.6 million and weighted average remaining contractual life of 4.3 years. As at December 31, 2016, options that are exercisable have an intrinsic value of $15.4 million and a weighted average remaining contractual life of 4.2 years. The intrinsic value of options exercised in 2016 was $5.4 million (2015 — $29.8 million, 2014 — $21.8 million).

As at December 31, 2016, the IMAX LTIP trustee held 66,093 shares purchased for $2.0 million in the open market to be issued upon the settlement of stock options. The shares held with the trustee are recorded at cost and are reported as a reduction against capital stock on the consolidated balance sheet.

Restricted Share Units

RSUs have been granted to employees, consultants and directors under the IMAX LTIP. Each RSU represents a contingent right to receive one common share and is the economic equivalent of one common share. The grant date fair value of each RSU is equal to the share price of the Company’s stock at the grant date. The Company recorded an expense of $15.8 million for the year ended December 31, 2016 (2015 — $8.2 million, 2014 — $5.8 million), related to RSU grants issued to employees and directors in the plan. The Company did not issue any RSU grants to advisors or strategic partners of the Company for the year ended December 31, 2016. The Company recorded an expense of $nil for the year ended December 31, 2016 (2015 — less than $0.1 million, 2014 — less than $0.1 million), related to RSU grants issued to certain advisors and strategic partners of the Company.

Total stock-based compensation expense related to non-vested RSUs not yet recognized at December 31, 2016 and the weighted average period over which the awards are expected to be recognized is $29.0 million and 2.4 years (2015 — $24.4 million and 3.0 years, 2014 — $11.0 million and 2.9 years). The Company’s actual tax benefits realized for the tax deductions related to the vesting of RSUs was $4.6 million for the year ended December 31, 2016 (2015 — $2.0 million, 2014 — $0.4 million).

Historically, RSUs granted under the IMAX LTIP have vested between immediately and four years from the grant date. In connection with the amendment and restatement of the IMAX LTIP at the Company’s annual and special meeting of shareholders on June 6, 2016, the IMAX LTIP plan was amended to impose a minimum one-year vesting period on future RSU grants, with a carve-out for 300,000 RSUs that may vest on a shorter schedule. During 2016, 39,726 RSUs with a vesting period of less than one year were issued from the carve-out of 300,000 RSUs under the amended IMAX LTIP plan. Vesting of the RSUs is subject to continued employment or service with the Company.

The following table summarizes certain information in respect of RSU activity under the IMAX LTIP:

	Number of Awards			Weighted Average Grant Date Fair Value Per Share
	2016	2015	2014		2016		2015		2014

RSUs outstanding, beginning of year	973,637	595,834	264,140	$	32.27	$	27.13	$	26.14
Granted	664,278	605,349	484,088		32.29		36.04		27.42
Vested and settled	(466,918)	(207,371)	(148,001)		30.63		28.81		26.29
Forfeited	(46,817)	(20,175)	(4,393)		31.16		29.27		26.88
RSUs outstanding, end of year	1,124,180	973,637	595,834		33.01		32.27		27.13

Issuer Purchases of Equity Securities

On June 16, 2014, the Company’s board of directors approved a new $150.0 million share repurchase program for shares of the Company’s common stock, which program was amended on April 20, 2016 to increase the aggregate purchase allowance to $200.0 million. Purchases under the program commenced during the third quarter of 2014, and the program expires on June 30, 2017. The repurchases may be made either in the open market or through private transactions, subject to market conditions, applicable legal requirements and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.

In 2016, the Company repurchased 3,849,222 (2015 ― 1,000,000) common shares at an average price of $30.25 per share (2015 ― $34.25 per share). The retired shares were purchased for $116.5 million (2015 ― $34.3 million). The average carrying value of the stock retired was deducted from common stock and the remaining excess over the average carrying value of stock was charged to accumulated deficit. Since the inception of the program, the Company has repurchased 4,961,256 common shares at an average price of $30.99 per share. The Company has $46.3 million available under its approved repurchase program.

The total number of shares purchased during the year ended December 31, 2016 and 2015 does not include any shares purchased in the administration of employee share-based compensation plans (which amounted to 630,720 (2015 – 269,501) common shares, at an average price of $31.52 (2015 – $37.11) per share).

Impact of Stock-based Compensation Accounting Standard Update

ASU 2016-09, related to stock-based compensation, was issued in March 2016 and early adopted in June 2016. ASU 2016-09 eliminates the requirement to estimate and apply a forfeiture rate to reduce stock compensation expense during the vesting period and, instead, account for forfeitures as they occur. ASU 2016-09 requires that this change be adopted using the modified retrospective approach. The impact from the adoption of the provisions related to forfeiture rates was reflected on a modified retrospective basis resulting in a $4.4 million decrease to Accumulated earnings, $0.9 million increase to Deferred income taxes and $5.3 million increase to Other equity. An increase in APIC and a reduction in stock-based compensation expense of $2.7 million for the year ended December 31, 2016 was also recorded. Additionally, ASU 2016-09 addresses the presentation of excess tax benefits and employee taxes paid on the consolidated statement of cash flows. The Company is required to present excess tax benefits as an operating activity on the consolidated statement of cash flows, which is where the Company previously classified these items. ASU 2016-09 also requires the presentation of employee taxes as a financing activity on the consolidated statement of cash flows. This change was reflected in the consolidated statement of cash flows retrospectively. See notes 3 and 9 for further discussion of the impact from the adoption of ASU 2016-09.

Income per share

Reconciliations of the numerator and denominator of the basic and diluted per-share computations are comprised of the following:

	Years Ended December 31,
	2016		2015		2014

Net income attributable to common shareholders	$	28,788	$	55,844	$	39,736
Less: Accretion charges associated with redeemable common stock		-		(769)		(426)
Net income applicable to common shareholders	$	28,788	$	55,075	$	39,310
Weighted average number of common shares (000's):
Issued and outstanding, beginning of period		69,673		68,988		67,841
Weighted average number of shares (repurchased) issued during the period, net		(2,098)		538		505
Weighted average number of shares used in computing basic earnings per share		67,575		69,526		68,346
Assumed exercise of stock options and RSUs, net of shares assumed repurchased		688		1,532		1,408
Weighted average number of shares used in computing diluted earnings per share		68,263		71,058		69,754

The calculation of diluted earnings per share exclude 2,814,907 (2015 ― 1,249,343) shares that are issuable upon exercise of 377,048 (2015 ― 313,645) RSUs and 2,437,859 (2015 ― 935,698) stock options for the years ended December 31, 2016 and 2015, as the impact of these exercises would be antidilutive.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

Consolidated Statements of Operations Supplemental Information	12 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Statements of Operations Supplemental Information	15. Consolidated Statements of Operations Supplemental Information Other Revenues The Company enters into theater system arrangements with customers that typically contain customer payment obligations prior to the scheduled installation of the theater systems. During the period of time between signing and theater system installation, certain customers each year are unable to, or elect not to, proceed with the theater system installation for a number of reasons, including business considerations, or the inability to obtain certain consents, approvals or financing. Once the determination is made that the customer will not proceed with installation, the customer and/or the Company may terminate the arrangement by default or by entering into a consensual buyout. In these situations, the parties are released from their future obligations under the arrangement, and the initial payments that the customer previously made to the Company are typically not refunded and are recognized as Other Revenues. In addition, the Company enters into agreements with customers to terminate their obligations for additional theater system configurations, which were in the Company’s backlog. Other revenues from settlement arrangements were $1.3 million, $0.1 million and $nil in 2016, 2015 and 2014, respectively. Foreign Exchange Included in selling, general and administrative expenses for the year ended December 31, 2016 is $0.9 million for a net foreign exchange loss related to the translation of foreign currency denominated monetary assets and liabilities as compared to a net loss of $2.4 million and a net loss of $1.5 million for the year ended December 31, 2015 and 2014, respectively. See note 19(d) for additional information. Collaborative Arrangements Joint Revenue Sharing Arrangements In a joint revenue sharing arrangement, the Company receives a portion of a theater’s box-office and concession revenues, and in some cases a small upfront or initial payment, in exchange for placing a theater system at the theater operator’s venue. Under joint revenue sharing arrangements, the customer has the ability and the right to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company’s joint revenue sharing arrangements are typically non-cancellable for 10 years or longer with renewal provisions. Title to equipment under joint revenue sharing arrangements generally does not transfer to the customer. The Company’s joint revenue sharing arrangements do not contain a guarantee of residual value at the end of the term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and extended warranty throughout the term. The customer is responsible for obtaining insurance coverage for the theater systems commencing on the date specified in the arrangement’s shipping terms and ending on the date the theater systems are delivered back to the Company. The Company has signed joint revenue sharing agreements with 48 exhibitors (2015 — 43) for a total of 995 theater systems (2015 — 741), of which 640 theaters (2015 — 529) were operating as at December 31, 2016. The terms of the Company’s joint revenue sharing arrangements are similar in nature, rights and obligations. The accounting policy for the Company’s joint revenue sharing arrangements is disclosed in note 2(m). Amounts attributable to transactions arising between the Company and its customers under joint revenue sharing arrangements are included in Equipment and Product Sales and Rentals revenue and for the year ended December 31, 2016 amounted to $91.4 million (2015 — $99.1 million, 2014 — $68.4 million). IMAX DMR In an IMAX DMR arrangement, the Company transforms conventional motion pictures into the Company’s large screen format, allowing the release of Hollywood content to the global IMAX theater network. In a typical IMAX DMR film arrangement, the Company will absorb its costs for the digital re-mastering and then recoup this cost from a percentage of the box-office receipts of the film, which in recent years has averaged approximately 12.5% outside of Greater China and a lower percentage for certain films within Greater China. The Company does not typically hold distribution rights or the copyright to these films. In 2016, the majority of IMAX DMR revenue was earned from the exhibition of 51 IMAX DMR films (2015 — 44) throughout the IMAX theater network. The accounting policy for the Company’s IMAX DMR arrangements is disclosed in note 2(m). Amounts attributable to transactions arising between the Company and its customers under IMAX DMR arrangements are included in Services revenues and for December 31, 2016 amounted to $106.4 million (2015 — $107.1 million, 2014 — $83.2 million). Co-Produced Film Arrangements In certain film arrangements, the Company co-produces a film with a third party whereby the third party retains the copyright and rights to the film except that the Company obtains exclusive theatrical distribution rights to the film. Under these arrangements, both parties contribute funding to the Company’s wholly-owned production company for the production of the film and for associated exploitation costs. Clauses in the film arrangements generally provide for the third party to take over the production of the film if the cost of the production exceeds its approved budget or if it appears as though the film will not be delivered on a timely basis. As at December 31, 2016, the Company has one significant co-produced film arrangement which primarily represents the VIE total assets and liabilities balance of $0.4 million and five other co-produced film arrangements, the terms of which are similar. The accounting policies relating to co-produced film arrangements are disclosed in notes 2(a) and 2(m). In 2016, amounts totaling $1.4 million (2015 — $1.5 million, 2014 — $3.5 million) attributable to transactions between the Company and other parties involved in the production of the films have been included in cost and expenses applicable to revenues-services.

Receivable Provisions, Net of Recoveries

12 Months Ended

Dec. 31, 2016

Receivable Provisions, Net of Recoveries [Abstract]

Receivable Provisions, Net of Recoveries

16. Receivable Provisions, Net of Recoveries

The following table reflects the Company’s receivable provisions net of recoveries recorded in the consolidated statements of operations:

	Years Ended December 31,
	2016		2015		2014
Accounts receivable provisions, net of recoveries	$	1,029	$	677	$	725
Financing receivable provisions, net of recoveries		(75)		75		193
Receivable provisions, net of recoveries	$	954	$	752	$	918

Consolidated Statements of Cash Flows Supplemental Information

12 Months Ended

Dec. 31, 2016

Consolidated Statements of Cash Flows Supplemental Information [Abstract]

Condensed Consolidated Statements of Cash Flows Supplemental Information

17. Consolidated Statements of Cash Flows Supplemental Information

Changes in other non-cash operating assets and liabilities are comprised of the following:

		Years Ended December 31,
			2016		2015		2014
Decrease (increase) in:
	Accounts receivable	$	(1,414)	$	(22,521)	$	(4,318)
	Financing receivables		(4,627)		(13,628)		(40)
	Inventories		(3,825)		(21,070)		(7,603)
	Prepaid expenses		(127)		(1,552)		(1,346)
	Commissions and other deferred selling expenses		206		(203)		(769)
	Insurance recoveries		132		4		10,958
	Other assets, prepaid tax		(5,664)		-		(2,984)
	Other assets		(1,376)		(456)		(459)
Increase (decrease) in:
	Accounts payable		(3,360)		9,183		(5,186)
	Accrued and other liabilities		3,914		(2,057)		6,002
	Deferred revenue		(14,733)		16,242		12,102
		$	(30,874)	$	(36,058)	$	6,357

Cash payments made on account of:

	Years Ended December 31,
		2016		2015		2014
Income taxes	$	24,640	$	22,798	$	8,885
Interest	$	721	$	411	$	48

Depreciation and amortization are comprised of the following:

		Years Ended December 31,
			2016		2015		2014
Film assets(1)		$	16,324	$	16,357	$	11,851
Property, plant and equipment
	Joint revenue sharing arrangements		15,840		13,663		12,148
	Other property, plant and equipment		9,692		7,698		5,616
Other intangible assets			3,235		3,285		2,988
Other assets			862		784		627
Deferred financing costs			532		1,016		526
		$	46,485	$	42,803	$	33,756

______________

(1)	Included in film asset amortization is a charge of $0.2 million (2015 —$0.9 million, 2014 —$0.3 million) relating to changes in estimates based on the ultimate recoverability of future films.

Write-downs, net of recoveries, are comprised of the following:

		Years Ended December 31,
			2016		2015		2014
Asset impairments
	Property, plant and equipment	$	223	$	405	$	314
	Impairment of investments		194		425		3,206
Other charges (recoveries)
	Accounts receivables		1,029		677		725
	Financing receivables		(75)		75		193
	Inventories(1)		458		572		359
	Film assets		3,020		-		-
	Property, plant and equipment(2)		885		1,485		440
	Other intangible assets		206		86		57
		$	5,940	$	3,725	$	5,294


Inventory charges
	Recorded in costs and expenses applicable to revenues - equipment & product sales	$	227	$	537	$	209
	Recorded in costs and expenses applicable to revenues - services		231		35		150
		$	458	$	572	$	359

______________

(1)	In 2016, the Company recorded a charge of $0.5 million (2015 — $0.6 million, 2014 — $0.4 million, respectively) in costs and expenses applicable to revenues, primarily for its laser-based projector inventories. Specifically, IMAX systems includes an inventory charge of $0.2 million (2015 — $0.5 million, 2014 — $0.2 million). Theater system maintenance includes inventory write-downs of $0.2 million (2015 — less than $0.1 million, 2014 — $0.2 million).

(2)	In 2016, the Company recorded a charge of $0.3 million (2015 — $0.4 million; 2014 — $0.5 million) reflecting property, plant and equipment that were no longer in use. In 2016, the Company also recorded a charge of $0.6 million (2015 — $0.6 million) in cost of sales applicable to Equipment and product sales upon the upgrade of xenon-based digital systems under operating lease arrangements to laser-based digital systems under sales or sales-type lease arrangements. In addition, in 2015, the Company recorded a charge of $0.5 million in cost of sales applicable to Rentals upon the upgrade of certain xenon-based digital systems to laser-based digital systems operating under joint revenue sharing arrangements.

Segmented Information

12 Months Ended

Dec. 31, 2016

Segmented Information [Abstract]

Segmented Information

18. Segmented Information

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment includes the design, manufacture, sale or lease of IMAX theater projection system equipment. The theater system maintenance segment includes the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment includes the provision of IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The film production and IMAX DMR segment includes the production of films and the performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment provides film post-production and film print services. The Company refers to all theaters using the IMAX theater system as “IMAX theaters”. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items. The accounting policies of the segments are the same as those described in note 2.

Management, including the Company’s Chief Executive Officer (“CEO”) who is the Company’s Chief Operating Decision Maker (as defined in the Segment Reporting Topic of the FASB ASC), assesses segment performance based on segment revenues, gross margins and film performance. Selling, general and administrative expenses, research and development costs, amortization of intangibles, receivables provisions (recoveries), write-downs net of recoveries, interest income, interest expense and tax (provision) recovery are not allocated to the segments.

Transactions between the film production and IMAX DMR segment and the film post-production segment are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

Transactions between the other segments are not significant.

Following recent changes in senior management, the Company is in the process of re-evaluating how it assesses the performance of the business. As a result of this process, modifications are being made to the CEO’s reporting package to support a revised reporting structure which will move away from the Company’s historical two primary reporting groups – IMAX Theater Systems and Film. The changes being contemplated will result in four primary reporting groups, comprising (1) Network Business, representing revenue generated by box-office results and which will include the reportable segments of DMR and JRSAs excluding hybrid fixed payments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments and which will also include the fixed hybrid payments from the JRSA segment; (3) New Business, which will include virtual reality, IMAX Shift and IMAX Home Entertainment and (4) Other. The new reporting groups are expected to be implemented in the first quarter of 2017. The new reporting structure is expected to assist users of the financial statements with an enhanced understanding of how management views the business.

Operating Segments

		Years Ended December 31,
			2016		2015		2014
Revenue(1)
IMAX theater systems
	IMAX systems	$	105,527	$	102,128	$	72,992
	Theater system maintenance		40,430		36,944		34,042
	Joint revenue sharing arrangements		91,413		99,120		68,418
			237,370		238,192		175,452

Films
	Production and IMAX DMR		106,403		107,089		83,172
	Distribution		5,254		3,876		8,932
	Post-production		8,873		7,069		10,831
			120,530		118,034		102,935

Other			19,434		17,579		12,154

Total		$	377,334	$	373,805	$	290,541

Gross margin
IMAX theater systems
	IMAX systems(2)	$	60,090	$	59,168	$	47,928
	Theater system maintenance(2)		13,659		12,702		12,375
	Joint revenue sharing arrangements(3)		59,837		68,372		44,714
			133,586		140,242		105,017

Films
	Production and IMAX DMR(3)		69,196		77,645		62,922
	Distribution(3)		(3,909)		(259)		2,274
	Post-production		3,729		1,381		3,046
			69,016		78,767		68,242

Other			76		279		129

Total		$	202,678	$	219,288	$	173,388

		Years Ended December 31,
		2016			2015		2014
Depreciation and amortization
IMAX systems		$	4,165	$	5,685	$	1,910
Theater systems maintenance			72		72		225
Joint revenue sharing arrangements			16,724		14,443		14,614
Films
	Production and IMAX DMR		15,028		14,330		10,751
	Distribution		1,444		2,129		1,512
	Post-production		2,769		1,465		481
Other			1,567		704		671
Corporate and other non-segment specific assets			4,716		3,975		3,592
Total		$	46,485	$	42,803	$	33,756

			Years Ended December 31,
			2016		2015		2014
Asset impairments and write-downs, net of recoveries
IMAX systems		$	916	$	2,298	$	1,128
Theater systems maintenance			1,002		277		150
Joint revenue sharing arrangements			266		528		397
Films
	Distribution		3,020		-		-
	Post-production		223		-		-
Other			-		-		314
Corporate and other non-segment specific assets			513		622		3,305
Total		$	5,940	$	3,725	$	5,294

		Years Ended December 31,
			2016		2015		2014
Purchase of property, plant and equipment
IMAX systems		$	3,170	$	8,846	$	8,822
Theater systems maintenance			481		555		229
Joint revenue sharing arrangements			42,910		28,474		16,838
Films
	Production and IMAX DMR		1,121		1,350		15,245
	Distribution		21		830		1,582
	Post-production		1,746		16,337		2,176
Other			5,874		1,986		1,337
Corporate and other non-segment specific assets			2,865		13,353		10,713
Total		$	58,188	$	71,731	$	56,942

		Years Ended December 31
			2016		2015
Assets
IMAX systems (4)		$	218,835	$	215,602
Theater systems maintenance (4)			28,763		20,907
Joint revenue sharing arrangements (4)			203,227		179,156
Films
	Production and IMAX DMR		39,688		46,262
	Distribution		21,059		17,534
	Post-production		35,865		26,759
Other			18,179		23,485
Corporate and other non-segment specific assets			291,718		400,924
Total		$	857,334	$	930,629

______________

(1)	The Company’s largest customer represents 13.5% of total revenues as at December 31, 2016 (2015 – 16.0%, 2014 – 14.5%).

(2)	In 2016, the Company recorded a charge of $0.5 million (2015 – $0.6 million, 2014 – $0.4 million, respectively) in costs and expenses applicable to revenues, primarily for its laser-based projector inventories. Specifically, IMAX systems includes an inventory charge of $0.2 million (2015 – $0.5 million, 2014 – $0.2 million). Theater system maintenance includes inventory write-downs of $0.2 million (2015 – less than $0.1 million, 2014 – $0.2 million).

(3)	IMAX systems include marketing and commission costs of $3.0 million, $3.0 million and $2.7 million in 2016, 2015 and 2014, respectively. Joint revenue sharing arrangements segment margins include advertising, marketing, and commission costs of $4.1 million, $4.3 million and $3.2 million in 2016, 2015 and 2014, respectively. Production and DMR segment margins include marketing costs of $17.5 million, $13.3 million and $7.1 million in 2016, 2015 and 2014, respectively. Distribution segment margins include marketing expense of $2.2 million, recovery of $0.1 million and expense of $0.6 million in 2016, 2015 and 2014, respectively.

(4)	Goodwill is allocated on a relative fair market value basis to the IMAX systems segment, theater system maintenance segment and joint revenue sharing segment. There has been no change in the allocation of goodwill from the prior year.

Geographic Information

Revenue by geographic area is based on the location of the customer. Revenue related to IMAX DMR is presented based upon the geographic location of the theaters that exhibit the re-mastered films. IMAX DMR revenue is generated through contractual relationships with studios and other third parties and these may not be in the same geographical location as the theater.

	Years Ended December 31,
	2016			2015		2014
Revenue
United States	$	129,844	$	136,017	$	107,830
Canada		12,822		11,665		10,309
Greater China		118,532		110,591		78,218
Western Europe		36,286		39,569		30,245
Asia (excluding Greater China)		35,283		38,143		26,276
Russia & the CIS		14,908		12,412		15,700
Latin America		12,191		10,179		12,672
Rest of the World		17,468		15,229		9,291
Total	$	377,334	$	373,805	$	290,541

No single country in the Rest of the World, Western Europe, Latin America and Asia (excluding Greater China) classifications comprise more than 10% of total revenue.

	As at December 31
		2016		2015
Property, plant and equipment
United States	$	104,083	$	105,641
Canada		39,467		40,943
Greater China		69,751		51,990
Western Europe		19,308		8,359
Asia (excluding Greater China)		8,460		10,369
Rest of the World		4,346		965
Total	$	245,415	$	218,267

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

Financial Instruments

12 Months Ended

Dec. 31, 2016

Financial Instruments [Abstract]

Financial Instruments

19. Financial Instruments

Financial Instruments

The Company maintains cash with various major financial institutions. The Company’s cash is invested with highly rated financial institutions.

The Company’s accounts receivables and financing receivables are subject to credit risk. The Company’s accounts receivable and financing receivables are concentrated with the theater exhibition industry and film entertainment industry. To minimize the Company’s credit risk, the Company retains title to underlying theater systems leased, performs initial and ongoing credit evaluations of its customers and makes ongoing provisions for its estimate of potentially uncollectible amounts. The Company believes it has adequately provided for related exposures surrounding receivables and contractual commitments.

Fair Value Measurements

The carrying values of the Company’s cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities due within one year approximate fair values due to the short-term maturity of these instruments. The Company’s other financial instruments at December 31, are comprised of the following:

		As at December 31, 2016				As at December 31, 2015
		Carrying		Estimated		Carrying		Estimated
		Amount		Fair Value		Amount		Fair Value
Cash and cash equivalents	$	204,759	$	204,759	$	317,449	$	317,449
Net financed sales receivable	$	114,041	$	115,014	$	106,286	$	108,184
Net investment in sales-type leases	$	8,084	$	8,372	$	10,945	$	11,154
Convertible loan receivable	$	1,000	$	1,000	$	-	$	-
Available-for-sale investment	$	1,000	$	1,007	$	1,000	$	997
Foreign exchange contracts — designated forwards	$	(296)	$	(296)	$	(4,423)	$	(4,423)
Borrowings under the Playa Vista Loan	$	(27,667)	$	(27,667)	$	(29,667)	$	(29,667)

Cash and cash equivalents are comprised of cash and interest-bearing investments with original maturity dates to the Company of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value (Level 1 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at December 31, 2016 and 2015, respectively.

The estimated fair values of the net financed sales receivable and net investment in sales-type leases are estimated based on discounting future cash flows at currently available interest rates with comparable terms (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at December 31, 2016 and 2015, respectively.

The fair value of the Company’s available-for-sale investment is determined using quoted prices in active markets (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at December 31, 2016.

The fair value of the Company’s convertible loan receivable approximates market value as at December 31, 2016, as the loan was recently issued (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy).

The fair value of foreign currency derivatives are determined using quoted prices in active markets (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at December 31, 2016 and 2015, respectively. These identical instruments are traded on a closed exchange.

The carrying value of borrowings under the Playa Vista Loan approximates fair value as the interest rates offered under the loan are close to December 31, 2016 market rates for the Company for debt of the same remaining maturities (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at December 31, 2016.

There were no significant transfers between Level 1 and Level 2 during the year ended December 31, 2016 or 2015. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement.

There were no transfers in or out of the Company’s Level 3 assets during the year ended December 31, 2016.

Financing Receivables

The Company’s net investment in leases and its net financed sale receivables are subject to the disclosure requirements of ASC 310 “Receivables”. Due to differing risk profiles of its net investment in leases and its net financed sales receivables, the Company views its net investment in leases and its net financed sale receivables as separate classes of financing receivables. The Company does not aggregate financing receivables to assess impairment.

The Company monitors the credit quality of each customer on a frequent basis through collections and aging analyses. The Company also holds meetings monthly in order to identify credit concerns and whether a change in credit quality classification is required for the customer. A customer may improve in their credit quality classification once a substantial payment is made on overdue balances or the customer has agreed to a payment plan with the Company and payments have commenced in accordance to the payment plan. The change in credit quality indicator is dependent upon management approval.

The Company classifies its customers into four categories to indicate the credit quality worthiness of its financing receivables for internal purposes only:

Good standing — Theater continues to be in good standing with the Company as the client’s payments and reporting are up-to-date.

Credit Watch — Theater operator has begun to demonstrate a delay in payments, and has been placed on the Company's credit watch list for continued monitoring, but active communication continues with the Company. Depending on the size of outstanding balance, length of time in arrears and other factors, transactions may need to be approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "Pre-approved transactions" category, but not in as good of condition as those receivables in "Good standing."

Pre-approved transactions only — Theater operator is demonstrating a delay in payments with little or no communication with the Company. All service or shipments to the theater must be reviewed and approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "All transactions suspended" category, but not in as good of condition as those receivables in "Credit Watch." Depending on the individual facts and circumstances of each customer, finance income recognition may be suspended if management believes the receivable to be impaired.

All transactions suspended — Theater is severely delinquent, non-responsive or not negotiating in good faith with the Company. Once a theater is classified as “All transactions suspended” the theater is placed on nonaccrual status and all revenue recognitions related to the theater are stopped.

The following table discloses the recorded investment in financing receivables by credit quality indicator:

	As at December 31, 2016						As at December 31, 2015
	Minimum		Financed				Minimum		Financed
	Lease		Sales				Lease		Sales
	Payments		Receivables		Total		Payments		Receivables		Total

In good standing	$	7,741	$	111,568	$	119,309	$	10,252	$	105,352	$	115,604
Credit Watch		-		1,514		1,514		-		-		-
Pre-approved transactions		-		842		842		-		757		757
Transactions suspended		1,015		611		1,626		1,365		745		2,110
	$	8,756	$	114,535	$	123,291	$	11,617	$	106,854	$	118,471

While recognition of finance income is suspended, payments received by a customer are applied against the outstanding balance owed. If payments are sufficient to cover any unreserved receivables, a recovery of provision taken on the billed amount, if applicable, is recorded to the extent of the residual cash received. Once the collectibility issues are resolved and the customer has returned to being in good standing, the Company will resume recognition of finance income.

The Company’s investment in financing receivables on nonaccrual status is as follows:

	As at December 31, 2016				As at December 31, 2015
	Recorded		Related		Recorded		Related
	Investment		Allowance		Investment		Allowance

Net investment in leases	$	1,015	$	(672)	$	1,365	$	(672)
Net financed sales receivables		611		(494)		1,502		(568)
Total	$	1,626	$	(1,166)	$	2,867	$	(1,240)

The Company considers financing receivables with aging between 60-89 days as indications of theaters with potential collection concerns. The Company will begin to focus its review on these financing receivables and increase its discussions internally and with the theater regarding payment status. Once a theater’s aging exceeds 90 days, the Company’s policy is to review and assess collectibility on the theater’s past due accounts. Over 90 days past due is used by the Company as an indicator of potential impairment as invoices up to 90 days outstanding could be considered reasonable due to the time required for dispute resolution or for the provision of further information or supporting documentation to the customer.

The Company’s aged financing receivables are as follows:

	As at December 31, 2016
									Related						Recorded
	Accrued						Billed		Unbilled		Total				Investment
	and						Financing		Recorded		Recorded		Related		Net of
	Current		30-89 Days		90+ Days		Receivables		Investment		Investment		Allowances		Allowances

Net investment in leases	$	28	$	159	$	781	$	968	$	7,788	$	8,756	$	(672)	$	8,084
Net financed sales receivables		2,393		1,724		2,368		6,485		108,050		114,535		(494)		114,041
Total	$	2,421	$	1,883	$	3,149	$	7,453	$	115,838	$	123,291	$	(1,166)	$	122,125


	As at December 31, 2015
									Related						Recorded
	Accrued						Billed		Unbilled		Total				Investment
	and						Financing		Recorded		Recorded		Related		Net of
	Current		30-89 Days		90+ Days		Receivables		Investment		Investment		Allowances		Allowances

Net investment in leases	$	840	$	177	$	446	$	1,463	$	10,154	$	11,617	$	(672)	$	10,945
Net financed sales receivables		908		1,013		1,177		3,098		103,756		106,854		(568)		106,286
Total	$	1,748	$	1,190	$	1,623	$	4,561	$	113,910	$	118,471	$	(1,240)	$	117,231

The Company’s recorded investment in past due financing receivables for which the Company continues to accrue finance income is as follows:

	As at December 31, 2016
									Related				Recorded
	Accrued						Billed		Unbilled				Investment
	and						Financing		Recorded		Related		Past Due
	Current		30-89 Days		90+ Days		Receivables		Investment		Allowance		and Accruing

Net investment in leases	$	-	$	54	$	244	$	298	$	1,646	$	-	$	1,944
Net financed sales receivables		284		634		1,854		2,772		20,147		-		22,919
Total	$	284	$	688	$	2,098	$	3,070	$	21,793	$	-	$	24,863


	As at December 31, 2015
									Related				Recorded
	Accrued						Billed		Unbilled				Investment
	and						Financing		Recorded		Related		Past Due
	Current		30-89 Days		90+ Days		Receivables		Investment		Allowance		and Accruing

Net investment in leases	$	41	$	47	$	205	$	293	$	1,076	$	-	$	1,369
Net financed sales receivables		129		224		839		1,192		10,795		-		11,987
Total	$	170	$	271	$	1,044	$	1,485	$	11,871	$	-	$	13,356

The Company considers financing receivables to be impaired when it believes it to be probable that it will not recover the full amount of principal or interest owing under the arrangement. The Company uses its knowledge of the industry and economic trends, as well as its prior experiences to determine the amount recoverable for impaired financing receivables. The following table discloses information regarding the Company’s impaired financing receivables:

	Impaired Financing Receivables
	For the Year Ended December 31, 2016
							Average		Interest
	Recorded		Unpaid		Related		Recorded		Income
	Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
Net financed sales receivables	$	525	$	75	$	(494)	$	637	$	-

Recorded investment for which there is no related allowance:
Net financed sales receivables		-		-		-		-		-

Total recorded investment in impaired loans:
Net financed sales receivables	$	525	$	75	$	(494)	$	637	$	-

	Impaired Financing Receivables
	For the Year Ended December 31, 2015
							Average		Interest
	Recorded		Unpaid		Related		Recorded		Income
	Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related
allowance:
Net financed sales receivables	$	748	$	298	$	(568)	$	748	$	-

Recorded investment for which there is no related allowance:
Net financed sales receivables		-		-		-		-		-

Total recorded investment in impaired loans:
Net financed sales receivables	$	748	$	298	$	(568)	$	748	$	-

The Company’s activity in the allowance for credit losses for the period and the Company’s recorded investment in financing receivables is as follows:

	Year Ended December 31, 2016
	Net Investment		Net Financed
	in Leases		Sales Receivables
Allowance for credit losses:

Beginning balance	$	672	$	568
Charge-offs		-		-
Recoveries		-		(74)
Provision		-		-
Ending balance	$	672	$	494

Ending balance: individually evaluated for impairment	$	672	$	494


Financing receivables:

Ending balance: individually evaluated for impairment	$	8,756	$	114,535

	Year Ended December 31, 2015
	Net Investment		Net Financed
	in Leases		Sales Receivables
Allowance for credit losses:

Beginning balance	$	972	$	494
Charge-offs		(300)		-
Recoveries		-		-
Provision		-		74
Ending balance	$	672	$	568

Ending balance: individually evaluated for impairment	$	672	$	568


Financing receivables:

Ending balance: individually evaluated for impairment	$	11,617	$	106,854

Foreign Exchange Risk Management

The Company is exposed to market risk from changes in foreign currency rates. A majority portion of the Company’s revenues is denominated in U.S. dollars while a substantial portion of its costs and expenses is denominated in Canadian dollars. A portion of the net U.S. dollar cash flows of the Company is periodically converted to Canadian dollars to fund Canadian dollar expenses through the spot market. In China and Japan the Company has ongoing operating expenses related to its operations in Chinese Renminbi and Japanese yen, respectively. Net cash flows are converted to and from U.S. dollars through the spot market. The Company also has cash receipts under leases denominated in Chinese Renminbi, Japanese yen, Canadian dollars and Euros which are converted to U.S. dollars through the spot market. In addition, because IMAX films generate box-office in 74 different countries, unfavourable exchange rates between applicable local currencies, and the U.S. dollar affect the Company’s reported gross box-office and revenues, further impacting the Company’s results of operations. The Company’s policy is to not use any financial instruments for trading or other speculative purposes.

The Company entered into a series of foreign currency forward contracts to manage the Company’s risks associated with the volatility of foreign currencies. Certain of these foreign currency forward contracts met the criteria required for hedge accounting under the Derivatives and Hedging Topic of the FASB ASC at inception, and continue to meet hedge effectiveness tests at December 31, 2016 (the “Foreign Currency Hedges”), with settlement dates throughout 2017 and 2018. Foreign currency derivatives are recognized and measured in the balance sheet at fair value. Changes in the fair value (gains or losses) are recognized in the consolidated statement of operations except for derivatives designated and qualifying as foreign currency hedging instruments. For foreign currency hedging instruments, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in other comprehensive income and reclassified to the consolidated statement of operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the consolidated statement of operations. The Company currently does not hold any derivatives which are not designated as hedging instruments and therefore no gain or loss pertaining to an ineffective portion has been recognized.

The following tabular disclosures reflect the impact that derivative instruments and hedging activities have on the Company’s consolidated financial statements:

Notional value of foreign exchange contracts:

		As at December 31,
		2016		2015
Derivatives designated as hedging instruments:
Foreign exchange contracts — Forwards	$	37,825	$	30,710

Fair value of derivatives in foreign exchange contracts:



			As at December 31,
	Balance Sheet Location	2016		2015
Derivatives designated as hedging instruments:
Foreign exchange contracts — Forwards	Other assets	$	480	$	-
	Accrued and other liabilities		(776)		(4,423)
		$	(296)	$	(4,423)

Derivatives in Foreign Currency Hedging relationships are as follows:

			Years Ended December 31,
			2016		2015		2014
Foreign exchange contracts - Forwards	Derivative Loss Recognized
	in OCI (Effective Portion)	$	1,049	$	(5,881)	$	(2,524)
		$	1,049	$	(5,881)	$	(2,524)

	Location of Derivative Loss
	Reclassified from AOCI		Years Ended December 31,
	into Income (Effective Portion)		2016		2015		2014
	Selling, general and
Foreign exchange contracts - Forwards	administrative expenses	$	(3,078)	$	(3,217)	$	(1,186)
		$	(3,078)	$	(3,217)	$	(1,186)

The Company's estimated net amount of the existing gains as at December 31, 2016 is $0.1 million, which is expected to be reclassified to earnings within the next twelve months

Investments in New Business Ventures

The Company accounts for investments in new business ventures using the guidance of the FASB ASC 323 and the FASB ASC 320, as appropriate. As at December 31, 2016, the equity method of accounting is being utilized for investments with a total carrying value of $nil (December 31, 2015 ─ $1.0 million). The Company’s accumulated losses in excess of its equity investment were $0.5 million as at December 31, 2016, and are classified in Accrued and other liabilities. For the year ended December 31, 2016, gross revenues, cost of revenue and net loss for the investment were $0.6 million, $6.8 million and $6.2 million, respectively (2015 ─ $nil, $9.3 million, and $9.1 million, respectively). The Company has determined it is not the primary beneficiary of this VIE, and therefore this entity has not been consolidated. In 2016, the Company issued a convertible loan of $1.0 million to this entity with a term of 3 years with an annual effective interest rate of 5.0%. The instrument is classified as an available-for-sale investment due to certain features that allow for conversion to common stock in the entity in the event of certain triggers occurring. In addition, the Company has an investment in preferred stock of another business venture of $1.5 million which meets the criteria for classification as a debt security under the FASB ASC 320 and is recorded at a fair value of $nil at December 31, 2016 (December 31, 2015 — $nil). This investment was classified as an available-for-sale investment. Furthermore, the Company has an investment of $1.0 million (December 31, 2015 — $1.0 million) in the shares of an exchange traded fund. This investment is also classified as an available-for-sale investment. The Company has an investment of $2.5 million in the preferred shares of an enterprise which meet the criteria for classification as an equity security under FASB ASC 325. As at December 31, 2016, the Company recognized an other-than-temporary impairment of $0.2 million (2015 — $0.4 million) in the consolidated statement of operations. The total carrying value of investments in new business ventures at December 31, 2016 and 2015 is $1.0 million and $2.2 million, respectively, and is recorded in Other Assets.

Employees Pension and Postretirement Benefits

12 Months Ended

Dec. 31, 2016

Employees Pension and Postretirement Benefits [Abstract]

Employees Pension and Postretirement Benefits

20. Employee's Pension and Postretirement Benefits

Defined Benefit Plan

The Company has an unfunded U.S. defined benefit pension plan, the SERP, covering Richard L. Gelfond, Chief Executive Officer (“CEO”) of the Company. The SERP provides for a lifetime retirement benefit from age 55 determined as 75% of Mr. Gelfond’s best average 60 consecutive months of earnings over his employment history. The benefits were 50% vested as at July 2000, the SERP initiation date. The vesting percentage increased on a straight-line basis from inception until age 55. As at December 31, 2016, the benefits of Mr. Gelfond were 100% vested. Upon a termination for cause, prior to a change of control, Mr. Gelfond shall forfeit any and all benefits to which he may have been entitled, whether or not vested.

Under the terms of the SERP, if Mr. Gelfond’s employment terminated other than for cause (as defined in his employment agreement), he is entitled to receive SERP benefits in the form of a lump sum payment. SERP benefit payments to Mr. Gelfond are subject to a deferral for six months after the termination of his employment, at which time Mr. Gelfond will be entitled to receive interest on the deferred amount credited at the applicable federal rate for short-term obligations. Pursuant to an employment agreement dated November 8, 2016, the term of Mr. Gelfond’s employment was extended through December 31, 2019, although Mr. Gelfond has not informed the Company that he intends to retire at that time. Under the terms of the arrangement, no compensation earned beginning in 2011 is included in calculating his entitlement under the SERP.

The following assumptions were used to determine the obligation and cost of the Company’s SERP at the plan measurement dates:

		As at December 31,
		2016	2015	2014
Discount rate		2.18%	1.34%	1.30%
Lump sum interest rate:
	First 20 years	1.87%	2.82%	2.89%
	Thereafter	2.37%	2.95%	3.12%
Cost of living adjustment on benefits		1.20%	1.20%	1.20%

The amounts accrued for the SERP are determined as follows:

		Years Ended December 31,
		2016		2015
Projected benefit obligation:
	Obligation, beginning of year	$	19,478	$	19,405
	Interest cost		261		253
	Actuarial gain		(159)		(180)
	Obligation, end of year and unfunded status	$	19,580	$	19,478

The following table provides disclosure of the pension benefit obligation recorded in the consolidated balance sheets:

	As at December 31,
	2016		2015
Accrued benefits cost	$	(19,580)	$	(19,478)
Accumulated other comprehensive loss		1,165		1,323
Net amount recognized in the consolidated balance sheets	$	(18,415)	$	(18,155)

The following table provides disclosure of pension expense for the SERP for the year ended December 31:

	Years ended December 31,
	2016		2015		2014
Interest cost	$	261	$	253	$	264
Pension expense	$	261	$	253	$	264

The accumulated benefit obligation for the SERP was $19.6 million at December 31, 2016 (2015 — $19.5 million).

The following amounts were included in accumulated other comprehensive income and will be recognized as components of net periodic benefit cost in future periods:

		As at December 31,
	2016		2015			2014
Unrealized actuarial loss	$	1,165	$	1,323	$	1,503

No contributions were made for the SERP during 2016. The Company expects interest costs of $0.4 million to be recognized as a component of net periodic benefit cost in 2017.

The following benefit payments are expected to be made as per the current SERP assumptions and the terms of the SERP in each of the next five years, and in the aggregate:

2017	$	-
2018		-
2019		-
2020		21,115
2021		-
Thereafter		-
	$	21,115

Defined Contribution Pension Plan

The Company also maintains defined contribution pension plans for its employees, including its executive officers. The Company makes contributions to these plans on behalf of employees in an amount up to 5% of their base salary subject to certain prescribed maximums. During 2016, the Company contributed and expensed an aggregate of $1.2 million (2015 — $1.1 million, 2014 — $1.4 million) to its Canadian plan and an aggregate of $0.6 million (2015 — $0.4 million, 2014 — $0.4 million) to its defined contribution employee pension plan under Section 401(k) of the U.S. Internal Revenue Code.

In September 2016, the Company entered into a new employment agreement with Greg Foster, CEO of IMAX Entertainment and Senior Executive Vice President of the Company, which provides for an employment term from July 2, 2016 through July 2, 2019. Under the agreement, the Company agreed to create a deferred compensation plan (the “Retirement Plan”) covering Mr. Foster, and to make a total contribution of $3.2 million over the three-year employment term. The Retirement Plan is subject to a vesting schedule based on continued employment with the Company, such that 25% will vest July 2019; 50% will vest July 2022; 75% will vest July 2025; and Mr. Foster will be 100% vested in July 2027. As at December 31, 2016, the Company had an unfunded benefit obligation recorded of $0.5 million.

Postretirement Benefits - Executives

The Company has an unfunded postretirement plan for Messrs. Gelfond and Bradley J. Wechsler, Chairman of the Company’s Board of Directors. The plan provides that the Company will maintain health benefits for Messrs. Gelfond and Wechsler until they become eligible for Medicare and, thereafter, the Company will provide Medicare supplemental coverage as selected by Messrs. Gelfond and Wechsler.

The amounts accrued for the plan are determined as follows:

	As at December 31,
	2016		2015
Obligation, beginning of year	$	763	$	830
Interest cost		31		30
Benefits paid		(33)		(24)
Actuarial gain		(114)		(73)
Obligation, end of year	$	647	$	763

The following details the net cost components, all related to continuing operations, and underlying assumptions of postretirement benefits other than pensions:

	Years Ended December 31,
	2016		2015		2014
Interest cost	$	31	$	30	$	17
Amortization of actuarial loss (gain)		69		135		(32)
	$	100	$	165	$	(15)

The following amounts were included in accumulated other comprehensive income and will be recognized as components of net periodic benefit cost in future periods:

		As at December 31,
	2016		2015			2014
Unrealized actuarial (gain) loss	$	(37)	$	146	$	346

Weighted average assumptions used to determine the benefit obligation are:

	As at December 31,
	2016		2015		2014
Discount rate	4.10	%	4.20	%	3.70	%

Weighted average assumption used to determine the net postretirement benefit expense are:

	Years Ended December 31,
	2016		2015		2014
Discount rate	4.20	%	3.70	%	4.50	%

The following benefit payments are expected to be made as per the current plan assumptions in each of the next five years:

2017	$	21
2018		24
2019		26
2020		33
2021		36
Thereafter		507
Total	$	647

Postretirement Benefits – Canadian Employees

The Company has an unfunded postretirement plan for its Canadian employees upon meeting specific eligibility requirements. The Company will provide eligible participants, upon retirement, with health and welfare benefits.

The amounts accrued for the plan are determined as follows:

	As at December 31,
	2016		2015
Obligation, beginning of year	$	1,778	$	2,139
Interest cost		68		71
Service cost		-		1
Benefits paid		(88)		(80)
Actuarial gain		(70)		(6)
Unrealized foreign exchange loss (gain)		57		(347)
Obligation, end of year	$	1,745	$	1,778

The following details the net cost components, all related to continuing operations, and underlying assumptions of postretirement benefits other than pensions:

	Years Ended December 31,
	2016		2015		2014
Interest cost	$	68	$	71	$	93
Service cost		-		1		6
	$	68	$	72	$	99

The following amounts were included in accumulated other comprehensive income and will be recognized as components of net periodic benefit cost in future periods:

		As at December 31,
	2016		2015			2014
Unrealized actuarial loss	$	353	$	423	$	429

Weighted average assumptions used to determine the benefit obligation are:

	As at December 31,
	2016		2015		2014
Discount rate	3.65	%	3.75	%	3.75	%

Weighted average assumptions used to determine the net postretirement benefit expense are:

	Years Ended December 31,
	2016		2015		2014
Discount rate	3.75	%	3.75	%	4.50	%

The Company expects interest costs of $0.1 million and service costs of $nil to be recognized as a component of net periodic benefit cost in 2017.

The following benefit payments are expected to be made as per the current plan assumptions in each of the next five years:

2017	$	92
2018		98
2019		104
2020		107
2021		109
Thereafter		1,235
Total	$	1,745

Non-Controlling Interests

12 Months Ended

Dec. 31, 2016

Temporary Equity Disclosure [Abstract]

Non-Controlling Interests [Text Block]

21. Non-Controlling Interests

IMAX China Non-Controlling Interest

On April 8, 2014, the Company announced sale and issuance of 20% of the shares of IMAX China to entities owned and controlled by CMC Capital Partners (“CMC”), an investment fund that is focused on media and entertainment, and FountainVest Partners (“FountainVest”), a China-focused private equity firm. The sale price for the interest was $80.0 million, and was paid by the investors in two equal installments on April 8, 2014 and February 10, 2015.

On October 8, 2015, IMAX China completed the IMAX China IPO. Following the IMAX China IPO, the Company continues to indirectly own approximately 68.2% of IMAX China, which remains a consolidated subsidiary of the Company. On October 15, 2015, in satisfaction of its obligations under the shareholders’ agreement, IMAX China paid a dividend of $9.5 million to the non-controlling interest shareholders.

The following summarizes the movement of the non-controlling interest in temporary equity, in the Company’s subsidiary for the year ended December 31, 2016:

Balance as at January 1, 2015	$	40,272
Issuance of subsidiary shares to a non-controlling interest		40,000
Share issuance costs from the issuance of subsidiary shares to a non-controlling interest		(2,000)
Net income prior to IMAX China IPO		5,401
Other comprehensive income prior to IMAX China IPO		164
Accretion charges associated with redeemable common stock		769
Redemption of redeemable common stock upon qualified IPO		(84,606)
Balance as at October 7, 2015	$	-

The following summarizes the movement of the non-controlling interest in shareholders’ equity, in the Company’s subsidiary for the year ended December 31, 2016:

Balance as at October 8, 2015	$	84,606
Net income after IMAX China IPO		3,712
Other comprehensive income after IMAX China IPO		252
Dividends paid to non-controlling shareholders		(9,511)
Reduction in value due to qualified initial public offering		(29,100)
Balance as at December 31, 2015	$	49,959
Net income		11,338
Other comprehensive loss, net of tax		(1,735)
Balance as at December 31, 2016	$	59,562

Other Non-Controlling Interest

In 2014, the Company announced the creation of the Film Fund to co-finance a portfolio of 10 original large-format films. The Film Fund, which is intended to be capitalized with up to $50.0 million, will finance an ongoing supply of original films that the Company believes will be more exciting and compelling than traditional documentaries. The initial investment in the Film Fund was committed to by a third party in the amount of $25.0 million, with the possibility of contributing additional funds. The Company agreed to contribute $9.0 million to the Film Fund over five years starting in 2014 and sees the Film Fund as a self-perpetuating vehicle designed to generate a continuous, steady flow of high-quality documentary content. As at December 31, 2016, the Film Fund invested $13.4 million toward the development of original films. The related production, financing and distribution agreement includes put and call rights relating to change of control of the rights, title and interest in the co-financed pictures.

Balance as at January 1, 2015	$	3,640
Net loss		(333)
Balance as at December 31, 2015	$	3,307
Issuance of subsidiary shares to a non-controlling interest		2,479
Net loss		(806)
Balance as at December 31, 2016	$	4,980

Asset Retirement Obligations

12 Months Ended

Dec. 31, 2016

Asset Retirement Obligation Disclosure [Abstract]

Asset Retirement Obligation Disclosure [Text Block]

22. Asset Retirement Obligations

The Company has accrued costs related to obligations in respect of required reversion costs for its owned and operated theaters under long-term real estate leases which will become due in the future. The Company does not have any legal restrictions with respect to settling any of these long-term leases. A reconciliation of the Company’s liability in respect of required reversion costs is shown below:

	Years Ended December 31,
	2016		2015		2014
Beginning balance, January 1	$	82	$	149	$	143
Accretion expense		14		13		12
Reduction in asset retirement obligation		-		(80)		(6)
Ending balance, December 31	$	96	$	82	$	149

Prior Years' Figures	12 Months Ended
Prior Years' Figures	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prior Period Reclassification Adjustment [Text Block]	24. Prior Year's Figures Upon the adoption of ASU 2015-03, certain of the prior years’ figures have been reclassified to conform to the current year’s presentation.

Selected Quarterly Financial Information (Unaudited)

12 Months Ended

Dec. 31, 2016

Selected Quarterly Financial Information (Unaudited)

Quarterly Financial Information [Text Block]

23. Selected Quarterly Financial Information (Unaudited)

(in thousands of U.S. dollars, except per share amounts)	2016
	Q1		Q2		Q3		Q4
Revenues	$	92,128	$	91,743	$	86,550	$	106,913
Costs and expenses applicable to revenues		39,952		41,466		41,651		51,587
Gross margin	$	52,176	$	50,277	$	44,899	$	55,326
Net income before cumulative effect from the adoption of ASU 2016-09	$	12,177	$	10,683	$	4,384	$	12,076
Net income	$	13,952	$	8,908	$	4,384	$	12,076
Net income attributable to common shareholders before cumulative
effect from the adoption of ASU 2016-09	$	9,527	$	7,791	$	2,525	$	8,945
Net income attributable to common shareholders	$	11,302	$	6,016	$	2,525	$	8,945

Net income per share attributable to common shareholders:
Net income per share before the adoption of ASU 2016-09 - basic	$	0.14	$	0.11	$	0.04	$	0.14
Net income per share before the adoption of ASU 2016-09 - diluted	$	0.14	$	0.11	$	0.04	$	0.13
Net income per share - basic	$	0.16	$	0.09	$	0.04	$	0.14
Net income per share - diluted	$	0.16	$	0.09	$	0.04	$	0.13

	2015
	Q1		Q2		Q3		Q4
Revenues	$	62,211	$	107,160	$	85,101	$	119,333
Costs and expenses applicable to revenues		26,230		38,125		42,712		47,450
Gross margin	$	35,981	$	69,035	$	42,389	$	71,883
Net income	$	1,485	$	26,380	$	10,514	$	26,245
Net income attributable to common shareholders	$	391	$	24,350	$	8,610	$	22,493

Net income per share attributable to common shareholders:
Net income per share - basic	$	-	$	0.34	$	0.12	$	0.33
Net income per share - diluted	$	-	$	0.34	$	0.12	$	0.32

The Company elected to early adopt ASU 2016-09 in 2016 and to account for forfeitures as they occur. The impact from the adoption of the provisions related to forfeiture rates was reflected in the Company’s consolidated financial statements on a modified retrospective basis. See note 3 for additional information.

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Variable interest entities

Basis Of Accounting [Policy Text Block]

All intercompany accounts and transactions, including all unrealized intercompany profits on transactions with equity-accounted investees, have been eliminated.

Equity and Cost Method Investments, Policy [Policy Text Block]

Use of Estimates, Policy [Policy Text Block]

Cash and Cash Equivalents, Policy [Policy Text Block]

The Company considers all highly liquid investments convertible to a known amount of cash and with an original maturity to the Company of three months or less to be cash equivalents.

Accounts Receivables Allowance for Doubtful Accounts, Policy

Financing Receivable, Allowance for Credit Losses, Policy for Uncollectible Amounts

Condition for Company's policy to review and assess collectability on theater's past due accounts

When the minimum lease payments are renegotiated and the lease continues to be classified as a sales-type lease, the reduction in payments is applied to reduce unearned finance income.

These provisions are adjusted when there is a significant change in the amount or timing of the expected future cash flows or when actual cash flows differ from cash flow previously expected.

Inventory, Policy [Policy Text Block]

Film Assets, Policy [Policy Text Block]

Film exploitation costs, including advertising costs, are expensed as incurred.

Property, Plant and Equipment, Policy [Policy Text Block]

Property, plant and equipment are recorded at cost and are depreciated on a straight-line basis over their estimated useful lives as follows:

Theater system components(1)	—	over the equipment’s anticipated useful life (7 to 20 years)
Camera equipment	—	5 to 10 years
Buildings	—	20 to 25 years
Office and product equipment	—	3 to 5 years
Leasehold improvements	—	over the shorter of the initial term of the underlying leases plus any
		reasonably assured renewal terms, and the useful life of the asset

______________

(1)	Includes equipment under joint revenue sharing arrangements.

Asset Retirement Obligations, Policy [Policy Text Block]

Other Assets, Policy [Policy Text Block]

Costs of debt financing are deferred and amortized over the term of the debt using the effective interest method.

Foreign currency derivatives are accounted for at fair value using quoted prices in closed exchanges (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy).

Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]

Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]

Revenue Recognition, Deferred Revenue [Policy Text Block]

Income Tax, Policy [Policy Text Block]

Revenue Recognition, Multiple-deliverable Arrangements, Description [Policy Text Block]

Multiple Element Arrangements

Theater Systems

Sales Arrangements

Improvements and Modifications

Revenue Recognition Leases [Policy Text Block]

Lease Arrangements

Revenue Recognition Finance Income, Policy [Policy Text Block]

Cost of Sales, Policy [Policy Text Block]

Cost of Equipment and Product Sales

Cost of Rentals, Policy [Policy Text Block]

Cost of Rentals

Terminations Consenual Buyouts And Concessions, Policy [Policy Text Block]

Terminations, Consensual Buyouts and Concessions

Revenue Recognition, Incentives [Policy Text Block]

Maintenance And Extended Warranty Services, Policy [Policy Text Block]

Maintenance and Extended Warranty Services

Films Revenue Recognition, Policy [Policy Text Block]

Film Production and IMAX DMR Services

Film Distribution

Film Post-Production Services

Other Revenue, Policy [Policy Text Block]

Other

Revenues on camera rentals are recognized in Rental revenues over the rental period.

Revenue from the sale of 3D glasses is recognized in Equipment and product sales revenue when the 3D glasses have been delivered to the customer.

Other service revenues are recognized in Service revenues when the performance of contracted services is complete.

Research and Development Expense, Policy [Policy Text Block]

Foreign Currency Translations [Policy Text Block]

Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Stock Options

The Company’s policy is to issue new common shares from treasury or shares purchased in the open market to satisfy stock options which are exercised.

Restricted Share Units

The Company’s RSUs have been classified as equity in accordance with Topic 505. The fair value of RSU awards is equal to the closing price of the Company’s common stock on the date of grant.

Awards to Non-Employees

Pension and Other Postretirement Plans, Policy [Policy Text Block]

For defined contribution pension plans, required contributions by the Company are recorded as an expense.

Guarantees, Indemnifications and Warranties Policies [Policy Text Block]

Commitments And Contingencies [Policy Text Block]

The Company’s lease commitments consist of rent and equipment under operating leases. The Company accounts for any incentives provided over the term of the lease.

Purchase obligations primarily consist of the Company’s commitments made under long-term supplier contracts.

Other financial commitments include the Company’s total minimum commitment toward the development, production, post-production and marketing, related to certain film and new content initiatives.

Legal Costs [Policy Text Block]

The Company expenses legal costs relating to its lawsuits, claims and proceedings as incurred.

Collaborative Arrangement Accounting [Policy]

In a joint revenue sharing arrangement, the Company receives a portion of a theater’s box-office and concession revenues, and in some cases a small upfront or initial payment, in exchange for placing a theater system at the theater operator’s venue. Under joint revenue sharing arrangements, the customer has the ability and the right to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company’s joint revenue sharing arrangements are typically non-cancellable for 10 years or longer with renewal provisions. Title to equipment under joint revenue sharing arrangements generally does not transfer to the customer. The Company’s joint revenue sharing arrangements do not contain a guarantee of residual value at the end of the term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and extended warranty throughout the term. The customer is responsible for obtaining insurance coverage for the theater systems commencing on the date specified in the arrangement’s shipping terms and ending on the date the theater systems are delivered back to the Company.

Segment Reporting Policy Policy [Text Block]

Following recent changes in senior management, the Company is in the process of re-evaluating how to assess the performance of the business. As a result of this process, modifications are being made to the CEO’s reporting package to support a revised reporting structure which will move away from the Company’s historical two primary reporting groups – IMAX Theater Systems and Film. The changes being contemplated will result in four primary reporting segments groups, comprising (1) Network Business, representing revenue generated by box-office results and which will include the reportable segments of DMR and JRSAs excluding hybrid fixed payments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments and which will also include the fixed hybrid payments from the JRSA segment; (3) New Business, which will include virtual reality, IMAX Shift and IMAX Home Entertainment and (4) Other. The new reporting groups are expected to be implemented in the first quarter of 2017. The new reporting structure is expected to assist users of the financial statements with an enhanced understanding of how management views the business..

Fair Value of Financial Instruments, Policy [Policy Text Block]

New Accounting Pronouncements Policy [Policy Text Block]

Adoption of New Accounting Policies

In January 2015, the FASB issued ASU No. 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items” (“ASU 2015-01”). Prior to the changes under ASU 2015-01, an entity was required to separately classify, present and disclose extraordinary events and transactions under the disclosure requirements of Subtopic 225-20, “Income Statement – Extraordinary and Unusual Items” (“Subtopic 225-20”). ASU 2015-01 eliminates from U.S. GAAP the concept of extraordinary items therefore such separate disclosure is no longer required in the Income Statement of an entity. For public companies, the amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments can be applied prospectively or retrospectively. The Company prospectively adopted the amendments under ASU 2015-01 on January 1, 2016. The adoption of the standard did not have an impact on the disclosures presented in the consolidated statements of operations for the years ended December 31, 2016 and 2015, respectively.

In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis” (“ASU 2015-02”). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities such as limited partnerships and similar entities, and variable interest entities that have free arrangements and related party relationships. Furthermore, all legal entities are subject to re-evaluation under the revised consolidation model. The amendments also provide a scope exception from consolidation guidance for reporting entities with interests in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds. For public companies, the amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments can be applied retrospectively or using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The Company adopted the amendments under ASU 2015-02 retrospectively on January 1, 2016. The adoption of the standard did not have an impact on the Company’s consolidated financial statements.

In April 2015, the FASB issued ASU No. 2015-03, “Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”), and in August 2015 issued ASU No. 2015-15, “Interest – Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements” (“ASU 2015-15”). Under ASU 2015-03, debt issuance costs reported on the balance sheet will be reflected as a direct deduction from the related debt liability rather than as an asset. While ASU 2015-03 addresses costs related to term debt, ASU 2015-15 provides clarification regarding costs to secure revolving lines of credit, which are, at the outset, not associated with an outstanding borrowing. ASU 2015-15 provides commentary that the U.S Securities and Exchange Commission (“SEC”) staff would not object to an entity deferring and presenting costs associated with line-of-credit arrangements as an asset and subsequently amortizing them ratably over the term of the revolving debt arrangement. For public companies, the amendments apply to annual periods beginning on or after December 15, 2015, and interim periods within those years and are to be applied retrospectively. The Company adopted these standards on January 1, 2016. As at December 31, 2015, $0.4 million of unamortized debt issuance costs related to the Company’s loan to finance the construction of its Playa Vista facility were reclassified in the consolidated balance sheet from Other assets to Bank indebtedness. The Company will continue to defer and present the debt issuance cost related to its senior secured revolving credit facility in Other assets and amortize it ratably over the term of the agreement.

In March 2016, the FASB issued ASU No. 2016-09, “Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”). The amendment is to simplify several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in ASU 2016-09 are effective for interim and annual reporting periods beginning after December 15, 2016. ASU 2016-09 requires that the Company elect to account for forfeitures based on an estimate of the number of awards for which the requisite service period will not be rendered or to account for forfeitures as they occur. The Company elected to early adopt ASU 2016-09 in 2016 and to account for forfeitures as they occur. The impact from the adoption of the provisions related to forfeiture rates was reflected in the Company’s consolidated financial statements on a modified retrospective basis resulting in a $4.4 million decrease to Accumulated earnings, $0.9 million increase to Deferred income taxes and $5.3 million increase to Other equity. A recovery of stock-based compensation expense of $2.7 million for the year ended December 31, 2016 was also recorded. Amendments related to accounting for excess tax benefits have been adopted prospectively resulting in a tax benefit of $0.1 million for the year ended December 31, 2016, and amendments related to the consolidated statement of cash flows have been adopted retrospectively. See notes 9 and 14 for further discussion of the impact on the Company’s consolidated financial statements from the adoption of ASU 2016-09.

In May 2016, the FASB issued ASU No. 2016-11, “Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 pursuant to Staff announcements at the March 3, 2016 EITF Meeting” (“ASU 2016-11”). The purpose of ASU 2016-11 is to rescind from the FASB Accounting Standards Codification certain SEC paragraphs as a result of two SEC Staff Announcements at the March 3, 2016 meeting. For public entities, the amendments in ASU 2016-11 related to Topic 605 are effective for interim and annual reporting periods beginning after December 15, 2017 and amendments related to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2015. The adoption of ASU 2016-11 related to Topic 815, on January 1, 2016, did not have an impact on the Company’s consolidated financial statements.

In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments” (“ASU 2016-15”). The purpose of ASU 2016-15 is to reduce the diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flow (Topic 230)”. The purpose of ASU 2016-18 is to require that a statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning of period and end of period total amounts shown on the statement of cash flows. For public entities, the amendments in ASU 2016-15 and ASU 2016-18 are effective for interim and annual reporting periods beginning after December 15, 2017. The Company has elected to early adopt this standard, which did not have an impact on the Company’s consolidated statements of cash flows.

In December 2016, the FASB issued ASU No. 2016-19, “Technical Corrections and Improvements”. The amendments in ASU 2016-19 represent changes to clarify the accounting standard codification, correct unintended application of guidance, or make minor improvements to the accounting standards codification that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. For public companies, the standard is effective immediately for amendments that do not have transition guidance. Amendments that are subject to transition guidance, the effective date is interim and annual reporting periods beginning after December 15, 2016. The Company adopted the standard immediately upon issuance for amendments that do not have transition guidance. The adoption of the standard did not have an impact on the Company’s consolidated financial statements.

Description of New Accounting Pronouncements Not yet Adopted [Text Block]

Recently Issued FASB Accounting Standard Codification Updates

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40)” (“ASU 2014-15”). This amendment requires management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern, which is currently performed by the external auditors. Management will be required to perform this assessment for both interim and annual reporting periods and must make certain disclosures if it concludes that substantial doubt exists. The amendments in ASU 2014-15 are effective for annual periods ending after December 31, 2016, and for annual and interim periods thereafter. The adoption of this standard did not have any effect on the consolidated financial statements as no substantial doubt exists about the Company’s ability to continue as a going concern.

In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” (“ASU 2015-11”). The purpose of the amendment is to more closely align the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards. The clarifications are not intended to result in any changes in practice and to reduce the complexity in guidance on the subsequent measurement of inventory. This standard only applies to inventory being measured using the first-in, first-out or average cost methods of accounting for inventory. For public entities, the amendments are effective for interim and annual reporting periods beginning after December 15, 2016. The adoption of ASU 2015-11 will not have a material impact to the Company’s consolidated financial statements.

In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). The purpose of the amendment is intended to provide users of financial statements with more useful information on the recognition, measurement, presentation, and disclosure of financial instruments. For public entities, the amendments in ASU 2016-01 are effective for interim and annual reporting periods beginning after December 15, 2017. While the Company continues to evaluate the effect of the standard on its ongoing financial reporting, it anticipates that the adoption of ASU 2016-01 may have an effect on the Company’s consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). The purpose of the amendment is to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. New disclosures will include qualitative and quantitative requirements to provide additional information about the amounts recorded in the financial statements. Lessor accounting will remain largely unchanged from current guidance, however ASU 2016-02 will provide improvements that are intended to align lessor accounting with the lessee model and with updated revenue recognition guidance. For public entities, the amendments in ASU 2016-02 are effective for interim and annual reporting periods beginning after December 15, 2018. While the Company continues to evaluate the effect of the standard on its ongoing financial reporting, it anticipates that the adoption of ASU 2016-02 may materially affect its consolidated financial statements.

In March 2016, the FASB issued ASU No. 2016-05, “Derivatives and Hedging (Topic 815): Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships” (“ASU 2016-05”). The amendments in ASU 2016-05 apply to all reporting entities for which there is a change in the counterparty to a derivative instrument that has been designated as a hedging instrument under Topic 815. The amendments clarify that a change in the counterparty to a derivative instrument that has been designated as the hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship provided that all other hedge accounting criteria (including those in paragraphs 815-20-35-14 through 35-18) continue to be met. For public entities, the amendments in ASU 2016-05 are effective for interim and annual reporting periods beginning after December 15, 2016. The adoption of this ASU 2016-05 will not have a material impact to the Company’s consolidated financial statements.

In March 2016, the FASB issued ASU No. 2016-07, “Investments – Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting” (“ASU 2016-07”). The purpose of the amendment is to eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by step basis as if the equity method had been in effect during all previous periods that the investment had been held. For public entities, the amendments in ASU 2016-07 are effective for interim and annual reporting periods beginning after December 15, 2016. The adoption of ASU 2016-07 will not have a material impact to the Company’s consolidated financial statements.

In March 2016, the FASB issued ASU No. 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations” (“ASU 2016-08”). The purpose of ASU 2016-08 is to clarify the implementation of guidance on principal versus agent considerations.

In April 2016, the FASB issued ASU No. 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” (“ASU 2016-10”). The purpose of ASU 2016-10 is to provide more detailed guidance in the following key areas: identifying performance obligations and licenses of intellectual property.

In May 2016, the FASB issued ASU No. 2016-11, to rescind from the FASB Accounting Standards Codification certain SEC paragraphs as a result of two SEC Staff Announcements at the March 3, 2016 meeting.

In May 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” (“ASU 2016-12”). The purpose of ASU 2016-12 is to clarify certain narrow aspects of Topic 606 such as assessing the collectibility criterion, presentation of sales taxes and other similar taxes collected from customers, noncash consideration, contract modifications at transition, completed contracts at transition, and technical corrections.

In December 2016, the FASB issued ASU No. 2016-20, “Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers”. The amendments in ASU 2016-20 represent changes to clarify the accounting standard codification, correct unintended application of guidance, or make minor improvements to the accounting standards codification that are related to Topic 606, Revenue from Contracts with Customers.

For public companies, ASU 2016-08, ASU 2016-10, ASU 2016-11, ASU 2016-12 and ASU 2016-20, which are all related to Topic 606, are effective for interim and annual reporting periods beginning after December 15, 2017. The Company has performed an analysis of its contracts to determine those in scope of the standard, has performed detailed analyses of those contracts and identified its performance obligations. The Company is currently in the process of determining contract consideration and is determining the appropriate timing for revenue recognition of those performance obligations. Since many of the Company’s contracts involve variable payments tied to box-office, the Company is currently assessing an appropriate constraint to variable revenue streams in determining contract consideration under the new standard. The Company is currently considering adopting the new standard using the modified retrospective method and has begun the process of gathering historical information on its contracts in preparation for the standard’s expanded disclosure requirements.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). The purpose of ASU 2016-13 is to require a financial asset measured on the amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. For public entities, the amendments in ASU 2016-13 are effective for interim and annual reporting periods beginning after December 15, 2019. The Company is currently assessing the impact of ASU 2016-13 on its consolidated financial statements.

In October 2016, the FASB issued ASU No. 2016-16, “Income Taxes (Topic 740)”. The purpose of ASU 2016-16 is to eliminate the exception for an intra-entity transfer of an asset other than inventory. The amendments require the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. For public entities, the amendments in ASU 2016-16 are effective for interim and annual reporting periods beginning after December 15, 2017. The Company is currently assessing the impact of ASU 2016-16 on its consolidated financial statements.

In October 2016, the FASB issued ASU No. 2016-17, “Consolidation (Topic 810)”. The purpose of ASU 2016-17 is to update the requirement of the reporting entity, in determining whether it satisfies the second characteristic of a primary beneficiary, to include all of its direct variable interests in a VIE and, on a proportionate basis, its indirect variable interests in a VIE held through related parties, including related parties that are under common control with the reporting entity. For public entities, the amendments in ASU 2016-17 are effective for interim and annual reporting periods beginning after December 15, 2016. While the Company continues to evaluate the effect of the standard on its ongoing financial reporting, the adoption of this guidance will not have any effect on the Company’s consolidated financial statements.

Recently issued FASB accounting standard codification updates, except for the above noted standards, were not material to the Company’s consolidated financial statements for the year ended December 31, 2016.

ASU No. 2011-01

The Company classifies its customers into four categories to indicate the credit quality worthiness of its financing receivables for internal purposes only:

Good standing — Theater continues to be in good standing with the Company as the client’s payments and reporting are up-to-date.

Fair Value Transfer, Policy [Policy Text Block]

Lease Arrangements (Tables)

12 Months Ended

Dec. 31, 2016

Lease Arrangements [Abstract]

Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales

	As at December 31,
	2016		2015
Gross minimum lease payments receivable	$	10,466	$	13,998
Unearned finance income		(1,710)		(2,381)
Minimum lease payments receivable		8,756		11,617
Accumulated allowance for uncollectible amounts		(672)		(672)
Net investment in leases		8,084		10,945
Gross financed sales receivables		154,301		146,232
Unearned finance income		(39,766)		(39,378)
Financed sales receivables		114,535		106,854
Accumulated allowance for uncollectible amounts		(494)		(568)
Net financed sales receivables		114,041		106,286
Total financing receivables	$	122,125	$	117,231

Net financed sales receivables due within one year	$	21,980	$	19,068
Net financed sales receivables due after one year	$	92,061	$	87,218

Contingent fees, reported in revenue from customers under various arrangements

	Years Ended December 31,
	2016		2015		2014
Sales	$	3,308	$	2,492	$	2,058
Sales-type leases		375		363		102
Operating leases		602		901		886
Subtotal - sales, sales-type leases and operating leases		4,285		3,756		3,046
Joint revenue sharing arrangements		73,976		82,016		57,973
	$	78,261	$	85,772	$	61,019

Schedule of Operating Leases and Sales Type Leases Minimum Payments [Table Text Block]

	Operating Leases		Sales-Type Leases
2017	$	614	$	1,513
2018		335		1,522
2019		166		1,499
2020		69		1,314
2021		69		1,118
Thereafter		286		1,999
Total	$	1,539	$	8,965

Inventories (Tables)

12 Months Ended

Dec. 31, 2016

Inventories [Abstract]

Inventories

	As at December 31,
	2016		2015
Raw materials	$	28,000	$	25,750
Work-in-process		3,818		2,628
Finished goods		10,303		10,375
	$	42,121	$	38,753

Film Assets (Table)

12 Months Ended

Dec. 31, 2016

Film Costs [Abstract]

Film Assets

		As at December 31,
		2016		2015
Completed and released films, net of accumulated amortization of		$	10,643	$	6,445
	$128,650 (2015 ― $112,571)
Films in production			325		1,538
Films in development			5,554		6,588
		$	16,522	$	14,571

Property, Plant and Equipment (Tables)

12 Months Ended

Dec. 31, 2016

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

		As at December 31, 2016
				Accumulated		Net Book
		Cost		Depreciation		Value
Equipment leased or held for use
	Theater system components(1)(2)(3)(4)	$	224,890	$	89,218	$	135,672
	Camera equipment		5,739		3,732		2,007
			230,629		92,950		137,679
Assets under construction(5)			18,315		-		18,315
Other property, plant and equipment
	Land		8,203		-		8,203
	Buildings		69,861		14,877		54,984
	Office and production equipment(6)		41,128		21,935		19,193
	Leasehold improvements		10,067		3,026		7,041
			129,259		39,838		89,421
		$	378,203	$	132,788	$	245,415

		As at December 31, 2015
				Accumulated		Net Book
		Cost		Depreciation		Value
Equipment leased or held for use
	Theater system components(1)(2)(3)	$	199,974	$	74,568	$	125,406
	Camera equipment		5,393		3,368		2,025
			205,367		77,936		127,431
Assets under construction(5)			9,616		-		9,616
Other property, plant and equipment
	Land		8,203		-		8,203
	Buildings		67,150		12,679		54,471
	Office and production equipment(6)		34,396		17,035		17,361
	Leasehold improvements		3,512		2,327		1,185
			113,261		32,041		81,220
		$	328,244	$	109,977	$	218,267

Other Assets (Table)

12 Months Ended

Dec. 31, 2016

Table Text Block Supplement [Abstract]

Schedule of Other Assets [Table Text Block]

	As at December 31,
	2016		2015
Prepaid taxes (note 9)	$	14,728	$	9,064
Lease incentives provided to theaters		5,632		5,852
Commissions and other deferred selling expenses		3,352		3,933
Insurance recoverable		2,708		2,842
Deferred charges on debt financing		1,713		2,247
Investment in film business		1,389		-
Other investments		2,000		1,193

Foreign currency derivatives		480		-
Equity-accounted investments		-		1,005
Other		1,193		-
	$	33,195	$	26,136

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2016

Table Text Block Supplement [Abstract]

Schedule of income (Loss) from continuing operations before income taxes by tax jurisdiction [Table Text Block]

	Years Ended December 31,
	2016		2015		2014

Canada	$	21,002	$	41,099	$	15,453
United States		505		4,504		10,350
China		41,224		45,818		26,327
Ireland		(9,768)		(10,581)		-
Other		4,890		6,238		5,221
	$	57,853	$	87,078	$	57,351

Schedule of Components of (Provision) Recovery for Income Taxes Related to Income from Continuing Operations [Table Text Block]

		Years Ended December 31,
		2016		2015		2014
Current:
	Canada	$	(1,396)	$	(10,862)	$	(3,495)
	United States		1,756		985		(4,072)
	China		(10,131)		(10,591)		(6,023)
	Ireland		(405)		-		-
	Other		(1,093)		(920)		(249)
			(11,269)		(21,388)		(13,839)
Deferred:(1)
	Canada		(3,583)		(518)		433
	United States		(4,359)		147		(791)
	China		776		(83)		(216)
	Ireland		2,352		1,840		-
	Other		(129)		(50)		(53)
			(4,943)		1,336		(627)
		$	(16,212)	$	(20,052)	$	(14,466)

______________

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

		Years Ended December 31,
		2016		2015		2014

Income tax provision at combined statutory rates		$	(15,330)	$	(23,081)	$	(15,189)
Adjustments resulting from:
	Stock based compensation		(565)		2,387		(2,244)
	Other non-deductible/non-includable items		(1,254)		(439)		1,257
	Decrease (increase) in valuation allowance relating to current year temporary
	differences		129		(16)		429
	Changes to tax reserves		1,628		(453)		230
	U.S. federal and state taxes		(767)		(27)		(200)
	Withholding taxes		(786)		(716)		(200)
	Income tax at different rates in foreign and other provincial jurisdictions		50		961		516
	Investment and other tax credits (non-refundable)		2,190		1,597		1,973
	Changes to deferred tax assets and liabilities resulting from audit and other tax
	return adjustments		(1,612)		(242)		(1,013)
	Windfall tax benefit		57		-		-
	Tax effect of loss from equity-accounted investments		-		-		(41)
	Other		48		(23)		16
Provision for income taxes, as reported		$	(16,212)	$	(20,052)	$	(14,466)

Schedule of Components of Net Deferred Income Tax Assets [Table Text Block]

	As at December 31,
	2016		2015


Net operating loss carryforwards	$	2,893	$	1,158
Investment tax credit and other tax credit carryforwards		-		-
Write-downs of other assets		759		720
Excess tax over accounting basis in property, plant and equipment, inventories and other assets		-		9,577
Accrued pension liability		6,571		6,626
Accrued stock-based compensation		12,352		9,261
Other accrued reserves		3,754		559
Total deferred income tax assets		26,329		27,901
Income recognition on net investment in leases		(3,985)		(1,809)
Excess accounting over tax basis in property, plant and equipment, inventories and other assets		(1,368)		-
		20,976		26,092
Valuation allowance		(197)		(326)
Net deferred income tax asset	$	20,779	$	25,766

Schedule of Tax Credit and Net Operating Loss Carryforwards [Table Text Block]

	Investment Tax
	Credits and
	Other		Net Operating
	Tax Credit		Loss
	Carryforwards		Carryforwards
2017	$	-	$	-
2018		-		-
2019		-		-
2020		-		-
2021		-		-
Thereafter		2,194		37,664
	$	2,194	$	37,664

Schedule of Income Tax Contingencies [Table Text Block]


(In thousands of U.S. Dollars)	2016		2015		2014
Balance at beginning of the year	$	14,221	$	1,972	$	2,202
Additions based on tax positions related to the current year		314		12,694		237
Reductions for tax positions of prior years		(500)		-		-
Reductions resulting from lapse of applicable statute of limitations and administrative
practices		(1,442)		(445)		(467)
Balance at the end of the year	$	12,593	$	14,221	$	1,972

Income Tax Effect on Comprehensive Income

	Years Ended December 31,
	2016		2015		2014

Unrecognized actuarial gain or loss on defined benefit plan	$	(41)	$	(47)	$	225
Unrecognized actuarial gain or loss on postretirement benefit plans		(48)		(21)		151
Amortization of actuarial gain or loss on postretirement benefit plan		(18)		(35)		8
Other-than-temporary impairment of available-for-sale investment		-		-		(45)
Unrealized change in cash flow hedging instruments		(271)		1,543		658
Realized change in cash flow hedging instruments upon settlement		(802)		(844)		(306)
Foreign currency translation adjustments		-		(85)		59
	$	(1,180)	$	511	$	750

Other Intangibles (Tables)

12 Months Ended

Dec. 31, 2016

Other Intangible Assets [Abstract]

Other Intangible Assets

	As at December 31, 2016
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	11,395	$	7,046	$	4,349
Licenses and intellectual property		22,490		7,620		14,870
Other		15,352		4,155		11,197
	$	49,237	$	18,821	$	30,416

	As at December 31, 2015
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	10,399	$	6,502	$	3,897
Licenses and intellectual property		22,390		6,464		15,926
Other		11,878		2,751		9,127
	$	44,667	$	15,717	$	28,950

Other Intangible Assets - Future Amortization [Table Text Block]

2017	$	3,470
2018		3,470
2019		3,470
2020		3,470
2021		3,470

Credit Facility and Playa Vista Loan (Tables)

12 Months Ended

Dec. 31, 2016

Credit Facility and Playa Vista Construction Loan [Abstract]

Bank indebtedness

	As at December 31,
	2016		2015
Playa Vista Loan		27,667		29,667
Deferred charges on debt financing		(351)		(391)
	$	27,316	$	29,276

Construction loan principal payments

2017	$	2,000
2018		2,000
2019		2,000
2020		2,000
2021		2,000
Thereafter		17,667
	$	27,667

Commitments (Table)

12 Months Ended

Dec. 31, 2016

Commitments, Contingencies and Guarantees [Abstract]

Total contractual obligations and commitments

	Payments Due by Fiscal Year
	Total
(In thousands of U.S. Dollars)	Obligations		2017		2018		2019		2020		2021		Thereafter

Purchase obligations	$	25,283	$	25,283	$	-	$	-	$	-	$	-	$	-
Pension obligations		21,115		-		-		-		21,115		-		-
Operating lease obligations		18,670		6,203		5,033		2,831		674		498		3,431
Playa Vista Loan		27,667		2,000		2,000		2,000		2,000		2,000		17,667
Postretirement benefits obligations		5,042		1,138		1,197		680		140		145		1,742
Other financial commitments		39,173		39,173		-		-		-		-		-
	$	136,950	$	73,797	$	8,230	$	5,511	$	23,929	$	2,643	$	22,840

Total rental expenses under operating leases

	Years Ended December 31,
	2016		2015		2014

Total rent expense	$	5,106	$	4,766	$	6,567

- Definition

Tabular disclosure of a lessee's leasing arrangements including: (1) the basis on which contingent rental payments are determined, (2) the existence and terms of renewal or purchase options and escalation clauses, (3) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, (4) rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions. Disclosure may also include the specific period used to amortize material leasehold improvements made at the inception of the lease or during the lease term. Additionally, for operating leases having initial or remaining noncancelable lease terms in excess of one year: (a) future minimum rental payments required as of the date of the latest balance sheet presented, in the aggregate and for each of the five succeeding fiscal years, (b) the total of minimum rentals to be received in the future under noncancelable subleases as of the date of the latest balance sheet presented, and (c) for all operating leases, rental expense for each period for which an income statement is presented, with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.

+ References + Details

Contingencies and Guarantees (Table)

12 Months Ended

Dec. 31, 2016

Commitments, Contingencies and Guarantees [Abstract]

Accrual for product warranties

	As at December 31,
	2016		2015
Balance at the beginning of the year	$	-	$	6
Warranty redemptions		-		(6)
Warranties issued		30		-
Revisions		-		-
Balance at the end of the year	$	30	$	-

Capital Stock (Tables)

12 Months Ended

Dec. 31, 2016

Capital Stock [Abstract]

Options to Employees

	2016	2015	2014

Average risk-free interest rate	1.67%	1.97%	2.46%
Expected option life (in years)	4.44 - 5.24	3.55 - 5.76	4.15 - 5.82
Expected volatility	30%	30%	32.5% - 37.5%
Dividend yield	0%	0%	0%

Options to Non-Employees

		Years Ended December 31
	2016		2015	2014

Average risk-free interest rate		n/a	n/a	0.53%
Contractual option life		n/a	n/a	2 years
Average expected volatility		n/a	n/a	32.5%
Dividend yield		n/a	n/a	0%

Option activity under the Stock Option Plan and IMAX LTIP

					Weighted Average Exercise
	Number of Shares				Price Per Share
	2016	2015	2014	2016		2015		2014

Options outstanding, beginning of year	4,805,244	5,925,660	6,263,121	$	27.03	$	24.24	$	21.11
Granted	984,452	873,929	872,155		31.49		31.59		27.48
Exercised	(518,018)	(1,761,675)	(1,149,587)		22.07		20.21		9.42
Forfeited	(66,903)	(232,670)	(36,242)		29.28		24.60		24.63
Cancelled	(14,233)	-	(23,787)		24.82		-		33.60
Options outstanding, end of year	5,190,542	4,805,244	5,925,660		28.35		27.03		24.24
Options exercisable, end of year	4,001,078	2,800,723	3,368,558		27.79		25.83		22.69

Movement in Restricted Stock Units

	Number of Awards			Weighted Average Grant Date Fair Value Per Share
	2016	2015	2014		2016		2015		2014

RSUs outstanding, beginning of year	973,637	595,834	264,140	$	32.27	$	27.13	$	26.14
Granted	664,278	605,349	484,088		32.29		36.04		27.42
Vested and settled	(466,918)	(207,371)	(148,001)		30.63		28.81		26.29
Forfeited	(46,817)	(20,175)	(4,393)		31.16		29.27		26.88
RSUs outstanding, end of year	1,124,180	973,637	595,834		33.01		32.27		27.13

Basic and diluted per-share computations

	Years Ended December 31,
	2016		2015		2014

Net income attributable to common shareholders	$	28,788	$	55,844	$	39,736
Less: Accretion charges associated with redeemable common stock		-		(769)		(426)
Net income applicable to common shareholders	$	28,788	$	55,075	$	39,310
Weighted average number of common shares (000's):
Issued and outstanding, beginning of period		69,673		68,988		67,841
Weighted average number of shares (repurchased) issued during the period, net		(2,098)		538		505
Weighted average number of shares used in computing basic earnings per share		67,575		69,526		68,346
Assumed exercise of stock options and RSUs, net of shares assumed repurchased		688		1,532		1,408
Weighted average number of shares used in computing diluted earnings per share		68,263		71,058		69,754

Receivable Provisions, Net of Recoveries (Table)

12 Months Ended

Dec. 31, 2016

Receivable Provisions, Net of Recoveries [Abstract]

Receivable Provisions, Net of Recoveries

	Years Ended December 31,
	2016		2015		2014
Accounts receivable provisions, net of recoveries	$	1,029	$	677	$	725
Financing receivable provisions, net of recoveries		(75)		75		193
Receivable provisions, net of recoveries	$	954	$	752	$	918

Consolidated Statements of Cash Flows Supplemental Information (Tables)

12 Months Ended

Dec. 31, 2016

Consolidated Statements of Cash Flows Supplemental Information [Abstract]

Changes in other non-cash operating assets and liabilities

		Years Ended December 31,
			2016		2015		2014
Decrease (increase) in:
	Accounts receivable	$	(1,414)	$	(22,521)	$	(4,318)
	Financing receivables		(4,627)		(13,628)		(40)
	Inventories		(3,825)		(21,070)		(7,603)
	Prepaid expenses		(127)		(1,552)		(1,346)
	Commissions and other deferred selling expenses		206		(203)		(769)
	Insurance recoveries		132		4		10,958
	Other assets, prepaid tax		(5,664)		-		(2,984)
	Other assets		(1,376)		(456)		(459)
Increase (decrease) in:
	Accounts payable		(3,360)		9,183		(5,186)
	Accrued and other liabilities		3,914		(2,057)		6,002
	Deferred revenue		(14,733)		16,242		12,102
		$	(30,874)	$	(36,058)	$	6,357

Cash payments

	Years Ended December 31,
		2016		2015		2014
Income taxes	$	24,640	$	22,798	$	8,885
Interest	$	721	$	411	$	48

Summary of depreciation and amortization

		Years Ended December 31,
			2016		2015		2014
Film assets(1)		$	16,324	$	16,357	$	11,851
Property, plant and equipment
	Joint revenue sharing arrangements		15,840		13,663		12,148
	Other property, plant and equipment		9,692		7,698		5,616
Other intangible assets			3,235		3,285		2,988
Other assets			862		784		627
Deferred financing costs			532		1,016		526
		$	46,485	$	42,803	$	33,756

______________

Write downs, net of recoveries

		Years Ended December 31,
			2016		2015		2014
Asset impairments
	Property, plant and equipment	$	223	$	405	$	314
	Impairment of investments		194		425		3,206
Other charges (recoveries)
	Accounts receivables		1,029		677		725
	Financing receivables		(75)		75		193
	Inventories(1)		458		572		359
	Film assets		3,020		-		-
	Property, plant and equipment(2)		885		1,485		440
	Other intangible assets		206		86		57
		$	5,940	$	3,725	$	5,294


Inventory charges
	Recorded in costs and expenses applicable to revenues - equipment & product sales	$	227	$	537	$	209
	Recorded in costs and expenses applicable to revenues - services		231		35		150
		$	458	$	572	$	359

______________

Segmented Information (Tables)

12 Months Ended

Dec. 31, 2016

Segmented Information [Abstract]

Revenue and Total Assets by Segment

		Years Ended December 31,
			2016		2015		2014
Revenue(1)
IMAX theater systems
	IMAX systems	$	105,527	$	102,128	$	72,992
	Theater system maintenance		40,430		36,944		34,042
	Joint revenue sharing arrangements		91,413		99,120		68,418
			237,370		238,192		175,452

Films
	Production and IMAX DMR		106,403		107,089		83,172
	Distribution		5,254		3,876		8,932
	Post-production		8,873		7,069		10,831
			120,530		118,034		102,935

Other			19,434		17,579		12,154

Total		$	377,334	$	373,805	$	290,541

Gross margin
IMAX theater systems
	IMAX systems(2)	$	60,090	$	59,168	$	47,928
	Theater system maintenance(2)		13,659		12,702		12,375
	Joint revenue sharing arrangements(3)		59,837		68,372		44,714
			133,586		140,242		105,017

Films
	Production and IMAX DMR(3)		69,196		77,645		62,922
	Distribution(3)		(3,909)		(259)		2,274
	Post-production		3,729		1,381		3,046
			69,016		78,767		68,242

Other			76		279		129

Total		$	202,678	$	219,288	$	173,388

		Years Ended December 31
			2016		2015
Assets
IMAX systems (4)		$	218,835	$	215,602
Theater systems maintenance (4)			28,763		20,907
Joint revenue sharing arrangements (4)			203,227		179,156
Films
	Production and IMAX DMR		39,688		46,262
	Distribution		21,059		17,534
	Post-production		35,865		26,759
Other			18,179		23,485
Corporate and other non-segment specific assets			291,718		400,924
Total		$	857,334	$	930,629

Depreciation and Amortization by Segment [Text Block]

		Years Ended December 31,
		2016			2015		2014
Depreciation and amortization
IMAX systems		$	4,165	$	5,685	$	1,910
Theater systems maintenance			72		72		225
Joint revenue sharing arrangements			16,724		14,443		14,614
Films
	Production and IMAX DMR		15,028		14,330		10,751
	Distribution		1,444		2,129		1,512
	Post-production		2,769		1,465		481
Other			1,567		704		671
Corporate and other non-segment specific assets			4,716		3,975		3,592
Total		$	46,485	$	42,803	$	33,756

Asset Impairments and Write-downs, Net of Recoveries, by Segment [Text Block]

			Years Ended December 31,
			2016		2015		2014
Asset impairments and write-downs, net of recoveries
IMAX systems		$	916	$	2,298	$	1,128
Theater systems maintenance			1,002		277		150
Joint revenue sharing arrangements			266		528		397
Films
	Distribution		3,020		-		-
	Post-production		223		-		-
Other			-		-		314
Corporate and other non-segment specific assets			513		622		3,305
Total		$	5,940	$	3,725	$	5,294

Purchase of property, plant and equipment, by Segment [Text Block]

		Years Ended December 31,
			2016		2015		2014
Purchase of property, plant and equipment
IMAX systems		$	3,170	$	8,846	$	8,822
Theater systems maintenance			481		555		229
Joint revenue sharing arrangements			42,910		28,474		16,838
Films
	Production and IMAX DMR		1,121		1,350		15,245
	Distribution		21		830		1,582
	Post-production		1,746		16,337		2,176
Other			5,874		1,986		1,337
Corporate and other non-segment specific assets			2,865		13,353		10,713
Total		$	58,188	$	71,731	$	56,942

Geographical Information, Revenues and Property, plant and equipment

	Years Ended December 31,
	2016			2015		2014
Revenue
United States	$	129,844	$	136,017	$	107,830
Canada		12,822		11,665		10,309
Greater China		118,532		110,591		78,218
Western Europe		36,286		39,569		30,245
Asia (excluding Greater China)		35,283		38,143		26,276
Russia & the CIS		14,908		12,412		15,700
Latin America		12,191		10,179		12,672
Rest of the World		17,468		15,229		9,291
Total	$	377,334	$	373,805	$	290,541

	As at December 31
		2016		2015
Property, plant and equipment
United States	$	104,083	$	105,641
Canada		39,467		40,943
Greater China		69,751		51,990
Western Europe		19,308		8,359
Asia (excluding Greater China)		8,460		10,369
Rest of the World		4,346		965
Total	$	245,415	$	218,267

Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2016

Financial Instruments [Abstract]

Fair Value of Financial Instruments

		As at December 31, 2016				As at December 31, 2015
		Carrying		Estimated		Carrying		Estimated
		Amount		Fair Value		Amount		Fair Value
Cash and cash equivalents	$	204,759	$	204,759	$	317,449	$	317,449
Net financed sales receivable	$	114,041	$	115,014	$	106,286	$	108,184
Net investment in sales-type leases	$	8,084	$	8,372	$	10,945	$	11,154
Convertible loan receivable	$	1,000	$	1,000	$	-	$	-
Available-for-sale investment	$	1,000	$	1,007	$	1,000	$	997
Foreign exchange contracts — designated forwards	$	(296)	$	(296)	$	(4,423)	$	(4,423)
Borrowings under the Playa Vista Loan	$	(27,667)	$	(27,667)	$	(29,667)	$	(29,667)

Recorded Investment in Financing Receivables

	As at December 31, 2016						As at December 31, 2015
	Minimum		Financed				Minimum		Financed
	Lease		Sales				Lease		Sales
	Payments		Receivables		Total		Payments		Receivables		Total

In good standing	$	7,741	$	111,568	$	119,309	$	10,252	$	105,352	$	115,604
Credit Watch		-		1,514		1,514		-		-		-
Pre-approved transactions		-		842		842		-		757		757
Transactions suspended		1,015		611		1,626		1,365		745		2,110
	$	8,756	$	114,535	$	123,291	$	11,617	$	106,854	$	118,471

Investment In Financing Receivables On Nonaccrual Status

	As at December 31, 2016				As at December 31, 2015
	Recorded		Related		Recorded		Related
	Investment		Allowance		Investment		Allowance

Net investment in leases	$	1,015	$	(672)	$	1,365	$	(672)
Net financed sales receivables		611		(494)		1,502		(568)
Total	$	1,626	$	(1,166)	$	2,867	$	(1,240)

Aging of Financing Receivables

	As at December 31, 2016
									Related						Recorded
	Accrued						Billed		Unbilled		Total				Investment
	and						Financing		Recorded		Recorded		Related		Net of
	Current		30-89 Days		90+ Days		Receivables		Investment		Investment		Allowances		Allowances

Net investment in leases	$	28	$	159	$	781	$	968	$	7,788	$	8,756	$	(672)	$	8,084
Net financed sales receivables		2,393		1,724		2,368		6,485		108,050		114,535		(494)		114,041
Total	$	2,421	$	1,883	$	3,149	$	7,453	$	115,838	$	123,291	$	(1,166)	$	122,125


	As at December 31, 2015
									Related						Recorded
	Accrued						Billed		Unbilled		Total				Investment
	and						Financing		Recorded		Recorded		Related		Net of
	Current		30-89 Days		90+ Days		Receivables		Investment		Investment		Allowances		Allowances

Net investment in leases	$	840	$	177	$	446	$	1,463	$	10,154	$	11,617	$	(672)	$	10,945
Net financed sales receivables		908		1,013		1,177		3,098		103,756		106,854		(568)		106,286
Total	$	1,748	$	1,190	$	1,623	$	4,561	$	113,910	$	118,471	$	(1,240)	$	117,231

Financing receivables continues to accrue finance income

	As at December 31, 2016
									Related				Recorded
	Accrued						Billed		Unbilled				Investment
	and						Financing		Recorded		Related		Past Due
	Current		30-89 Days		90+ Days		Receivables		Investment		Allowance		and Accruing

Net investment in leases	$	-	$	54	$	244	$	298	$	1,646	$	-	$	1,944
Net financed sales receivables		284		634		1,854		2,772		20,147		-		22,919
Total	$	284	$	688	$	2,098	$	3,070	$	21,793	$	-	$	24,863


	As at December 31, 2015
									Related				Recorded
	Accrued						Billed		Unbilled				Investment
	and						Financing		Recorded		Related		Past Due
	Current		30-89 Days		90+ Days		Receivables		Investment		Allowance		and Accruing

Net investment in leases	$	41	$	47	$	205	$	293	$	1,076	$	-	$	1,369
Net financed sales receivables		129		224		839		1,192		10,795		-		11,987
Total	$	170	$	271	$	1,044	$	1,485	$	11,871	$	-	$	13,356

Impaired financing receivables

	Impaired Financing Receivables
	For the Year Ended December 31, 2016
							Average		Interest
	Recorded		Unpaid		Related		Recorded		Income
	Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
Net financed sales receivables	$	525	$	75	$	(494)	$	637	$	-

Recorded investment for which there is no related allowance:
Net financed sales receivables		-		-		-		-		-

Total recorded investment in impaired loans:
Net financed sales receivables	$	525	$	75	$	(494)	$	637	$	-

	Impaired Financing Receivables
	For the Year Ended December 31, 2015
							Average		Interest
	Recorded		Unpaid		Related		Recorded		Income
	Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related
allowance:
Net financed sales receivables	$	748	$	298	$	(568)	$	748	$	-

Recorded investment for which there is no related allowance:
Net financed sales receivables		-		-		-		-		-

Total recorded investment in impaired loans:
Net financed sales receivables	$	748	$	298	$	(568)	$	748	$	-

Allowance for credit losses and investment in financing receivables

	Year Ended December 31, 2016
	Net Investment		Net Financed
	in Leases		Sales Receivables
Allowance for credit losses:

Beginning balance	$	672	$	568
Charge-offs		-		-
Recoveries		-		(74)
Provision		-		-
Ending balance	$	672	$	494

Ending balance: individually evaluated for impairment	$	672	$	494


Financing receivables:

Ending balance: individually evaluated for impairment	$	8,756	$	114,535

	Year Ended December 31, 2015
	Net Investment		Net Financed
	in Leases		Sales Receivables
Allowance for credit losses:

Beginning balance	$	972	$	494
Charge-offs		(300)		-
Recoveries		-		-
Provision		-		74
Ending balance	$	672	$	568

Ending balance: individually evaluated for impairment	$	672	$	568


Financing receivables:

Ending balance: individually evaluated for impairment	$	11,617	$	106,854

Notional amount of derivative

		As at December 31,
		2016		2015
Derivatives designated as hedging instruments:
Foreign exchange contracts — Forwards	$	37,825	$	30,710

Fair value of foreign exchange contracts



			As at December 31,
	Balance Sheet Location	2016		2015
Derivatives designated as hedging instruments:
Foreign exchange contracts — Forwards	Other assets	$	480	$	-
	Accrued and other liabilities		(776)		(4,423)
		$	(296)	$	(4,423)

Derivatives in Foreign Currency Hedging relationships

			Years Ended December 31,
			2016		2015		2014
Foreign exchange contracts - Forwards	Derivative Loss Recognized
	in OCI (Effective Portion)	$	1,049	$	(5,881)	$	(2,524)
		$	1,049	$	(5,881)	$	(2,524)

	Location of Derivative Loss
	Reclassified from AOCI		Years Ended December 31,
	into Income (Effective Portion)		2016		2015		2014
	Selling, general and
Foreign exchange contracts - Forwards	administrative expenses	$	(3,078)	$	(3,217)	$	(1,186)
		$	(3,078)	$	(3,217)	$	(1,186)

Pension and Post-retirement benefits (Tables)

12 Months Ended

Dec. 31, 2016

SERP Benefits [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]

Assumptions used to determine obligation and cost status

		As at December 31,
		2016	2015	2014
Discount rate		2.18%	1.34%	1.30%
Lump sum interest rate:
	First 20 years	1.87%	2.82%	2.89%
	Thereafter	2.37%	2.95%	3.12%
Cost of living adjustment on benefits		1.20%	1.20%	1.20%

Amounts accrued

		Years Ended December 31,
		2016		2015
Projected benefit obligation:
	Obligation, beginning of year	$	19,478	$	19,405
	Interest cost		261		253
	Actuarial gain		(159)		(180)
	Obligation, end of year and unfunded status	$	19,580	$	19,478

The following table provides disclosure of the pension benefit obligation recorded in the consolidated balance sheets:

	As at December 31,
	2016		2015
Accrued benefits cost	$	(19,580)	$	(19,478)
Accumulated other comprehensive loss		1,165		1,323
Net amount recognized in the consolidated balance sheets	$	(18,415)	$	(18,155)

Pension Expense

	Years ended December 31,
	2016		2015		2014
Interest cost	$	261	$	253	$	264
Pension expense	$	261	$	253	$	264

Components of net periodic benefit cost

		As at December 31,
	2016		2015			2014
Unrealized actuarial loss	$	1,165	$	1,323	$	1,503

Schedule of expected benefit payments

2017	$	-
2018		-
2019		-
2020		21,115
2021		-
Thereafter		-
	$	21,115

Postretirement Benefits Executives [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]

Assumptions used to determine obligation and cost status

	As at December 31,
	2016		2015		2014
Discount rate	4.10	%	4.20	%	3.70	%

Weighted average assumption used to determine the net postretirement benefit expense are:

	Years Ended December 31,
	2016		2015		2014
Discount rate	4.20	%	3.70	%	4.50	%

Amounts accrued

	As at December 31,
	2016		2015
Obligation, beginning of year	$	763	$	830
Interest cost		31		30
Benefits paid		(33)		(24)
Actuarial gain		(114)		(73)
Obligation, end of year	$	647	$	763

Pension Expense

	Years Ended December 31,
	2016		2015		2014
Interest cost	$	31	$	30	$	17
Amortization of actuarial loss (gain)		69		135		(32)
	$	100	$	165	$	(15)

Components of net periodic benefit cost

		As at December 31,
	2016		2015			2014
Unrealized actuarial (gain) loss	$	(37)	$	146	$	346

Schedule of expected benefit payments

2017	$	21
2018		24
2019		26
2020		33
2021		36
Thereafter		507
Total	$	647

Postretirement Benefits Canadian Employees [Member]

Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]

Assumptions used to determine obligation and cost status

	As at December 31,
	2016		2015		2014
Discount rate	3.65	%	3.75	%	3.75	%

Weighted average assumptions used to determine the net postretirement benefit expense are:

	Years Ended December 31,
	2016		2015		2014
Discount rate	3.75	%	3.75	%	4.50	%

Amounts accrued

	As at December 31,
	2016		2015
Obligation, beginning of year	$	1,778	$	2,139
Interest cost		68		71
Service cost		-		1
Benefits paid		(88)		(80)
Actuarial gain		(70)		(6)
Unrealized foreign exchange loss (gain)		57		(347)
Obligation, end of year	$	1,745	$	1,778

Pension Expense

	Years Ended December 31,
	2016		2015		2014
Interest cost	$	68	$	71	$	93
Service cost		-		1		6
	$	68	$	72	$	99

Components of net periodic benefit cost

		As at December 31,
	2016		2015			2014
Unrealized actuarial loss	$	353	$	423	$	429

Schedule of expected benefit payments

2017	$	92
2018		98
2019		104
2020		107
2021		109
Thereafter		1,235
Total	$	1,745

Non-Controlling Interests (Tables)

12 Months Ended

Dec. 31, 2016

IMAX China Non-Controlling Interest [Member]

Non-controlling Interests [Line Items]

Non-controlling Interests

Balance as at January 1, 2015	$	40,272
Issuance of subsidiary shares to a non-controlling interest		40,000
Share issuance costs from the issuance of subsidiary shares to a non-controlling interest		(2,000)
Net income prior to IMAX China IPO		5,401
Other comprehensive income prior to IMAX China IPO		164
Accretion charges associated with redeemable common stock		769
Redemption of redeemable common stock upon qualified IPO		(84,606)
Balance as at October 7, 2015	$	-

The following summarizes the movement of the non-controlling interest in shareholders’ equity, in the Company’s subsidiary for the year ended December 31, 2016:

Balance as at October 8, 2015	$	84,606
Net income after IMAX China IPO		3,712
Other comprehensive income after IMAX China IPO		252
Dividends paid to non-controlling shareholders		(9,511)
Reduction in value due to qualified initial public offering		(29,100)
Balance as at December 31, 2015	$	49,959
Net income		11,338
Other comprehensive loss, net of tax		(1,735)
Balance as at December 31, 2016	$	59,562

Other Noncontrolling Interest [Member]

Non-controlling Interests [Line Items]

Non-controlling Interests

Balance as at January 1, 2015	$	3,640
Net loss		(333)
Balance as at December 31, 2015	$	3,307
Issuance of subsidiary shares to a non-controlling interest		2,479
Net loss		(806)
Balance as at December 31, 2016	$	4,980

Asset Retirement Obligations (Tables)

12 Months Ended

Dec. 31, 2016

Asset Retirement Obligation Disclosure [Abstract]

Schedule of Change in Asset Retirement Obligation [Table Text Block]

	Years Ended December 31,
	2016		2015		2014
Beginning balance, January 1	$	82	$	149	$	143
Accretion expense		14		13		12
Reduction in asset retirement obligation		-		(80)		(6)
Ending balance, December 31	$	96	$	82	$	149

Selected Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2016

Selected Quarterly Financial Information (Unaudited)

Selected Quarterly Financial Information

(in thousands of U.S. dollars, except per share amounts)	2016
	Q1		Q2		Q3		Q4
Revenues	$	92,128	$	91,743	$	86,550	$	106,913
Costs and expenses applicable to revenues		39,952		41,466		41,651		51,587
Gross margin	$	52,176	$	50,277	$	44,899	$	55,326
Net income before cumulative effect from the adoption of ASU 2016-09	$	12,177	$	10,683	$	4,384	$	12,076
Net income	$	13,952	$	8,908	$	4,384	$	12,076
Net income attributable to common shareholders before cumulative
effect from the adoption of ASU 2016-09	$	9,527	$	7,791	$	2,525	$	8,945
Net income attributable to common shareholders	$	11,302	$	6,016	$	2,525	$	8,945

Net income per share attributable to common shareholders:
Net income per share before the adoption of ASU 2016-09 - basic	$	0.14	$	0.11	$	0.04	$	0.14
Net income per share before the adoption of ASU 2016-09 - diluted	$	0.14	$	0.11	$	0.04	$	0.13
Net income per share - basic	$	0.16	$	0.09	$	0.04	$	0.14
Net income per share - diluted	$	0.16	$	0.09	$	0.04	$	0.13

	2015
	Q1		Q2		Q3		Q4
Revenues	$	62,211	$	107,160	$	85,101	$	119,333
Costs and expenses applicable to revenues		26,230		38,125		42,712		47,450
Gross margin	$	35,981	$	69,035	$	42,389	$	71,883
Net income	$	1,485	$	26,380	$	10,514	$	26,245
Net income attributable to common shareholders	$	391	$	24,350	$	8,610	$	22,493

Net income per share attributable to common shareholders:
Net income per share - basic	$	-	$	0.34	$	0.12	$	0.33
Net income per share - diluted	$	-	$	0.34	$	0.12	$	0.32

Description of the Business (Details)	Dec. 31, 2016 Countries
Description of Business (Textuals) [Abstract]
Number of Countries in which Entity Operates	75

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Basis of Presentation (Textuals) [Abstract]
Number of Variable Interest Entities	11
Variable Interest Entity, Primary Beneficiary [Member]
Basis of Presentation (Textuals) [Abstract]
Number Of Variable Interest Entities Primary Beneficiary	5
Total assets	$ 10.3	$ 7.2
Total liabilities	$ 6.4	4.1
Variable Interest Entity, Not Primary Beneficiary [Member]
Basis of Presentation (Textuals) [Abstract]
Number Of Variable Interest Entities Not Primary Beneficiary	6
Total assets	$ 0.4	0.4
Total liabilities	0.4	0.4
Earnings of the investees	0.0	0.0
Carrying value of investments	0.0	0.0
Loss exposure	$ 0.0	$ 0.0

New Accounting Standards And Accounting Changes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Deferred charges on debt financing	$ 1,713	$ 2,247
Accumulated earnings relcass due to adoption of ASU 2016-09	4,400
Deferred tax asset reclass due to adoption of ASU 2016-09	900
Other equity reclass due to adoption of ASU 2016-09	5,300
Stock-based compensation expense recovery due to adoption of ASU 2016-09	2,700
Excess tax benefit due to adoption of ASU 2016-09	100
Playa Vista Loan [Member]
Deferred charges on debt financing	$ 351	$ 391

Lease Arrangements (Details) - USD ($) $ in Thousands	12 Months Ended
Lease Arrangements (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales
Gross minimum lease payments receivable	$ 10,466	$ 13,998
Unearned finance income	(1,710)	(2,381)
Minimum lease payments receivable	8,756	11,617
Accumulated allowance for uncollectible amounts	(672)	(672)
Net investment in leases	8,084	10,945
Gross financed sales receivables	154,301	146,232
Unearned finance income	(39,766)	(39,378)
Financed sales receivables	114,535	106,854
Accumulated allowance for uncollectible amounts	(494)	(568)
Net financed sales receivables	114,041	106,286
Total financing receivables	122,125	117,231
Net financed sales receivables due within one year	21,980	19,068
Net financed sales receivables due after one year	92,061	87,218
Contingent Fees [Abstract]
Sales	3,308	2,492	$ 2,058
Sales-type leases	375	363	102
Operating leases	602	901	886
Subtotal - sales, sales-type leases and operating leases	4,285	3,756	3,046
Joint revenue sharing arrangements	73,976	82,016	57,973
Total	78,261	$ 85,772	$ 61,019
Operating Leases, Future Minimum Payments Receivable [Abstract]
2017	614
2018	335
2019	166
2020	69
2021	69
Thereafter	286
Total	1,539
Sales-type Leases, Future Minimum Payments Receivable [Abstract]
2017	1,513
2018	1,522
2019	1,499
2020	1,314
2021	1,118
Thereafter	1,999
Total	$ 8,965

Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Inventories
Raw materials	$ 28,000	$ 25,750
Work-in-process	3,818	2,628
Finished goods	10,303	10,375
Total	$ 42,121	$ 38,753

Film Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Film Costs [Abstract]
Completed and released films, net of accumulated amortization of $128,650 (2015 - $112,571)	$ 10,643	$ 6,445
Films in production	325	1,538
Films in development	5,554	6,588
Film Costs, Total	$ 16,522	$ 14,571

Property, Plant and Equipment (Details) - USD ($)
$ in Thousands

Dec. 31, 2016

Dec. 31, 2015

Property, plant and equipment

Cost

$ 378,203

$ 328,244

Accumulated Depreciation

132,788

109,977

Net Book Value

245,415

218,267

Other property, plant and equipment [Member]

Property, plant and equipment

Cost

129,259

113,261

Accumulated Depreciation

39,838

32,041

Net Book Value

89,421

81,220

Land [Member]

Property, plant and equipment

Cost

8,203

Accumulated Depreciation

Net Book Value

8,203

Buildings [Member]

Property, plant and equipment

Cost

69,861

67,150

Accumulated Depreciation

14,877

12,679

Net Book Value

54,984

54,471

Office and Production Equipment [Member]

Property, plant and equipment

Cost

^[1]

41,128

34,396

Accumulated Depreciation

^[1]

21,935

17,035

Net Book Value

^[1]

19,193

17,361

Leasehold Improvements [Member]

Property, plant and equipment

Cost

10,067

3,512

Accumulated Depreciation

3,026

2,327

Net Book Value

7,041

1,185

Asset under Construction [Member]

Property, plant and equipment

Cost

^[2]

18,315

9,616

Accumulated Depreciation

^[2]

Net Book Value

^[2]

18,315

9,616

Equipment leased or held for use [Member]

Property, plant and equipment

Cost

230,629

205,367

Accumulated Depreciation

92,950

77,936

Net Book Value

137,679

127,431

Theater System Components [Member]

Property, plant and equipment

Cost

^[4],[5],[6]

224,890

^[3]

199,974

Accumulated Depreciation

^[4],[5],[6]

89,218

^[3]

74,568

Net Book Value

^[4],[5],[6]

135,672

^[3]

125,406

Camera Equipment [Member]

Property, plant and equipment

Cost

5,739

5,393

Accumulated Depreciation

3,732

3,368

Net Book Value

$ 2,007

$ 2,025

[1]	Fully amortized office and production equipment is still in use by the Company. In 2016, the Company identified and wrote off $0.7 million (2015 — $3.1 million) of office and production equipment that is no longer in use and fully amortized.
[2]	Included in assets under construction are components with costs of $8.6 million (2015 — $6.0 million) that will be utilized to construct assets to be used in joint revenue sharing arrangements.
[3]	During 2016, the Company signed certain amending agreements which increased the length of the term for all applicable existing and future theaters under joint revenue sharing arrangement. As a result, the Company adjusted the estimated useful life of its theater system components in use for those respective joint revenue sharing theaters, on a prospective basis, to reflect the change in term. This resulted in decreased depreciation expense of $0.1 million in 2016 and $1.0 million in each of the next 5 years since the Systems will now be depreciated over a longer useful life.
[4]	In 2016, the Company identified and wrote off $0.6 million (2015 — $1.1 million) of theater system components upon the upgrade of xenon-based digital systems under operating lease arrangements to laser-based digital systems under sales or sales-type lease arrangements. In 2016, the Company recorded $nil (2015 — $2.2 million) related to theater system components that are no longer in use and fully amortized.
[5]	Included in theater system components are assets with costs of $10.3 million (2015 — $11.5 million) and accumulated depreciation of $8.1 million (2015 — $7.3 million) that are leased to customers under operating leases.
[6]	Included in theater system components are assets with costs of $205.2 million (2015 — $178.0 million) and accumulated depreciation of $75.7 million (2015 — $62.2 million) that are used in joint revenue sharing arrangements.

Other Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Other Assets [Abstract]
Prepaid taxes (note 9)	$ 14,728	$ 9,064
Lease incentives provided to theaters	5,632	5,852
Commissions and other deferred selling expenses	3,352	3,933
Insurance recoverable	2,708	2,842
Deferred charges on debt financing	1,713	2,247
Investment in film business	1,389	0
Other investments	2,000	1,193
Foreign currency derivatives	480	0
Equity-accounted investments	0	1,005
Other	1,193	0
Other Assets, Total	$ 33,195	$ 26,136

Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract]
Canada	$ 21,002	$ 41,099	$ 15,453
United States	505	4,504	10,350
China	41,224	45,818	26,327
Ireland	(9,768)	(10,581)	0
Other	4,890	6,238	5,221
Income (loss) from Continuing Operations before income taxes, Total	$ 57,853	$ 87,078	$ 57,351

Other Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Other Intangible Assets
Other Intangible Assets, Cost	$ 49,237	$ 44,667
Other Intangible Assets, Accumulated Amortization	18,821	15,717
Other Intangible Assets, Net Book Value	30,416	28,950
Patents and Trademarks [Member]
Other Intangible Assets
Other Intangible Assets, Cost	11,395	10,399
Other Intangible Assets, Accumulated Amortization	7,046	6,502
Other Intangible Assets, Net Book Value	4,349	3,897
Licenses And Intellectual Property [Member]
Other Intangible Assets
Other Intangible Assets, Cost	22,490	22,390
Other Intangible Assets, Accumulated Amortization	7,620	6,464
Other Intangible Assets, Net Book Value	14,870	15,926
Other
Other Intangible Assets
Other Intangible Assets, Cost	15,352	11,878
Other Intangible Assets, Accumulated Amortization	4,155	2,751
Other Intangible Assets, Net Book Value	$ 11,197	$ 9,127

Credit Facility and Playa Vista Loan (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Playa Vista Loan	$ 27,667
Deferred charges on debt financing	(1,713)	$ (2,247)
Total bank indebtedness	27,316	29,276
Playa Vista loan principal payments
2017	2,000
2018	2,000
2019	2,000
2020	2,000
2021	2,000
Thereafter	17,667
Playa Vista Loan	27,667
Playa Vista Loan [Member]
Debt Instrument [Line Items]
Playa Vista Loan	27,667	29,667
Deferred charges on debt financing	(351)	(391)
Total bank indebtedness	27,316	29,276
Playa Vista loan principal payments
Playa Vista Loan	$ 27,667	$ 29,667

Commitments (Details) $ in Thousands	Dec. 31, 2016 USD ($)
Purchase obligations
Purchase obligations, Total	$ 25,283
2017, Purchase obligations	25,283
2018, Purchase obligations	0
2019, Purchase obligations	0
2020, Purchase obligations	0
2021, Purchase obligations	0
Thereafter, Purchase obligations	0
Operating lease obligations
Operating Leases, Total	18,670
2017, Operating Leases	6,203
2018, Operating Leases	5,033
2019, Operating Leases	2,831
2020, Operating Leases	674
2021, Operating Leases	498
Thereafter, Operating Leases	3,431
Playa Vista Loan
Playa Vista Loan, Total	27,667
2017, Playa Vista Loan	2,000
2018, Playa Vista Loan	2,000
2019, Playa Vista Loan	2,000
2020, Playa Vista Loan	2,000
2021, Playa Vista Loan	2,000
Thereafter, Playa Vista Loan	17,667
Other financial commitments
Other financial commitments, Total	39,173
2017, Other financial commitments	39,173
2018, Other financial commitments	0
2019, Other financial commitments	0
2020, Other financial commitments	0
2021, Other financial commitments	0
Thereafter, Other financial commitments	0
Total contractual obligations and commitments
Total contractual obligations and commitments, Total	136,950
2017, Total contractual obligations and commitments	73,797
2018, Total contractual obligations and commitments	8,230
2019, Total contractual obligations and commitments	5,511
2020, Total contractual obligations and commitments	23,929
2021, Total contractual obligations and commitments	2,643
Thereafter, Total contractual obligations and commitments	22,840
Pension obligations [Member]
Pension and Postretirement benefits obligations
Total expected future benefit payment	21,115
2017	0
2018	0
2019	0
2020	21,115
2021	0
Thereafter	0
Postretirement benefits obligations [Member]
Pension and Postretirement benefits obligations
Total expected future benefit payment	5,042
2017	1,138
2018	1,197
2019	680
2020	140
2021	145
Thereafter	$ 1,742

Contingencies and Guarantees (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]
Balance at the beginning of the year	$ 0	$ 6
Warranty redemptions	0	(6)
Warranties issued	30	0
Revisions	0	0
Balance at the end of the year	$ 30	$ 0

Capital Stock (Details) - Employee Stock Option [Member]	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Option to Employees
Average risk-free interest rate	1.67%	1.97%	2.46%
Expected volatility	30.00%	30.00%
Dividend yield	0.00%	0.00%	0.00%
Maximum [Member]
Option to Employees
Expected option life (in years)	5 years 2 months 26 days	5 years 9 months 4 days	5 years 9 months 25 days
Expected volatility			37.50%
Minimum [Member]
Option to Employees
Expected option life (in years)	4 years 5 months 8 days	3 years 6 months 18 days	4 years 1 month 24 days
Expected volatility			32.50%

Consolidated Statement of Operations Supplemental Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Other Revenues
Other revenues from settlement arrangements	$ 1,275	$ 141	$ 0
Foreign Exchange
Net foreign exchange translation losses related to foreign currency denominated monetary assets and liabilities	$ (900)	$ (2,400)	(1,500)
Collaborative Arrangements
Non-cancellable joint revenue sharing arrangements	10 years or longer
Total number of exhibitors under joint revenue sharing agreements	48	43
Total number of theater systems signed under joint revenue sharing agreements	995	741
Total number of operating theaters under joint revenue sharing agreement	640	529
Amounts attributable to transactions arising between the company and its customers under joint revenue sharing arrangements included in Equipment and Product Sales and Rentals revenue	$ 91,413	$ 99,120	68,418
Average percentage of the box-office receipts of the film for recovering digital re-mastering cost	12.50%
IMAX DMR films exhibited in the current period	51	44
Amounts attributable to transactions arising between the company and its customers under IMAX DMR arrangements	$ 106,403	$ 107,089	83,172
Number of significant co-produced film arrangement	1
Number of other co-produced film arrangements	5
Amounts attributable to transactions between the company and other parties involved in the production of films included in cost and expense	$ 1,400	1,500	$ 3,500
Variable Interest Entity, Not Primary Beneficiary [Member]
Collaborative Arrangements
Total assets of VIE	400	400
Total liabilities of VIE	$ 400	$ 400

Receivable Provisions, Net of Recoveries (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Receivable Provisions, Net of Recoveries [Abstract]
Accounts receivable provisions, net of recoveries	$ 1,029	$ 677	$ 725
Financing receivables provisions, net of recoveries	(75)	75	193
Receivable provisions, net of recoveries	$ 954	$ 752	$ 918

Consolidated Statements of Cash Flows Supplemental Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Decrease (increase) in:
Accounts receivable	$ (1,414)	$ (22,521)	$ (4,318)
Financing receivables	(4,627)	(13,628)	(40)
Inventories	(3,825)	(21,070)	(7,603)
Prepaid expenses	(127)	(1,552)	(1,346)
Commissions and other deferred selling expenses	206	(203)	(769)
Insurance recoveries	132	4	10,958
Other assets, prepaid tax	(5,664)	0	(2,984)
Other assets	(1,376)	(456)	(459)
Increase (decrease) in:
Accounts payable	(3,360)	9,183	(5,186)
Accrued and other liabilities	3,914	(2,057)	6,002
Deferred revenue	(14,733)	16,242	12,102
Changes in other non-cash operating assets and liabilities	(30,874)	(36,058)	6,357
Cash payments made on account of:
Income taxes	24,640	22,798	8,885
Interest	$ 721	$ 411	$ 48

Segmented Information (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Revenues

Revenue

$ 106,913

$ 86,550

$ 91,743

$ 92,128

$ 119,333

$ 85,101

$ 107,160

$ 62,211

$ 377,334

$ 373,805

$ 290,541

Gross margins

Gross margin

55,326

$ 44,899

$ 50,277

$ 52,176

71,883

$ 42,389

$ 69,035

$ 35,981

202,678

219,288

173,388

Depreciation and amortization

Depreciation and amortization

46,485

42,803

33,756

Asset Impairments and Write-downs, Net of Recoveries

Asset impairments and write-downs, net of recoveries

5,940

3,725

5,294

Purchase of property, plant and equipment

Purchase of property, plant and equipment

58,188

71,731

56,942

Assets

Assets

857,334

930,629

857,334

930,629

IMAX Theater Systems Total [Member]

Revenues

Revenue

^[1]

237,370

238,192

175,452

Gross margins

Gross margin

133,586

140,242

105,017

IMAX systems [Member]

Revenues

Revenue

^[1]

105,527

102,128

72,992

Gross margins

Gross margin

^[2]

60,090

59,168

47,928

Depreciation and amortization

Depreciation and amortization

4,165

5,685

1,910

Asset Impairments and Write-downs, Net of Recoveries

Asset impairments and write-downs, net of recoveries

916

2,298

1,128

Purchase of property, plant and equipment

Purchase of property, plant and equipment

3,170

8,846

8,822

Assets

Assets

^[3]

218,835

215,602

218,835

215,602

Theater system maintenance [Member]

Revenues

Revenue

^[1]

40,430

36,944

34,042

Gross margins

Gross margin

^[2]

13,659

12,702

12,375

Depreciation and amortization

Depreciation and amortization

225

Asset Impairments and Write-downs, Net of Recoveries

Asset impairments and write-downs, net of recoveries

1,002

277

150

Purchase of property, plant and equipment

Purchase of property, plant and equipment

481

555

229

Assets

Assets

^[3]

28,763

20,907

28,763

20,907

Joint revenue sharing arrangements [Member]

Revenues

Revenue

^[1]

91,413

99,120

68,418

Gross margins

Gross margin

^[4]

59,837

68,372

44,714

Depreciation and amortization

Depreciation and amortization

16,724

14,443

14,614

Asset Impairments and Write-downs, Net of Recoveries

Asset impairments and write-downs, net of recoveries

266

528

397

Purchase of property, plant and equipment

Purchase of property, plant and equipment

42,910

28,474

16,838

Assets

Assets

^[3]

203,227

179,156

203,227

179,156

Films Total [Member]

Revenues

Revenue

^[1]

120,530

118,034

102,935

Gross margins

Gross margin

69,016

78,767

68,242

Production and IMAX DMR [Member]

Revenues

Revenue

^[1]

106,403

107,089

83,172

Gross margins

Gross margin

^[4]

69,196

77,645

62,922

Depreciation and amortization

Depreciation and amortization

15,028

14,330

10,751

Purchase of property, plant and equipment

Purchase of property, plant and equipment

1,121

1,350

15,245

Assets

Assets

39,688

46,262

39,688

46,262

Distribution [Member]

Revenues

Revenue

^[1]

5,254

3,876

8,932

Gross margins

Gross margin

^[4]

(3,909)

(259)

2,274

Depreciation and amortization

Depreciation and amortization

1,444

2,129

1,512

Asset Impairments and Write-downs, Net of Recoveries

Asset impairments and write-downs, net of recoveries

3,020

Purchase of property, plant and equipment

Purchase of property, plant and equipment

830

1,582

Assets

Assets

21,059

17,534

21,059

17,534

Post-production [Member]

Revenues

Revenue

^[1]

8,873

7,069

10,831

Gross margins

Gross margin

3,729

1,381

3,046

Depreciation and amortization

Depreciation and amortization

2,769

1,465

481

Asset Impairments and Write-downs, Net of Recoveries

Asset impairments and write-downs, net of recoveries

223

Purchase of property, plant and equipment

Purchase of property, plant and equipment

1,746

16,337

2,176

Assets

Assets

35,865

26,759

35,865

26,759

Other [Member]

Revenues

Revenue

^[1]

19,434

17,579

12,154

Gross margins

Gross margin

279

129

Depreciation and amortization

Depreciation and amortization

1,567

704

671

Asset Impairments and Write-downs, Net of Recoveries

Asset impairments and write-downs, net of recoveries

314

Purchase of property, plant and equipment

Purchase of property, plant and equipment

5,874

1,986

1,337

Assets

Assets

18,179

23,485

18,179

23,485

Corporate and other non-segment specific assets [Member]

Depreciation and amortization

Depreciation and amortization

4,716

3,975

3,592

Asset Impairments and Write-downs, Net of Recoveries

Asset impairments and write-downs, net of recoveries

513

622

3,305

Purchase of property, plant and equipment

Purchase of property, plant and equipment

2,865

13,353

$ 10,713

Assets

Assets

$ 291,718

$ 400,924

$ 291,718

$ 400,924

[1]	The Company’s largest customer represents 13.5% of total revenues as at December 31, 2016 (2015 – 16.0%, 2014 – 14.5%).
[2]	In 2016, the Company recorded a charge of $0.5 million (2015 –$0.6 million, 2014 – $0.4 million, respectively) in costs and expenses applicable to revenues, primarily for its laser-based projector inventories. Specifically, IMAX systems includes an inventory charge of $0.2 million (2015 – $0.5 million, 2014 – $0.2 million). Theater system maintenance includes inventory write-downs of 0.2 million (2015 – less than $0.1 million, 2014 – $0.2 million).
[3]	Goodwill is allocated on a relative fair market value basis to the IMAX systems segment, theater system maintenance segment and joint revenue sharing segment. There has been no change in the allocation of goodwill from the prior year.
[4]	IMAX systems include marketing and commission costs of $3.0 million, $3.0 million and $2.7 million in 2016, 2015 and 2014, respectively. Joint revenue sharing arrangements segment margins include advertising, marketing, and commission costs of $4.1 million, $4.3 million and $3.2 million in 2016, 2015 and 2014, respectively. Production and DMR segment margins include marketing costs of $17.5 million, $13.3 million and $7.1 million in 2016, 2015 and 2014, respectively. Distribution segment margins include marketing expense of $2.2 million, recovery of $0.1 million and expense of $0.6 million in 2016, 2015 and 2014, respectively.

Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Other Financial Instrument
Cash and cash equivalents	$ 204,759	$ 317,449	$ 106,503	$ 29,546
Net financed sales receivable	114,041	106,286
Net investment in sales-type leases	8,084	10,945
Convertible loan receivable	1,000
Foreign exchange contracts - designated forwards	(296)	(4,423)
Borrowings under the Playa Vista Loan	(27,667)
Carrying (Reported) Amount, Fair Value Disclosure [Member]
Other Financial Instrument
Cash and cash equivalents	204,759	317,449
Net financed sales receivable	114,041	106,286
Net investment in sales-type leases	8,084	10,945
Convertible loan receivable	1,000	0
Available-for-sale investment	1,000	1,000
Foreign exchange contracts - designated forwards	(296)	(4,423)
Borrowings under the Playa Vista Loan	(27,667)	(29,667)
Estimate of Fair Value, Fair Value Disclosure [Member]
Other Financial Instrument
Cash and cash equivalents	204,759	317,449
Net financed sales receivable	115,014	108,184
Net investment in sales-type leases	8,372	11,154
Convertible loan receivable	1,000	0
Available-for-sale investment	1,007	997
Foreign exchange contracts - designated forwards	(296)	(4,423)
Borrowings under the Playa Vista Loan	$ (27,667)	$ (29,667)

Employees Pension and Postretirement Benefits (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
SERP Benefits [Member]
Assumptions used to determine obligation and cost status
Discount rate					2.18%	1.34%	1.30%
Lump sum interest rate - First 20 years		1.87%	2.82%	2.89%
Lump sum interest rate - thereafter		2.37%	2.95%	3.12%
Cost of living adjustment on benefits		1.20%	1.20%	1.20%
Amounts Accrued
Obligation, beginning of year	$ 19,580	$ 19,478	$ 19,405
Interest cost	400	261	253	$ 264
Actuarial gain		(159)	(180)
Obligation, end of year		19,580	19,478	19,405
Amounts recorded in the consolidated balance sheet
Accrued benefits cost	19,580	19,478	19,478	19,405	$ 19,580	$ 19,478	$ 19,405
Accumulated other comprehensive loss					1,165	1,323
Net amount recognized in the consolidated balance sheets					(18,415)	(18,155)
Net periodic benefit cost
Interest cost	400	261	253	264
Pension expense		$ 261	$ 253	$ 264
Components of net periodic benefit cost in future periods
Unrealized actuarial loss (gain)					$ 1,165	$ 1,323	$ 1,503
Postretirement Benefits Executives [Member]
Assumptions used to determine obligation and cost status
Discount rate					4.10%	4.20%	3.70%
Discount rate used in calculating net periodic benefit cost		4.20%	3.70%	4.50%
Amounts Accrued
Obligation, beginning of year	647	$ 763	$ 830
Interest cost		31	30	$ 17
Benefits paid		(33)	(24)
Actuarial gain		(114)	(73)
Obligation, end of year		647	763	830
Amounts recorded in the consolidated balance sheet
Accrued benefits cost	647	763	763	830	$ 647	$ 763	$ 830
Net periodic benefit cost
Interest cost		31	30	17
Amortization of actuarial loss (gain)		69	135	(32)
Pension expense		$ 100	$ 165	$ (15)
Components of net periodic benefit cost in future periods
Unrealized actuarial loss (gain)					$ (37)	$ 146	$ 346
Postretirement Benefits Canadian Employees [Member]
Assumptions used to determine obligation and cost status
Discount rate					3.65%	3.75%	3.75%
Discount rate used in calculating net periodic benefit cost		3.75%	3.75%	4.50%
Amounts Accrued
Obligation, beginning of year	1,745	$ 1,778	$ 2,139
Interest cost	100	68	71	$ 93
Service cost		0	1	6
Benefits paid		(88)	(80)
Actuarial gain		(70)	(6)
Unrealized foreign exchange loss (gain)		57	(347)
Obligation, end of year		1,745	1,778	2,139
Amounts recorded in the consolidated balance sheet
Accrued benefits cost	1,745	1,778	1,778	2,139	$ 1,745	$ 1,778	$ 2,139
Net periodic benefit cost
Interest cost	$ 100	68	71	93
Service cost		0	1	6
Pension expense		$ 68	$ 72	$ 99
Components of net periodic benefit cost in future periods
Unrealized actuarial loss (gain)					$ 353	$ 423	$ 429

Asset Retirement Obligations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]
Beginning balance, January 1	$ 82	$ 149	$ 143
Accretion expense	14	13	12
Reduction in asset retirement obligation	0	(80)	(6)
Ending balance, December 31	$ 96	$ 82	$ 149

Commitments (Details 1) - USD ($) $ in Thousands	12 Months Ended
Commitments (Details 1) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Commitments, Contingencies and Guarantees [Abstract]
Total rent expense	$ 5,106	$ 4,766	$ 6,567

Non-Controlling Interests (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Oct. 07, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Non-controlling Interests [Line Items]
Issuance of subsidiary shares to a non-controlling interest			$ 0	$ 178,226	$ 0
Net income (loss)			10,532	8,780	2,433
Dividends paid to non-controlling interests			0	(9,511)	0
Reduction in non-controlling interest value upon qualified initial public offering				0
IMAX China Non-Controlling Interest [Member]
Non-controlling Interests [Line Items]
Net income (loss)			11,338
Other comprehensive loss, net of tax			(1,735)
Dividends paid to non-controlling interests				(9,500)
Ending Balance			59,562
IMAX China Non-Controlling Interest [Member] \| Pre IPO [Member]
Non-controlling Interests [Line Items]
Beginning Balance		$ 40,272		40,272
Issuance of subsidiary shares to a non-controlling interest		40,000
Share issuance costs from the issuance of subsidiary shares to a non-controlling interest		(2,000)
Net income (loss)		5,401
Other comprehensive loss, net of tax		164
Accretion charges associated with redeemable common stock		769
Redemption of redeemable common stock upon qualified IPO		(84,606)
Ending Balance		0			40,272
IMAX China Non-Controlling Interest [Member] \| Post IPO [Member]
Non-controlling Interests [Line Items]
Beginning Balance	$ 84,606		49,959
Net income (loss)	3,712
Other comprehensive loss, net of tax	252
Dividends paid to non-controlling interests	(9,511)
Reduction in non-controlling interest value upon qualified initial public offering	(29,100)
Ending Balance	49,959			49,959
Other Noncontrolling Interest [Member]
Non-controlling Interests [Line Items]
Beginning Balance		$ 3,640	3,307	3,640
Issuance of subsidiary shares to a non-controlling interest			2,479
Net income (loss)			(806)	(333)
Ending Balance	$ 3,307		$ 4,980	$ 3,307	$ 3,640

Summary of Significant Accounting Policies (Details 1)

12 Months Ended

Dec. 31, 2016

Leasehold Improvements [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant And Equipment, Useful Life, Maximum

over the shorter of the initial term of the underlying lease plus any reasonably assured renewal terms, and the useful life of the asset

Minimum [Member] | Theater System Components [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant and Equipment, Useful Life

7 years

^[1]

Minimum [Member] | Camera Equipment [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant and Equipment, Useful Life

5 years

Minimum [Member] | Buildings [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant and Equipment, Useful Life

20 years

Minimum [Member] | Office and Production Equipment [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant and Equipment, Useful Life

3 years

Maximum [Member] | Theater System Components [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant and Equipment, Useful Life

20 years

^[1]

Maximum [Member] | Camera Equipment [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant and Equipment, Useful Life

10 years

Maximum [Member] | Buildings [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant and Equipment, Useful Life

25 years

Maximum [Member] | Office and Production Equipment [Member]

Property, Plant and Equipment Policy (Textuals) [Abstract]

Property, Plant and Equipment, Useful Life

5 years

[1]	includes equipment under joint revenue sharing arrangements.

Summary of Significant Accounting Policies (Details 2)	12 Months Ended
Summary of Significant Accounting Policies (Details 2)	Dec. 31, 2016
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Useful Life	4 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Useful Life	10 years

Summary of Significant Accounting Policies (Details 3) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cost of Sales Policy (Textuals) [Abstract]
Commissions recognized as costs and expenses	$ 3.3	$ 3.4	$ 2.5
Cost of equipment and product sales prior to direct selling costs	$ 66.5	$ 60.2	$ 34.5

Summary of Significant Accounting Policies (Details 4) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cost of Rentals Policy (Textuals) [Abstract]
Commissions recognized as cost and expenses	$ 1.8	$ 1.1	$ 1.1
Direct advertising and marketing costs related to theater	$ 0.9	$ 1.9	$ 1.5

Summary of Significant Accounting Policies (Details 5) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Production and IMAX DMR [Member]
Film Exploitation Costs [Line Items]
Film exploitation costs, including advertising and marketing	$ 17.5	$ 13.3	$ 7.1
Film Distribution [Member]
Film Exploitation Costs [Line Items]
Film exploitation costs, including advertising and marketing	$ 2.2	$ (0.1)	$ 0.6

Summary of Significant Accounting Policies (Details 6)	12 Months Ended
Summary of Significant Accounting Policies (Details 6)	Dec. 31, 2016
Pension Plans and Postretirement Benefits (Textuals) [Abstract]
Pension policy details	10.00%
Remaining Weighted Average Service Life of Employee	3 years

Other Intangible Assets (Details 1) $ in Thousands	Dec. 31, 2016 USD ($)
Other Intangible Assets (Additional Textuals) [Abstract]
2017	$ 3,470
2018	3,470
2019	3,470
2020	3,470
2021	$ 3,470

Other Intangible Assets (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Other Intangible Assets (Textuals) [Abstract]
Other intangible assets, ERP System	$ 15,352
Net book value of intellectual rights disposed of in the year	200	$ 100
Acquisition of patents and Trademarks, cost	4,800
Acquisition of patents and Trademarks, net book value	$ 4,300
Weighted average amortization period for additions to other intangible assets	10 years
Costs incurred to renew or extend the term of acquired other intangible assets		less than
Costs incurred to renew or extend the term of acquired other intangible assets	$ 200	$ 100

Lease Arrangements (Details Textual) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Financing Receivables (Textuals) [Abstract]
Non-cancellable joint revenue sharing arrangements	10 years or longer
Non-cancellable lease arrangements	10 to 20 years
Financed sale receivables, weighted average effective interest rate	9.30%	9.40%
Amounts billed but not yet received excluded from total future minimum rental payments receivable from sales-type leases	$ 1.5

Inventories (Details Textual) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Inventories (Textuals) [Abstract]
Finished goods inventory for which title had passed to customer	$ 2.3	$ 5.4
Impairments and write-downs for excess and obsolete inventory	$ 0.5	$ 0.6

Film Assets (Details Textual) - USD ($) $ in Thousands	12 Months Ended
Film Assets (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Film Costs (Textuals) [Abstract]
Film costs expected to be amortized within three years from balance sheet date	$ 4,800	$ 6,300
Film Costs, Amortized in Next Operating Cycle	2,400
Amount of participation payments expected to be made to third parties in the next operating cycle	4,200	3,900
Accumulated amortization, completed and released films	128,650	112,571
Asset impairment charges for certain documentary films	$ 3,020	$ 0	$ 0

Property, Plant and Equipment (Details Textual) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Property, Plant and Equipment [Line Items]

Theater system components written off in the period

^[1]

$ 885

$ 1,485

$ 440

Impairment charges against property, plant and equipment

223

405

$ 314

Office and Production Equipment [Member]

Property, Plant and Equipment [Line Items]

Office and production equipment written off in the period

700

3,100

Asset under Construction [Member]

Property, Plant and Equipment [Line Items]

Assets under joint revenue sharing arrangements included in Assets under construction

8,600

6,000

Theater System Components [Member]

Property, Plant and Equipment [Line Items]

Assets leased to customers under operating lease, Gross

10,300

11,500

Accumulated Depreciation, assets leased to customers under operating lease

8,100

7,300

Assets under joint revenue sharing arrangements included in Theater system components

205,200

178,000

Accumulated Depreciation , Assets under joint revenue sharing arrangements included in Theater system components

75,700

62,200

Theater system components written off in the period

600

1,100

Theater system components written off in the period no longer in use and fully amortized

$ 2,200

Joint Revenue Sharing Arrangement Change In Depreciation Expense Due To Change In Estimated Useful Life Current Year

100

Joint Revenue Sharing Arrangement Change In Depreciation Expense Due To Change In Estimated Useful Life Year One

1,000

Joint Revenue Sharing Arrangement Change In Depreciation Expense Due To Change In Estimated Useful Life Year Two

1,000

Joint Revenue Sharing Arrangement Change In Depreciation Expense Due To Change In Estimated Useful Life Year Three

1,000

Joint Revenue Sharing Arrangement Change In Depreciation Expense Due To Change In Estimated Useful Life Year Four

1,000

Joint Revenue Sharing Arrangement Change In Depreciation Expense Due To Change In Estimated Useful Life Year Five

$ 1,000

[1]

In 2016, the Company recorded a charge of $0.3 million (2015 — $0.4 million; 2014 — $0.5 million) reflecting property, plant and equipment that were no longer in use. In 2016, the Company also recorded a charge of $0.6 million (2015 - $0.6 million) in cost of sales applicable to Equipment and product sales upon the upgrade of xenon-based digital systems under operating lease arrangements to laser-based digital systems under sales or sales-type lease arrangements. In addition, in 2015, the Company recorded a charge of $0.5 million in cost of sales applicable to Rentals upon the upgrade of certain xenon-based digital systems to laser-based digital systems operating under joint revenue sharing arrangements.

Credit Facility and Playa Vista Loan (Details Textuals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Oct. 19, 2015	Mar. 03, 2015	Oct. 06, 2014
Credit Facility and Playa Vista Construction Loan (Textuals) [Abstract]
Term Loan Repayment Terms	P120M
Maturity date	Oct. 19, 2025
Playa Vista Construction Loan [Member]
Credit Facility and Playa Vista Construction Loan (Textuals) [Abstract]
Playa Vista construction loan funding					$ 22,300
Interest rate description		Prior to the conversion, the Playa Vista Construction Loan bore interest at a variable interest rate per annum equal to 2.25% above the 30-day LIBOR rate, and PV Borrower was required to make monthly payments of interest only.
Playa Vista Loan [Member]
Credit Facility and Playa Vista Construction Loan (Textuals) [Abstract]
Maximum borrowing capacity			$ 30,000
Amounts drawn	$ 27,667	$ 29,667
Playa Vista Construction Loan conversion date		Oct. 19, 2015
Additional borrowing under revolving term loan		$ 7,700
Term of loan	120 months
Effective interest rate	2.52%	2.40%
Interest rate description	As a result of the conversion, the interest rate decreased from 2.25% to 2.0% above the 30-day LIBOR rate
Maturity date	Oct. 19, 2025
Debt Instrument Payment Terms	PV Borrower will be required to make monthly payments of combined principal and interest over a 10-year term with a lump sum payment at the end of year 10. The Playa Vista Loan is being amortized over 15 years. The Playa Vista Loan will be fully due and payable on October 19, 2025.
Playa Vista Loan - Security	The Playa Vista Loan is secured by a deed of trust from PV Borrower in favor of Wells Fargo and other documents evidencing and securing the loan (the “Loan Documents”), granting a first lien on and security interest in the Playa Vista property and the Playa Vista Project, including all improvements to be constructed thereon.
Credit Facility [Member]
Credit Facility and Playa Vista Construction Loan (Textuals) [Abstract]
Credit Facility Maturity Date	Mar. 03, 2020
Maximum borrowing capacity				$ 200,000
Amounts drawn	$ 0	$ 0
Remaining borrowing capacity	$ 200,000	200,000
Credit Facility [Member] \| Playa Vista Loan [Member]
Credit Facility and Playa Vista Construction Loan (Textuals) [Abstract]
Line of credit facility covenant terms	The Company was in compliance with all of its requirements at December 31, 2016.
Description of conversion option for the Playa Vista Constuction Loan	On February 22, 2016, the Company amended the terms of the Credit Agreement to increase the general restricted payment basket thereunder (which covers, among other things, the repurchase of shares) from $150.0 million to $350.0 million in the aggregate after the amendment date.
Credit Facility [Member] \| Letter Of Credit And APG [Member]
Credit Facility and Playa Vista Construction Loan (Textuals) [Abstract]
Amounts drawn	$ 0	0
Wells Fargo Foreign Exchange Facility [Member] \| Foreign Currency Forward Contracts [Member]
Credit Facility and Playa Vista Construction Loan (Textuals) [Abstract]
Settlement risk on its foreign currency forward contracts	300
Notional value of foreign currency forward contracts outstanding	37,825
Bank of Montreal Facilities [Member]
Credit Facility and Playa Vista Construction Loan (Textuals) [Abstract]
Remaining borrowing capacity	10,000	10,000
Letters of credit and advance payment guarantees	$ 100	$ 300

Commitments (Details Textual) - USD ($) $ in Thousands	12 Months Ended
Commitments (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Commitments (Textuals) [Abstract]
Accrued rent and lease inducements recognized as an offset to rent expense included in Accrued liabilities	$ 1,600	$ 1,100
Accrued commission on sale or lease of the theater systems payable in future periods	$ 2,000	1,700
Commitments subsequent event	Subsequent to December 31, 2016, the Company entered into a premises lease arrangement, related to the New York corporate office, with a commitment of approximately $17.1 million over a 12-year term. The term is expected to begin in January 2018.
Commitments (Additional Textuals)
Maturity date	Oct. 19, 2025
Playa Vista Loan repayment terms	P120M
Bank of Montreal Facilities [Member]
Commitments (Additional Textuals)
Outstanding letter of credit and advance payment guarantees secured	$ 139	278
Credit Facility [Member]
Commitments (Additional Textuals)
Outstanding letter of credit and advance payment guarantees secured	$ 0	$ 0

Contingencies and Guarantees (Details Textuals) - USD ($) $ in Thousands	25 Months Ended	51 Months Ended	95 Months Ended
	Dec. 14, 2015	Mar. 27, 2008	Dec. 02, 2011	Dec. 31, 2016	Dec. 31, 2015
Contingencies and Guarantees Disclosure (Textuals) [Abstract]
Final award in favor of company		Amount of $11.3 million plus an additional $2,512 each day in interest from October 1, 2007 until the date the award is paid	$30,000 to cover the costs of the application
Damages sought	up to approximately
Damages sought	$ 10,400
Counterclaim sought	in excess of
Counterclaim sought	$ 24,000
Duties and taxes payable related to customs audit				$ 2,950
Underpayment of the freight and insurance portion of the customs duties and taxes related to the customs audit				100
Financial Guarantees				0
Indemnification of its directors/officers				0	$ 0
Other Indemnification				$ 0

Consolidated Statements of Cash Flows Supplemental Information (Details 1) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Summary of Depreciation and amortization

Film assets (1)

^[1]

$ 16,324

$ 16,357

$ 11,851

Property, plant and equipment

Joint revenue sharing arrangements

15,840

13,663

12,148

Other property, plant and equipment

9,692

7,698

5,616

Other intangible assets

3,235

3,285

2,988

Other assets

862

784

627

Deferred financing costs

532

1,016

526

Depreciation and amortization

$ 46,485

$ 42,803

$ 33,756

[1]	Included in film asset amortization is a charge of $0.2 million (2015 —$0.9 million, 2014 —$0.3 million) relating to changes in estimates based on the ultimate recoverability of future films.

Consolidated Statements of Cash Flows Supplemental Information (Details 2) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Asset impairments

Property, plant and equipment

$ 223

$ 405

$ 314

Impairment of investments

194

425

3,206

Other charges (recoveries)

Accounts receivable

1,029

677

725

Financing receivables

(75)

193

Inventories (1)

^[1]

458

572

359

Film assets

3,020

Property, plant and equipment (2)

^[2]

885

1,485

440

Other intangible assets

206

Write-downs, net of recoveries

$ 5,940

$ 3,725

$ 5,294

[1]

In 2016, the Company recorded a charge of $0.5 million (2015 –$0.6 million, 2014 – $0.4 million, respectively) in costs and expenses applicable to revenues, primarily for its laser-based projector inventories. Specifically, IMAX systems includes an inventory charge of $0.2 million (2015 – $0.5 million, 2014 – $0.2 million). Theater system maintenance includes inventory write-downs of 0.2 million (2015 – less than $0.1 million, 2014 – $0.2 million).

[2]

Consolidated Statements of Cash Flows Supplemental Information (Details 3) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Inventory charges

Recorded in costs and expenses applicable to revenues - equipment & product sales

$ 227

$ 537

$ 209

Recorded in costs and expenses applicable to revenues - services

231

150

Total

^[1]

458

572

359

IMAX systems [Member]

Inventory charges

Recorded in costs and expenses applicable to revenues - equipment & product sales

227

537

209

Theater System Maintenance [Member]

Inventory charges

Recorded in costs and expenses applicable to revenues - services

231

150

Film Based Projector [Member]

Inventory charges

Total

$ 458

$ 572

$ 359

[1]

Consolidated Statements of Cash Flows Supplemental Information (Details Textual) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Consolidated Statements of Cash Flows Supplemental Information [Abstract]

Charge recorded in film asset amortization relating to changes in estimates based on ultimate recoverability of future films

$ 200

$ 900

$ 300

Recorded in costs and expenses applicable to revenues - total

^[1]

458

572

359

Recorded in costs and expenses applicable to revenues - equipment & product sales

227

537

209

Recorded in costs and expenses applicable to revenues - services

231

150

Charges reflecting property, plant and equipment that were no longer in use

300

400

500

Theater systems written off upon the upgrade of systems under operating lease arrangements to sales or sales-type lease arrangements

600

Theater systems written off upon the upgrade of systems under joint revenue sharing arrangements to sales or sales-type lease arrangements

$ 0

$ 500

$ 0

[1]

Income Taxes (Details 1) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Current income tax (provision) recovery [Abstract]

Canada

$ (1,396)

$ (10,862)

$ (3,495)

United States

1,756

985

(4,072)

China

(10,131)

(10,591)

(6,023)

Ireland

(405)

Other

(1,093)

(920)

(249)

Current income tax provision, Total

(11,269)

(21,388)

(13,839)

Deferred income tax (provision) recovery [Abstract]

Canada

^[1]

(3,583)

(518)

433

United States

^[1]

(4,359)

147

(791)

China

^[1]

776

(83)

(216)

Ireland

^[1]

2,352

1,840

Other

^[1]

(129)

(50)

(53)

Deferred income tax (provision) recovery, Total

(4,943)

1,336

(627)

Provisions for income taxes, as reported

$ (16,212)

$ (20,052)

$ (14,466)

[1]

Income Taxes (Details 2) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details 2) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
(Provision) Recovery of Income Taxes from Continuing Operations, Income Tax Reconciliation [Abstract]
Income tax provision at combined statutory rates	$ (15,330)	$ (23,081)	$ (15,189)
Stock based compensation	(565)	2,387	(2,244)
Other non-deductible/non-includable items	(1,254)	(439)	1,257
Decrease (increase) in valuation allowance relating to current year temporary differences	129	(16)	429
Changes to tax reserves	1,628	(453)	230
U.S. federal and state taxes	(767)	(27)	(200)
Withholding taxes	(786)	(716)	(200)
Income tax at different rates in foreign and other provincial jurisdictions	50	961	516
Investment and other tax credits (non-refundable)	2,190	1,597	1,973
Changes to deferred tax assets and liabilities resulting from audit and other tax return adjustments	(1,612)	(242)	(1,013)
Windfall tax benefit	57	0	0
Tax effect of loss from equity-accounted investments	0	0	(41)
Other	48	(23)	16
Provisions for income taxes, as reported	$ (16,212)	$ (20,052)	$ (14,466)

Income Taxes (Details 3) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Deferred Tax Assets, Net [Abstract]
Net operating loss carryforwards	$ 2,893	$ 1,158
Write-downs of other assets	759	720
Excess tax over accounting basis in property, plant and equipment, inventories and other assets	0	9,577
Accrued pension liability	6,571	6,626
Accrued stock-based compensation	12,352	9,261
Other accrued reserves	3,754	559
Total deferred income tax assets	26,329	27,901
Income recognition on net investment in leases	(3,985)	(1,809)
Excess accounting over tax basis in property, plant and equipment, inventories and other assets	(1,368)	0
Total deferred income tax assets, before valuation allowance	20,976	26,092
Valuation allowance	(197)	(326)
Net deferred income tax asset	$ 20,779	$ 25,766

Income Taxes (Details 4) $ in Thousands	12 Months Ended
Income Taxes (Details 4) $ in Thousands	Dec. 31, 2016 USD ($)
Net Operating Loss Carryforwards [Line Items]
Investment Tax Credits and Other Tax Credit Carryforwards	$ 2,194
Net Operating Loss Carryforwards	37,664
In One Year [Member]
Net Operating Loss Carryforwards [Line Items]
Investment Tax Credits and Other Tax Credit Carryforward By Expiration Dates	0
Net Operating Loss Carryforwards By Expiration Dates	0
In Two Years [Member]
Net Operating Loss Carryforwards [Line Items]
Investment Tax Credits and Other Tax Credit Carryforward By Expiration Dates	0
Net Operating Loss Carryforwards By Expiration Dates	0
In Three Years [Member]
Net Operating Loss Carryforwards [Line Items]
Investment Tax Credits and Other Tax Credit Carryforward By Expiration Dates	0
Net Operating Loss Carryforwards By Expiration Dates	0
In Four Years [Member]
Net Operating Loss Carryforwards [Line Items]
Investment Tax Credits and Other Tax Credit Carryforward By Expiration Dates	0
Net Operating Loss Carryforwards By Expiration Dates	0
In Five Years [Member]
Net Operating Loss Carryforwards [Line Items]
Investment Tax Credits and Other Tax Credit Carryforward By Expiration Dates	0
Net Operating Loss Carryforwards By Expiration Dates	0
Thereafter [Member]
Net Operating Loss Carryforwards [Line Items]
Investment Tax Credits and Other Tax Credit Carryforward By Expiration Dates	2,194
Net Operating Loss Carryforwards By Expiration Dates	$ 37,664

Income Taxes (Details 5) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details 5) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of beginning and ending amount of unrecognized tax benefits (excluding interest and penalties)
Balance at beginning of the year	$ 14,221	$ 1,972	$ 2,202
Additions based on tax positions related to the current year	314	12,694	237
Reductions for tax positions of prior years	(500)	0	0
Reductions resulting from lapse of applicable statute of limitations and administrative practices	(1,442)	(445)	(467)
Balance at the end of the year	$ 12,593	$ 14,221	$ 1,972

Income Taxes (Details 6) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details 6) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent [Abstract]
Unrecognized actuarial gain or loss on defined benefit plan	$ (41)	$ (47)	$ 225
Unrecognized actuarial gain or loss on postretirement benefit plans	(48)	(21)	151
Amortization of actuarial gain or loss on postretirement benefit plan	(18)	(35)	8
Other-than-temporary impairment of available-for-sale investment	0	0	(45)
Unrealized change in cash flow hedging instruments	(271)	1,543	658
Realized change in cash flow hedging instruments upon settlement	(802)	(844)	(306)
Foreign currency translation adjustments	0	(85)	59
Income tax effect on comprehensive (loss) income	$ (1,180)	$ 511	$ 750

Income Taxes (Details Textual) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Footnote disclosure - Deferred income tax (provision) recovery [Abstract]
Change in valuation allowance relating to the future utilization of deductible temporary differences, tax credits, and certain net operating loss carryforwards		less than
Change in valuation allowance relating to the future utilization of deductible temporary differences, tax credits, and certain net operating loss carryforwards	$ (100)	$ 100
Change in valuation allowance recorded to deferred income tax expense	129	(16)	$ 429
Deferred tax provision for amounts recorded in and reclassified from other comprehensive income	1,180	(511)	(750)
Deferred Tax Assets, Net [Abstract]
Deferred tax assets, Other	100
Excess tax benefit due to adoption of ASU 2016-09	100
Deferred tax asset reclass due to adoption of ASU 2016-09	900
Adjustment to deferred tax assets related to windfall tax benefit from exercise of stock options		14,000
Deferred tax assets relating to share based compensation		5,900
Provision for uncertain tax positions recorded to income tax provision		3,900
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation		8,100
Provision for uncertain tax positions recorded to shareholders' equity		$ 7,900
Tax Credits and Net Operating Loss Carryfowards [Abstract]
Net Operating Loss Carryforwards	$ 37,664
Net Operating Loss Carryforwards, Limitations on Use	Estimated net operating loss carryforwards of $17.6 million can be carried forward to reduce taxable income through to 2037 and the remaining $20.1 million can be carried forward indefinitely.
Investment Tax Credits and Other Tax Credit Carryforward, Expiration Dates	Dec. 31, 2037
Net Operating Loss Carryforwards, Expiration Dates	Dec. 31, 2037
Valuation Allowance [Abstract]
Change in valuation allowance relating to the future utilization of deductible temporary differences, tax credits, and certain net operating loss carryforwards		less than
Net income tax (recovery) expense related to change in valuation allowance	$ (100)	$ 100
Change in valuation allowance recorded to deferred income tax expense	129	(16)	429
Valuation allowance	197	326
Disclosure relating to adoption of FIN 48 [Abstract]
Tax Adjustments, Settlements, and Unusual Provisions	(1,600)
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	12,600
Total unrecognized tax benefits (including interest and penalties)	$ 12,600	$ 14,600
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]
Interest and penalty associated with unrecognized tax benefits	less than	less than
Interest and penalty associated with unrecognized tax benefits	$ (100)	$ (100)	$ (200)
Maximum [Member] \| Internal Revenue Service (IRS) [Member]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]
Open Tax Years by Major Tax Jurisdiction	2016
Maximum [Member] \| Canada Revenue Agency [Member]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]
Open Tax Years by Major Tax Jurisdiction	2016
Minimum [Member] \| Internal Revenue Service (IRS) [Member]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]
Open Tax Years by Major Tax Jurisdiction	2011
Minimum [Member] \| Canada Revenue Agency [Member]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]
Open Tax Years by Major Tax Jurisdiction	2006

Capital Stock (Details 1) - Options Non Employees [Member]	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Options to Non-Employees
Average risk-free interest rate			0.53%
Average risk-free interest rate	n/a	n/a
Contractual option life			2 years
Contractual option life	n/a	n/a
Average expected volatility			32.50%
Average expected volatility	n/a	n/a
Dividend yield			0.00%
Dividend yield	n/a	n/a

Capital Stock (Details 2) - $ / shares	12 Months Ended
Capital Stock (Details 2) - $ / shares	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Option activity under the Stock Option Plan
Exercised	518,018	1,761,675	1,149,587
Employee Stock Option [Member]
Option activity under the Stock Option Plan
Options outstanding, beginning of year	4,805,244	5,925,660	6,263,121
Options outstanding, per share beginning of year	$ 27.03	$ 24.24	$ 21.11
Granted	984,452	873,929	872,155
Weighted average exercise price of options granted	$ 31.49	$ 31.59	$ 27.48
Exercised	(518,018)	(1,761,675)	(1,149,587)
Weighted average exercise price of options exercised	$ 22.07	$ 20.21	$ 9.42
Forfeited	(66,903)	(232,670)	(36,242)
Weighted average exercise price of options forfeited	$ 29.28	$ 24.60	$ 24.63
Cancelled	(14,233)	0	(23,787)
Weighted average exercise price of options cancelled	$ 24.82	$ 0	$ 33.60
Options outstanding, end of year	5,190,542	4,805,244	5,925,660
Options outstanding, per share end of year	$ 28.35	$ 27.03	$ 24.24
Options exercisable, end of year	4,001,078	2,800,723	3,368,558
Options exercisable, weighted average exercise price	$ 27.79	$ 25.83	$ 22.69

Capital Stock (Details 3) - Restricted Stock Units (RSUs) [Member] - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Resticted Share Units activity under the LTIP
RSUs oustanding, beginning of year	973,637	595,834	264,140
RSUs outstanding, weighted average grant date fair value per share, beginning of year	$ 32.27	$ 27.13	$ 26.14
Granted	664,278	605,349	484,088
Granted, weighted average grant date fair value per share	$ 32.29	$ 36.04	$ 27.42
Vested and settled	(466,918)	(207,371)	(148,001)
Vested and settled, weighted average grant date fair value per share	$ 30.63	$ 28.81	$ 26.29
Forfeited	(46,817)	(20,175)	(4,393)
Forfeited, weighted average grant date fair value per share	$ 31.16	$ 29.27	$ 26.88
RSUs oustanding, end of year	1,124,180	973,637	595,834
RSUs outstanding, weighted average grant date fair value per share, end of year	$ 33.01	$ 32.27	$ 27.13

Capital Stock (Details 5) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Capital Stock (Details 5) - USD ($) $ in Thousands	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Jan. 01, 2016	Jan. 01, 2015	Jan. 01, 2014
Basic and diluted per-share computations
Net income attributable to common shareholders	$ 8,945	$ 2,525	$ 6,016	$ 11,302	$ 22,493	$ 8,610	$ 24,350	$ 391	$ 28,788	$ 55,844	$ 39,736
Less: accretion charges associated with redeemable common stock									0	(769)	(426)
Net income applicable to common shareholders									$ 28,788	$ 55,075	$ 39,310
Weighted average number of common shares (000's):
Issued and outstanding, beginning of period	66,159,902				69,673,244				66,159,902	69,673,244		69,673	68,988	67,841
Weighted average number of shares (repurchased) issued during the period, net									(2,098)	538	505
Weighted average number of shares used in computing basic earnings per share									67,575	69,526	68,346
Assumed exercise of stock options and RSUs, net of shares assumed repurchased									688	1,532	1,408
Weighted average number of shares used in computing diluted earnings per share									68,263	71,058	69,754

Capital Stock (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended			31 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016	Apr. 20, 2016	Oct. 08, 2015	Jun. 16, 2014	Dec. 31, 2013
Capital Stock [Abstract]
Common Shares, Authorized			Unlimited
Common Shares, Voting Rights			The holders of the common shares are entitled to one vote for each common share held at all meetings of the shareholders.
Common shares issued pursuant to exercise of stock options			518,018	1,761,675	1,149,587
Common shares issued pursuant to vesting of RSUs, net of tax			54,159	25,551	109,264
Capital Stock (Textuals) [Abstract]
Cash proceeds from the issuance of common shares pursuant to exercise of stock options			$ 13,113	$ 35,609	$ 10,834
Share-based compensation costs (recovery) recorded			$ 30,500	$ 21,900	$ 15,100
Antidilutive shares issuable upon exercise of stock options and RSUs			2,814,907	1,249,343
Common shares issued from treasury			347,814	1,659,643	1,149,587
Common shares purchased from the open market			630,720	269,501
Weighted average price of common shares purchased in open market by trustee in connection with RSUs			$ 31.52	$ 37.11
Accumulated earnings relcass due to adoption of ASU 2016-09			$ 4,400
Deferred tax asset reclass due to adoption of ASU 2016-09			900
Other equity reclass due to adoption of ASU 2016-09			5,300
Stock-based compensation expense recovery due to adoption of ASU 2016-09			$ 2,700
Number of treasury shares held in trust			64,565	0
Treasury stock purchased for future settlement of share based awards	$ 1,939	$ 0	$ 1,939	$ 0		$ 1,939
Details of the share repurchase program				On June 16, 2014, the Company’s board of directors approved a new $150.0 million share repurchase program for shares of the Company’s common stock, which program was amended on April 20, 2016 to increase the aggregate purchase allowance to $200.0 million. Purchases under the program commenced during the third quarter of 2014, and the program expires on June 30, 2017. The repurchases may be made either in the open market or through private transactions, subject to market conditions, applicable legal requirements and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.
Stock Repurchase Program, Authorized Amount							$ 200,000		$ 150,000
Stock Repurchase Program, Expiration Date			Jun. 30, 2017
Stock Repurchased and Retired During Period, Shares			3,849,222	1,000,000		4,961,256
Stock Acquired, Average Cost per Share			$ 30.25	$ 34.25		$ 30.99
Payments for Repurchase of Common Stock			$ 116,518	$ 34,276	$ 3,063
Remaining available amount under share repurchase plan	$ 46,300		$ 46,300			$ 46,300
Employee Stock Option [Member]
Common shares issued pursuant to exercise of stock options			(518,018)	(1,761,675)	(1,149,587)
Capital Stock (Textuals) [Abstract]
Cash proceeds from the issuance of common shares pursuant to exercise of stock options			$ 11,431	$ 35,609	$ 10,834
Share-based compensation costs (recovery) recorded			12,795	$ 10,700	$ 8,900
Income tax benefit from stock based compensation			$ 3,800
Reserved common shares for future issuance	12,012,572	7,023,258	12,012,572	7,023,258		12,012,572
Options outstanding	5,190,542	4,805,244	5,190,542	4,805,244	5,925,660	5,190,542				6,263,121
Options outstanding, weighted average exercise price	$ 28.35	$ 27.03	$ 28.35	$ 27.03	$ 24.24	$ 28.35				$ 21.11
Employee Stock-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	$ 5,900	$ 12,600	$ 5,900	$ 12,600	$ 14,800	$ 5,900
Employee Stock-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition			2 years 3 months 18 days	1 year 8 months 12 days	2 years 3 months 18 days
Granted			984,452	873,929	872,155
Weighted average fair value of options granted			$ 8.16	$ 8.07	$ 8.25
Options exercisable	4,001,078	2,800,723	4,001,078	2,800,723	3,368,558	4,001,078
Options exercisable, weighted average exercise price	$ 27.79	$ 25.83	$ 27.79	$ 25.83	$ 22.69	$ 27.79
Options cancelled			14,233	0	23,787
Options fully vested and unvested	5,190,542		5,190,542			5,190,542
Options fully vested and unvested, weighted average exercise price	$ 28.35		$ 28.35			$ 28.35
Options fully vested and unvested, aggregate intrinsic value	$ 17,600		$ 17,600			$ 17,600
Options fully vested and unvested, weighted average remaining contractual life			4 years 3 months 18 days
Options exercisable intrinsic value	$ 15,400		$ 15,400			$ 15,400
Weighted average remaining contractual life of exercisable option			4 years 2 months 12 days
Intrinsic value of options exercised			$ 5,400	$ 29,800	$ 21,800
Forfeited			(66,903)	(232,670)	(36,242)
Weighted average exercise price of options forfeited			$ 29.28	$ 24.60	$ 24.63
Options common shares were vested and exercisable	4,001,078		4,001,078			4,001,078
Antidilutive shares issuable upon exercise of stock options and RSUs			2,437,859	935,698
Common shares purchased from the open market			170,204	102,032	0
Number of treasury shares held in trust			66,093
Treasury stock purchased for future settlement of share based awards	$ 2,000		$ 2,000			$ 2,000
Options Non Employees [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs charged for the period Text			less than
Share-based compensation costs (recovery) recorded			$ 100	$ 100	$ 100
Options outstanding	17,000	38,750	17,000	38,750	31,500	17,000
Options outstanding, weighted average exercise price	$ 29.64	$ 26.79	$ 29.64	$ 26.79	$ 21.75	$ 29.64
Granted			0	0	10,000
Options granted to purchase the company's common stock, average exercise price					$ 26.47
Weighted average fair value of options granted					$ 4.84
Options exercisable	15,200	21,525	15,200	21,525	16,100	15,200
Options exercisable, weighted average exercise price	$ 30.10	$ 26.34	$ 30.10	$ 26.34	$ 18.14	$ 30.10
Amount of stock options or rights included in accrued liabilities			less than	less than
Amount of stock options or rights included in accrued liabilities	$ 100	$ 100	$ 100	$ 100		$ 100
Options fully vested and unvested, aggregate intrinsic value	100	200	100	200	$ 200	100
Options fully vested and unvested, weighted average remaining contractual life					7 years
Employee Stock Option China Incentive Plan [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs charged for the period		$ 2,100	1,000
Share-based compensation costs (recovery) recorded				$ (600)	$ 300
Options outstanding								186,446
Options outstanding, weighted average exercise price								$ 23.70
Employee Stock-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition				5 years
Common share options subject to vesting based on performance commitment		186,446		186,446
Fair Value of Options Outstanding				$ 1,900
Options cancelled				186,446
Options fully vested and unvested, weighted average remaining contractual life				7 years
Total fair value of awards granted				$ 3,900
CSSBP [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs charged for the period		$ 1,400	400
Amount of stock options or rights included in accrued liabilities	300	400	300	400		$ 300
Options vested and settled during period	$ 500	$ 1,000
Total fair value of awards granted				$ 2,100
China RSU [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs charged for the period			$ 500
Restricted Stock Units (RSUs) [Member]
Capital Stock (Textuals) [Abstract]
Number RSUs outstanding	1,124,180	973,637	1,124,180	973,637	595,834	1,124,180				264,140
Employee Stock-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition			2 years 4 months 24 days	3 years	2 years 10 months 24 days
Restricted Stock Unit Contingent Right			1
Restricted Stock Unit Economic Equivalent			1
Share-based compensation costs, not yet recognized	$ 29,000	$ 24,400	$ 29,000	$ 24,400	$ 11,000	$ 29,000
Tax benefits realized			$ 4,600	$ 2,000	$ 400
Stock appreciation rights granted			664,278	605,349	484,088
Number of awards other than options outstanding	1,124,180	973,637	1,124,180	973,637	595,834	1,124,180				264,140
Fair value of RSUs outstanding	$ 33.01	$ 32.27	$ 33.01	$ 32.27	$ 27.13	$ 33.01				$ 26.14
Antidilutive shares issuable upon exercise of stock options and RSUs			377,048	313,645
Common shares purchased from the open market			394,423	167,469	27,816
RSUs that may vest on shorter schedule			300,000
RSUs issued from carve-out			39,726
Common Shares issued in connection with vested RSUs			466,918	207,371	148,001
Shares withheld for tax withholding			18,336	14,351	10,921
Restricted Stock Units (RSUs) [Member] \| Non Employee [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs charged for the period Text				less than	less than
Share-based compensation costs charged for the period			$ 0	$ 100	$ 100
Restricted Stock Units (RSUs) [Member] \| Employee [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs charged for the period			$ 15,800	$ 8,200	$ 5,800
Maximum [Member] \| Employee Stock Option [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			5 years
Stock based awards expiration period or remaining contractual life			Jun. 07, 2026
Maximum [Member] \| Restricted Stock Units (RSUs) [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			4 years
Minimum [Member] \| Employee Stock Option [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			0 years
Stock based awards expiration period or remaining contractual life			Jan. 01, 2017
Minimum [Member] \| Restricted Stock Units (RSUs) [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			0 years

Segmented Information (Details 1) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Segmented Information (Details 1) - USD ($) $ in Thousands	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Geographical Information - Revenue
Revenue	$ 106,913	$ 86,550	$ 91,743	$ 92,128	$ 119,333	$ 85,101	$ 107,160	$ 62,211	$ 377,334	$ 373,805	$ 290,541
Geographical Information - Property, plant and equipment
Property, plant and equipment	245,415				218,267				245,415	218,267
United States [Member]
Geographical Information - Revenue
Revenue									129,844	136,017	107,830
Geographical Information - Property, plant and equipment
Property, plant and equipment	104,083				105,641				104,083	105,641
Canada [Member]
Geographical Information - Revenue
Revenue									12,822	11,665	10,309
Geographical Information - Property, plant and equipment
Property, plant and equipment	39,467				40,943				39,467	40,943
Greater China [Member]
Geographical Information - Revenue
Revenue									118,532	110,591	78,218
Geographical Information - Property, plant and equipment
Property, plant and equipment	69,751				51,990				69,751	51,990
Western Europe [Member]
Geographical Information - Revenue
Revenue									36,286	39,569	30,245
Geographical Information - Property, plant and equipment
Property, plant and equipment	19,308				8,359				19,308	8,359
Asia (excluding Greater China) [Member]
Geographical Information - Revenue
Revenue									35,283	38,143	26,276
Geographical Information - Property, plant and equipment
Property, plant and equipment	8,460				10,369				8,460	10,369
Russia & the CIS [Member]
Geographical Information - Revenue
Revenue									14,908	12,412	15,700
Latin America [Member]
Geographical Information - Revenue
Revenue									12,191	10,179	12,672
Rest of the World [Member]
Geographical Information - Revenue
Revenue									17,468	15,229	$ 9,291
Geographical Information - Property, plant and equipment
Property, plant and equipment	$ 4,346				$ 965				$ 4,346	$ 965

Segmented Information (Details Textual)
$ in Thousands

3 Months Ended

12 Months Ended

Mar. 31, 2017

Segments

Dec. 31, 2016

USD ($)

Segments

Dec. 31, 2015

USD ($)

Dec. 31, 2014

USD ($)

Segmented Information [Abstract]

Number of Reportable Segments | Segments

Number of Primary Reporting Groups | Segments

Description of products and services from which each reportable segment derives its revenues

Description of the basis of accounting for transactions between reportable segments

The accounting policies of the segments as those described in note 2. Transactions between the film production and IMAX DMR segment and the film post-production segment are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below. Transactions between the other segments are not significant.

Percentage of total revenues represented by two largest customers

13.5%

16.0%

14.5%

Segment Reporting Information [Line Items]

Inventory (Recovery) Write Down

^[1]

$ 458

$ 572

$ 359

Recorded in costs and expenses applicable to revenues - equipment & product sales

227

537

209

Recorded in costs and expenses applicable to revenues - services

$ 231

150

Disclosure on Geographic Areas, Description of Revenue from External Customers

No single country in the Rest of the World, Western Europe, Latin America and Asia (excluding Greater China) classifications compromise more than 10% of the total revenue.

IMAX Systems [Member]

Segment Reporting Information [Line Items]

Advertising, marketing and commission costs

$ 3,000

3,000

2,700

Recorded in costs and expenses applicable to revenues - equipment & product sales

227

537

209

Theater System Maintenance [Member]

Segment Reporting Information [Line Items]

Recorded in costs and expenses applicable to revenues - services

231

150

Joint Revenue Sharing Arrangements [Member]

Segment Reporting Information [Line Items]

Advertising, marketing and commission costs

4,100

4,300

3,200

Production and IMAX DMR [Member]

Segment Reporting Information [Line Items]

Marketing Expense

17,500

13,300

7,100

Film Distribution [Member]

Segment Reporting Information [Line Items]

Marketing Expense

$ 2,200

$ (100)

$ 600

[1]

Employees Pension and Postretirement Benefits (Details 1) $ in Thousands	Dec. 31, 2016 USD ($)
SERP Benefits [Member]
Schedule of expected benefit payments
2017	$ 0
2018	0
2019	0
2020	21,115
2021	0
Thereafter	0
Total expected future benefit payment	21,115
Postretirement Benefits Executives [Member]
Schedule of expected benefit payments
2017	21
2018	24
2019	26
2020	33
2021	36
Thereafter	507
Total expected future benefit payment	647
Postretirement Benefits Canadian Employees [Member]
Schedule of expected benefit payments
2017	92
2018	98
2019	104
2020	107
2021	109
Thereafter	1,235
Total expected future benefit payment	$ 1,745

Employees Pension and Postretirement Benefits (Details Textual) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Jul. 31, 2000
SERP Benefits [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Accumulated benefit obligation for the SERP		$ 19,600	$ 19,500
Interest cost	$ 400	261	253	$ 264
Postretirement benefits obligation		$ 19,580	19,478	19,405
Defined benefit pension plan		The Company has an unfunded U.S. defined benefit pension plan, the SERP, covering Richard L. Gelfond, Chief Executive Officer (“CEO”) of the Company and Bradley J. Wechsler, Chairman of the Company’s Board of Directors. The SERP provides for a lifetime retirement benefit from age 55 determined as 75% of the member’s best average 60 consecutive months of earnings over the member’s employment history. The benefits were 50% vested as at July 2000, the SERP initiation date. The vesting percentage increases on a straight-line basis from inception until age 55. As at December 31, 2014, the benefits of Mr. Gelfond were 100% vested. Upon a termination for cause, prior to a change of control, the executive shall forfeit any and all benefits to which such executive may have been entitled, whether or not vested.
Percentage of benefits vested since plan inception date					50.00%
Termination Benefit Vested		100.00%
Defined Contribution Plan [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Defined contribution pension plans for employees		The Company also maintains defined contribution pension plans for its employees, including its executive officers. The Company makes contributions to these plans on behalf of employees in an amount up to 5% of their base salary subject to certain prescribed maximums.
Maximum percentage of base salary contributed to Pension Plan by Company		5.00%
Canadian Plan [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Companies contribution and expenses		$ 1,155	1,099	1,391
U.S. Internal Revenue Code [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Companies contribution and expenses		$ 592	422	358
Deferred Compensation Plan [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Deferred compensation plan description		In September 2016, the Company entered into a new employment agreement with Greg Foster, CEO of IMAX Entertainment, which provides for an employment term from July 2, 2016 through July 2, 2019. Under the agreement, the Company agreed to create a deferred compensation plan (the “Retirement Plan”) covering Mr. Foster, and to make a total contribution of $3.2 million over the three-year employment term. The Retirement Plan is subject to a vesting schedule based on continued employment with the Company, such that 25% will vest July 2019; 50% will vest July 2022; 75% will vest July 2025; and will be 100% vested in July 2027.
Requisite employment term		2 years 6 months 2 days
Total contibution obligation over employment term		$ 3,200
Unfunded benefit obligation recorded		500
Postretirement Benefits Executives [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Interest cost		31	30	17
Postretirement benefits obligation		647	763	830
Postretirement Benefits Canadian Employees [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Amortization of prior year service costs	0
Interest cost	$ 100	68	71	93
Postretirement benefits obligation		$ 1,745	$ 1,778	$ 2,139

Non-Controlling Interests (Details Textual) $ in Thousands			12 Months Ended
Non-Controlling Interests (Details Textual) $ in Thousands	Feb. 10, 2015 USD ($)	Apr. 08, 2014 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($) Film
Redeemable Noncontrolling Interest [Line Items]
Aggregate subscription price			$ 0	$ 178,226	$ 0
Dividends paid to non-controlling interests			0	9,511	0
Investment in film assets			$ (22,308)	(15,119)	$ (19,233)
IMAX China Non-Controlling Interest [Member]
Redeemable Noncontrolling Interest [Line Items]
Non-controlling interest description		On April 8, 2014, the Company announced the sale and issuance of 20.0% of the shares in IMAX China Holding, Inc. ("IMAX China") to entities owned and controlled by CMC Capital Partners ("CMC"), an investment fund focused on media and entertainment, and FountainVest Partners ("FountainVest"), a China-focused private equity firm.
Minority Interest Ownership Percentage By Company			68.20%
Minority Interest Ownership Percentage By Noncontrolling Owners		20.00%
Dividends paid to non-controlling interests				$ 9,500
IMAX China Non-Controlling Interest [Member] \| Class C Shares [Member]
Redeemable Noncontrolling Interest [Line Items]
Aggregate subscription price	$ 40,000	$ 40,000
Other Noncontrolling Interest [Member]
Redeemable Noncontrolling Interest [Line Items]
Non-controlling interest description					In 2014, the Company announced the creation of the Film Fund to co-finance a portfolio of 10 original large-format films. The Film Fund, which is intended to be capitalized with up to $50.0 million, will finance an ongoing supply of original films that the Company believes will be more exciting and compelling than traditional documentaries. The initial investment in the Film Fund was committed to by a third party in the amount of $25.0 million, with the possibility of contributing additional funds. The Company agreed to contribute $9.0 million to the Film Fund over five years starting in 2014 and sees the Film Fund as a self-perpetuating vehicle designed to generate a continuous, steady flow of high-quality documentary content. As at December 31, 2016, the Film Fund invested $13.4 million toward the development of original films. The related production, financing and distribution agreement includes put and call rights relating to change of control of the rights, title and interest in the co-financed pictures.
Aggregate subscription price			$ 2,479
Number Of Expected Original Films \| Film					10
Film Fund Expected Capital Contribution					$ 50,000
Investment in film assets			$ 13,400
Other Noncontrolling Interest [Member] \| Third Party [Member]
Redeemable Noncontrolling Interest [Line Items]
Film Fund commitment amount					25,000
Other Noncontrolling Interest [Member] \| IMAX [Member]
Redeemable Noncontrolling Interest [Line Items]
Film Fund commitment amount					$ 9,000
Contribution Period					5

Financial Instruments (Details 2) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	$ 8,756	$ 11,617
Financed Sales Receivables	114,535	106,854
Total	123,291	118,471
In Good Standing [Member]
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	7,741	10,252
Financed Sales Receivables	111,568	105,352
Total	119,309	115,604
Credit Watch [Member]
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	0	0
Financed Sales Receivables	1,514	0
Total	1,514	0
Pre-Approved Transactions [Member]
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	0	0
Financed Sales Receivables	842	757
Total	842	757
Transactions Suspended [Member]
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	1,015	1,365
Financed Sales Receivables	611	745
Total	$ 1,626	$ 2,110

Financial Instruments (Details 3) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investment In Financing Receivables On Nonaccrual Status
Net investment in leases recorded investment	$ 1,015	$ 1,365
Net investment in leases related allowance	(672)	(672)
Net financed sales receivables recorded investment	611	1,502
Net financed sales receivables related allowance	(494)	(568)
Total recorded investment	1,626	2,867
Total related allowance	$ (1,166)	$ (1,240)

Financial Instruments (Details 4) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	$ 7,453	$ 4,561
Related Unbilled Recorded Investment	115,838	113,910
Total Recorded Investment	123,291	118,471
Related Allowances	(1,166)	(1,240)
Recorded Investment Past Due and Accruing	122,125	117,231
Financing Receivables 1 To 29 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	2,421	1,748
Financing Receivables 30 To 89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	1,883	1,190
Financing Receivables Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	3,149	1,623
Net Financed Sales Receivables [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	6,485	3,098
Related Unbilled Recorded Investment	108,050	103,756
Total Recorded Investment	114,535	106,854
Related Allowances	(494)	(568)	$ (494)
Recorded Investment Past Due and Accruing	114,041	106,286
Net Financed Sales Receivables [Member] \| Financing Receivables 1 To 29 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	2,393	908
Net Financed Sales Receivables [Member] \| Financing Receivables 30 To 89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	1,724	1,013
Net Financed Sales Receivables [Member] \| Financing Receivables Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	2,368	1,177
Finance Leases Financing Receivable [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	968	1,463
Related Unbilled Recorded Investment	7,788	10,154
Total Recorded Investment	8,756	11,617
Related Allowances	(672)	(672)	$ (972)
Recorded Investment Past Due and Accruing	8,084	10,945
Finance Leases Financing Receivable [Member] \| Financing Receivables 1 To 29 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	28	840
Finance Leases Financing Receivable [Member] \| Financing Receivables 30 To 89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	159	177
Finance Leases Financing Receivable [Member] \| Financing Receivables Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	781	446
Financing Receivables Continue To Accrue Finance Income [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	3,070	1,485
Related Unbilled Recorded Investment	21,793	11,871
Related Allowances	0	0
Recorded Investment Past Due and Accruing	24,863	13,356
Financing Receivables Continue To Accrue Finance Income [Member] \| Financing Receivables 1 To 29 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	284	170
Financing Receivables Continue To Accrue Finance Income [Member] \| Financing Receivables 30 To 89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	688	271
Financing Receivables Continue To Accrue Finance Income [Member] \| Financing Receivables Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	2,098	1,044
Financing Receivables Continue To Accrue Finance Income [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	2,772	1,192
Related Unbilled Recorded Investment	20,147	10,795
Related Allowances	0	0
Recorded Investment Past Due and Accruing	22,919	11,987
Financing Receivables Continue To Accrue Finance Income [Member] \| Net Financed Sales Receivables [Member] \| Financing Receivables 1 To 29 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	284	129
Financing Receivables Continue To Accrue Finance Income [Member] \| Net Financed Sales Receivables [Member] \| Financing Receivables 30 To 89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	634	224
Financing Receivables Continue To Accrue Finance Income [Member] \| Net Financed Sales Receivables [Member] \| Financing Receivables Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	1,854	839
Financing Receivables Continue To Accrue Finance Income [Member] \| Finance Leases Financing Receivable [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	298	293
Related Unbilled Recorded Investment	1,646	1,076
Related Allowances	0	0
Recorded Investment Past Due and Accruing	1,944	1,369
Financing Receivables Continue To Accrue Finance Income [Member] \| Finance Leases Financing Receivable [Member] \| Financing Receivables 1 To 29 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	0	41
Financing Receivables Continue To Accrue Finance Income [Member] \| Finance Leases Financing Receivable [Member] \| Financing Receivables 30 To 89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	54	47
Financing Receivables Continue To Accrue Finance Income [Member] \| Finance Leases Financing Receivable [Member] \| Financing Receivables Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Billed Financing Receivables	$ 244	$ 205

Financial Instruments (Details 5) - USD ($) $ in Thousands	12 Months Ended
Financial Instruments (Details 5) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Financing Receivable, Impaired [Line Items]
Recorded Investment	$ 525	$ 748
Unpaid Principal	75	298
Related Allowance	(494)	(568)
Average Recorded Investment	637	748
Interest Income Recognized	0	0
Net Financed Sales Receivables [Member]
Financing Receivable, Impaired [Line Items]
Impaired Financing Receivable with Related Allowance, Recorded Investment	525	748
Impaired Financing Receivable With Related Allowance, Unpaid Principal	75	298
Impaired Financing Receivable With Related Allowance, Average Recorded Investment	637	748
Impaired Financing Receivable With Related Allowance, Interest Income Recognized	0	0
Impaired Financing Receivable With No Related Allowance, Recorded Investment	0	0
Impaired Financing Receivable With No Related Allowance, Unpaid Principal	0	0
Impaired Financing Receivable With No Related Allowance, Average Recorded Investment	0	0
Impaired Financing Receivable With No Related Allowance, Interest Income Recognized	0	0
Related Allowance	$ (494)	$ (568)

Financial Instruments (Details 6) - USD ($) $ in Thousands	12 Months Ended
Financial Instruments (Details 6) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Allowance for credit losses:
Beginning balance	$ 1,240
Provision	954	$ 752	$ 918
Ending balance	1,166	1,240
Net Investment in Leases [Member]
Allowance for credit losses:
Beginning balance	672	972
Charge-offs	0	(300)
Recoveries	0	0
Provision	0	0
Ending balance	672	672	972
Ending balance: individually evaluated for impairment	672	672
Financing receivables:
Ending balance: individually evaluated for impairment	8,756	11,617
Net Financed Sales Receivables [Member]
Allowance for credit losses:
Beginning balance	568	494
Charge-offs	0	0
Recoveries	(74)	0
Provision	0	74
Ending balance	494	568	$ 494
Ending balance: individually evaluated for impairment	494	568
Financing receivables:
Ending balance: individually evaluated for impairment	$ 114,535	$ 106,854

Financial Instruments (Details 7) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Foreign exchange contracts - Forwards [Member] \| Designated as Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Foreign exchange contracts - Forwards	$ 37,825	$ 30,710

Financial Instruments (Details 8) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Fair value of foreign exchange contracts
Derivative Asset, Fair Value	$ 480	$ 0
Foreign exchange contracts - designated forwards	(296)	(4,423)
Other Assets [Member] \| Foreign exchange contracts - Forwards [Member] \| Designated as Hedging Instrument [Member]
Fair value of foreign exchange contracts
Derivative Asset, Fair Value	480	0
Accrued and other liabilities [Member] \| Foreign exchange contracts - Forwards [Member] \| Designated as Hedging Instrument [Member]
Fair value of foreign exchange contracts
Derivative Liability, Fair Value	$ (776)	$ (4,423)

Financial Instruments (Details 9) - USD ($) $ in Thousands	12 Months Ended
Financial Instruments (Details 9) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivatives in Foreign Currency Hedging relationships
Derivative Loss Recognized in OCI (Effective Portion)	$ 1,049	$ (5,881)	$ (2,524)
Location of Derivative Loss Reclassified from AOCI into Income (Effective Portion)	(3,078)	(3,217)	(1,186)
Foreign Exchange Forward [Member] \| Fair Value Hedging [Member]
Derivatives in Foreign Currency Hedging relationships
Derivative Loss Recognized in OCI (Effective Portion)	1,049	(5,881)	(2,524)
Foreign Exchange Forward [Member] \| Fair Value Hedging [Member] \| Selling, General and Administrative Expenses [Member]
Derivatives in Foreign Currency Hedging relationships
Location of Derivative Loss Reclassified from AOCI into Income (Effective Portion)	$ (3,078)	$ (3,217)	$ (1,186)

Financial Instruments (Details Textual) $ in Thousands	12 Months Ended
Financial Instruments (Details Textual) $ in Thousands	Dec. 31, 2016 USD ($) Countries	Dec. 31, 2015 USD ($)
Financial Instruments Additional (Textuals) [Abstract]
Carrying value of equity investments	$ 0	$ 1,005
Financial Instruments (Textuals) [Abstract]
Number of countries that generate box office \| Countries	74
Impairment of available-for-sale investment	$ 200	400
Total carrying value of investments in new business ventures	1,000	2,200
Gross revenues of investment new business ventures	600	0
Cost of revenue of investment new business ventures	6,800	9,300
Loss on equity-accounted investments	(6,200)	(9,100)
Convertible loan receivable	$ 1,000
Convertible loan effective interest rate	5.00%
Receivable with Imputed Interest, Due Date	Sep. 26, 2019
Estimated gain to be reclassified to earnings within the next twelve months	$ 100
Schedule of Available For Sale Securities [Line Items]
Investment classified as available-for-sale - cost	1,500
Investment classified as available-for-sale - fair value	0	0
Equity method investment, difference between carrying amount and underlying equity	500
New Equity Accounted Investment [Member]
Financial Instruments Additional (Textuals) [Abstract]
Carrying value of equity investments	2,500
Fixed Income Securities [Member]
Schedule of Available For Sale Securities [Line Items]
Investment classified as available-for-sale - cost	$ 1,000	$ 1,000

Selected Quarterly Financial Information (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Selected Quarterly Financial Information (Unaudited)
Revenues	$ 106,913	$ 86,550	$ 91,743	$ 92,128	$ 119,333	$ 85,101	$ 107,160	$ 62,211	$ 377,334	$ 373,805	$ 290,541
Costs and expenses applicable to revenues	51,587	41,651	41,466	39,952	47,450	42,712	38,125	26,230	174,656	154,517	117,153
Gross margin	55,326	44,899	50,277	52,176	71,883	42,389	69,035	35,981	202,678	219,288	173,388
Net income before cumulative effect from the adoption of ASU 2016-09	12,076	4,384	10,683	12,177
Net income	12,076	4,384	8,908	13,952	26,245	10,514	26,380	1,485	39,320	64,624	42,169
Net income attributable to common shareholders before cumulative effect from the adoption of ASU 2016-09	8,945	2,525	7,791	9,527
Net income attributable to common shareholders	$ 8,945	$ 2,525	$ 6,016	$ 11,302	$ 22,493	$ 8,610	$ 24,350	$ 391	$ 28,788	$ 55,844	$ 39,736
Net income per share attributable to common shareholders:
Net income per share before the adoption of ASU 2016-09 - basic	$ 0.14	$ 0.04	$ 0.11	$ 0.14
Net income per share before the adoption of ASU 2016-09 - diluted	0.13	0.04	0.11	0.14
Net income per share - basic	0.14	0.04	0.09	0.16	$ 0.33	$ 0.12	$ 0.34	$ 0	$ 0.43	$ 0.79	$ 0.58
Net income per share - diluted	$ 0.13	$ 0.04	$ 0.09	$ 0.16	$ 0.32	$ 0.12	$ 0.34	$ 0	$ 0.42	$ 0.78	$ 0.56